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ABSTRACT 
 
Trans-cinnamaldehyde incorporated chitosan and alginate nanoparticles were 
synthesized using the ionic gelation and polyelectrolyte complexation technique. 
Alginate, chitosan, calcium chloride, and trans-cinnamaldehyde at predetermined 
concentrations were complexed electrostatically to optimize size and loading efficiency 
(i.e. preliminary study). A final extrapolated methodology using optimized processing 
parameters (e.g. stirring, homogenization, and equilibration time; droplet size) was 
developed and utilized for controlled release, morphological, thermal, antioxidant, and 
antimicrobial studies. The best working alginate to chitosan mass ratio was determined 
to be 1.5:1 at a pH dispersion of 4.7.  Particle size (166.26 nm) and encapsulation 
efficiency (73.24%) were further optimized at this mass ratio using an alginate:calcium 
chloride mass ratio of 4.8:1, alginate:trans-cinnamaldhyde mass ratio of 37.5:1, 18 
gauge syringe needle, stirring times of 90 minutes, 15 minutes of homogenization, and 
equilibration time of 24 hours. Optimized nanoparticles showed increased shelf life (6 
weeks) and translucency in solution.  Release tests showed trans-cinnamaldehyde 
release from loaded nanoparticles best followed the bioexponential model; a burst 
release function (32.5% cumulative release) followed by a sustained release function 
(62.31% final cumulative release). Differential scanning calorimetry confirmed inclusion 
of oil into nanoparticles by indirectly comparing thermal stability of free trans-
cinnamaldehyde with loaded trans-cinnamaldehyde in the inclusion complex. 
Nanoparticles resembled a spherical shell and core type arrangement (i.e. spherical, 
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distinct, and regular) and were in the size range of 10-100 nm. The final radical 
scavenging effect of loaded particles in apple juice was 62% and trans-cinnamaldehyde 
was just as available to react in free form as it was in inclusion complexes. Minimum 
inhibitory concentration values (MIC) for trans-cinnamaldehyde loaded nanoparticles 
was 7,031.25 μg/ml for Escherichia coli O157:H7 and 14,062.5 μg/ml for Listeria 
monocytogenes. The concentration of trans-cinnamaldehyde in the inclusion complexes 
corresponded to a MIC of approximately 730 and 1,4062 μg/ml of free trans-
cinnamaldehyde for E. coli O157:H7 and L. monocytogenes, respectively. Results 
indicated that L. monocytogenes was more tolerant to the inhibition by trans-
cinnamaldehyde inclusion complex in comparison to E. coli O157:H7.  Overall, results 
suggest that the application of antimicrobial polymeric nanoparticles optimized for 
essential oil loading in food systems may be effective at inhibiting specific pathogens.  
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NOMENCLATURE 
 
AG   Aginate 
AntiMO  Antimicrobial 
ATCC   American Type Culture Collection  
CAG   Calcium-alginate 
C-A   Chitosan-alginate  
CFU Colony forming unit 
CMC Critical micelle concentration 
CS Chitosan  
DLS Dynamic light scattering 
DPPH 1,1-Diphenyl-2-picrylhydrazyl  
DSC Differential scanning calorimetry 
EE Encapsulation efficiency 
FW  Formula weight 
G Guluronic acid unit (G block)  
GRAS Generally Recognized As Safe 
h Hour 
HCl Hydrochloric acid 
ID Internal diameter 
IG Ionotropic gelation  
IG-PEC Ionic gelation and polyelectrolyte complexation  
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In vitro  Taking place outside the living body 
In vivo Taking place in the living body 
L Liter 
LCA-NP Trans-cinnamaldehyde loaded chitosan-alginate nanoparticle 
kDa Kilodalton 
kV Kilovolt 
M Mannuronic units (M block) or Molar 
mA Milliamp 
MBC Minimum bactericidal concentration 
MIC Minimum inhibitory concentration 
min  Minute 
ml Milliliter 
mTorr Millitorr 
N Normal 
NaOH Sodium hydroxide 
nm Nano-meter 
NNI National Nanotechnology Initiative  
NP Nanoparticle 
PBS Phosphate buffered saline 
PEC Polyelectrolyte complexation  
psi Pounds per square inch 
PW Peptone water 
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RPM  Rotations per minute 
s Second 
SEM Scanning electron microscopy 
TC Trans-cinnamaldehyde  
TEM Transmission electron microscopy 
TSA Tryptic soy agar 
TSA-YE Tryptic soy agar with yeast extract 
TSB Tryptic soy broth 
TPB Tryptose phosphate broth 
ULCA-NP Unloaded chitosan-alginate nanoparticle 
UV-Vis Ultraviolet visible 
w/v Weight/volume 
°C Degree Celsius 
°F Degree Fahrenheit 
μg Microgram 
μl Microliter 
μm Micrometer 
μM Micromolar 
2XTSB Double strength TSB 
2XTPB Double strength TPB
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1. INTRODUCTION 
 
1.1 Background 
Nanotechnology has received significant interest in the agricultural, medical, 
pharmaceutical, and biotechnology sectors in the past two decades. Nanotechnology is 
best described as the science and technology that has enabled the study of phenomena at 
the nanometer scale. This includes the design, manipulation, production, 
characterization, and application of nano-level structures and devices by controlling 
particle size in the range of 1 to 100 nm (Tiwari and Takhistov 2012).  
  Analytical tools have become available allowing the field of nanotechnology to 
develop into a multi-billion dollar industry. Recent technological advances in 
nanomedicine and nanomaterials in parallel with the food industries ambition to discover 
new and alternative solutions has created a new sector in the food industry where 
nanotechnology is emerging as a new solution to quality and safety assurance of foods.  
Most advances in the field of nano-sized carriers are a result of drug development 
strategies as well as the desire of pharmaceutical companies to create and patent new 
drugs (Thies 1996; Pray and Yaktin 2009). Food scientists have adopted the medical 
concept of targeted drug delivery and are extrapolating these intervention strategies for 
use in food applications.  
Nanotechnology related fields have impacted billions of dollars across the global 
economy in the past decade, including the United States federal budget calling for $1.8  
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billion to be invested into the National Nanotechnology Initiative (NNI 2012). The 
National Nanotechnology Initiative, or NNI, is a central point of communication, 
cooperation, and collaboration for all federal agencies that participate in nanotechnology 
research and allows the expertise in this field to be consolidated.  
Nanotechnology will provide new ways of controlling and structuring foods with 
greater functionality and value. Food technology experts have identified the following 
major applications of nanotechnology in the food industry: improved delivery of 
micronutrients and bioactive food components, controlled release of bioactive 
compounds, product traceability, food safety intervention using nanosensors, detection 
of zoonotic diseases, and development of new packaging materials. Nanomaterials being 
researched due to their potential food applications include microemulsions and 
nanoemulsions, solid lipid nanoparticles, nanofibers, liposomes, micelles, and polymeric 
nanoparticles with entrapment capabilities. These nanosystems are all being utilized to 
add functionality, nutrient delivery, and increase overall value of food (Anal and Stevens 
2005; Mohanraj and Chen 2006; Pray and Yaktin 2009). 
Nanoparticles are a form of nanotechnology which can be described as 
particulate dispersions ranging in size from 10 to 1000 nm and can consist of polymeric 
materials in which an active substance is dissolved, entrapped, encapsulated, absorbed, 
or chemically bound to a polymer matrix (Caban and others 2014). The small size of 
nanoparticles increasingly allows for the ability to cross biological barriers as well as 
increased cellular uptake and transport (Jong and Borm 2008). Nanoparticles are being 
developed to advance current food safety interventions and improve food quality. These 
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systems, when added to a food, can have antimicrobial and antioxidant effects and also 
improve quality parameters in raw, fresh, or ready to eat foods.  Encapsulation can be 
described as the process of enclosing particles of solids, droplets of liquids, or gasses in 
an inert shell which in turn isolates and protects them from the external environment 
(Ghosh 2006). Encapsulation offers the following potential benefits to an active 
encapsulant: protection from environmental stressors and deteriorative reactions, high 
processing ability, odor masking, enzyme and microorganism immobilization, specific 
controlled release, and diffusion mechanisms. Encapsulation systems require a drug or 
active compound to be released at a rate required for a specified treatment to be 
effective. Many current nanoencapsulation systems apply biodegradable, biocompatible, 
and natural polymers (Anal and Stevens 2005). Nanotechnology in combination with 
encapsulation provides a viable solution to create controlled release systems with desired 
properties. Depending upon the method of preparation, nanospheres or nanocapsules can 
be obtained.  These polymeric nanoparticles in the scale of 50 to 300 nm have begun to 
attract much interest in food applications technology and will be emphasized in this 
research.  
A variety of materials have been used to entrap hydrophilic and hydrophobic 
substances including and not limited to polysaccharides, dendrimers, synthetic and 
natural polymers, lipids, proteins, and peptides (Ghosh 2006).  Naturally occurring 
polysaccharides such as chitosan and sodium alginate are considered safe for human 
consumption and have been utilized by pharmaceutical companies for entrapment 
studies. The distinct advantages of using these polysaccharide matrices are the ability to 
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control the release of the encapsulated material, prevent encapsulant degradation, and 
size control (Thwala 2012). 
1.2 Problem Statement 
The food industry is the largest manufacturing sector in the world; with an annual 
turnover approximating US $4 trillion (FoodDrinkEurope 2013). However, most of what 
has been done with nano-sized food materials has occurred in a largely uncontrolled 
way, and there is still a lot to be learned about the natural nano-structure of foods. 
Nanotechnology holds tremendous promise to provide benefits not just within food 
products but also around food products. Nanotechnology can be used to structure new 
food ingredients and also build new types of packaging, quality detection tools, and 
other types of measurement and delivery systems (Pray and Yaktin 2009). Food safety 
and quality are of extreme importance in the food industry. Drug delivery systems offer 
an innovative approach for the food industry to keep foods safe and assure quality. 
Although improvements in nanoencapsulation have been significant, minor drawbacks 
include: low bioavailability, inability to target harmful agents, poor aqueous solubility, 
side effects of entrapped compound, and compound instability when entrapped (Thwala 
2012).  The major limitations associated with nanotechnology are the small size leading 
to gastrointestinal tract uptake which could have potential toxicity concerns, as well as 
lipophilic and hydrophilic compound‘s poor solubility, and difficulty to be entrapped 
with hydrophilic systems (Bergin and Witzmann 2013; Jong and Borm 2008). Thus, 
design flaws accompanied by potential toxicity concerns have been limiting nanoparticle 
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systems from becoming commercialized. It is important to consider potential toxicity 
and metabolic effects of nanoparticles in vitro and in vivo. 
Current antioxidant and antimicrobial delivery systems are being developed 
primarily as large hydrophilic systems. Disadvantages of using polysaccharides in these 
systems include the poor solubility of active lipophilic compounds. This creates a major 
barrier for the hydrophobic molecules absorption, bioavailability, and clinical efficacy in 
vivo as well as entrapment in vitro. Thus, encapsulating hydrophobic or lipophilic 
actives is difficult and problematic. Lipophilic active compounds are often prepared in 
an emulsion with a surfactant to be entrapped in hydrophilic nanosystems. Poor 
solubility, stability, efficacy, and cost are often the downfall of these systems. The use of 
surfactants to solubilize oils can cause cloudiness and turbidity which leads to decreased 
shelf life due to increased volatility and poor stability (Thwala 2012).  
Particle size and entrapment efficiency must also be optimized to assemble 
nanoparticles with highest payload capacity, increased cellular uptake, good mechanical 
strength, proper permeability and diffusion characteristics, faster drug release, as well as 
handling ease (Sinjan and Robinson 2003). Proper size and payload will allow for more 
significant characterization as well as efficacy in antimicrobial and antioxidant 
applications. Chitosan and alginate nanoparticles final particle size and entrapment 
efficiency can be improved as concentration dependence on biopolymers relates to 
particle size (Gupta 2011). Additional processing parameters such as droplet size, and 
homogenization rate will affect size of chitosan and alginate particle size and entrapment 
efficiency.  
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1.3 Justification of Study  
Assembling and characterizing trans-cinnamaldehyde loaded chitosan-alginate 
nanoparticles will help pave the way for understanding the advantages and limitations of 
their potential use in food applications. This understanding will enable more precise 
manipulation of these molecules for the design of safer, healthier, and tastier food 
products. Characterization will allow for future optimization of the delivery systems as 
well as the development of improved taste, color, flavor, and shelf life stability of foods 
containing nanoparticles.   
The development of novel nanoparticulate drug carriers is a main focus of food 
safety and food quality research.  Nanoencapsulation has the potential to limit or inhibit 
microbial growth and also prevent oxidation in food products.  Also, nanoencapsulation 
can improve the solubility of lipophilic compounds and protect labile molecules from the 
biological environment.  Nanoencapsulation systems include oily drugs in liposomes, 
dendrimers, micelles, lipophilic and polymeric nanoparticles, cyclodextrins, and 
hydrogels.  
Nanoscale delivery systems are being formulated with biodegradable, 
biocompatible, safe, non-toxic, naturally occurring and cost effective polymers. 
Specifically, biopolymers with hydrophilic surfaces have been utilized as building 
blocks of nanosystems in many studies. Alginate and chitosan are two prime examples 
of these hydrophilic colloids. Their high availability, low cost, and simplicity of 
handling makes these polymers unique and attractive choices when choosing 
nanoparticle building blocks (Sinjan and Robinson 2003).  Similar to proteins, peptides, 
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and polynucleotides, chitosan and alginate work synergistically to protect entrapped 
active molecules from oxidation and enzymatic degradation. These polymers also help 
enhance the chemical stability of compounds that are photosensitive or prone to 
hydrolysis.   Chitosan and alginate contain hydroxyl, amino, and carboxyl groups. These 
chemical groups form non-covalent bonds and allow for bioadhesion which has been 
shown to help increase the solubility and residence time of lipophilic molecules in a 
nanoparticulate system (Thwala 2012). Ionic interactions between active drug molecules 
and matrix materials have been shown to increase drug loading for small molecules 
(Caban and others 2014; Mohanraj and Chen 2006). Chitosan and alginate are unique in 
that their chemical and physical properties can be manipulated and enhanced in 
comparison to bulk materials (Sahoo and Labhasetwar 2003).  The surface area to 
volume ratio of chitosan-alginate nanoparticles allows for formulation improvements of 
nanosystems (Caban and others 2014). With improved formulations, nanoparticle 
systems can release lipophilic molecules at their full potential. Thus, it is important to 
develop a standard formulation method and optimize processing parameters of loaded 
chitosan-alginate nanoparticles with hydrophobic compounds.  
Characterization will allow for optimization of antimicrobial and antioxidant 
delivery systems as well as the development of improved taste, color, flavor, texture, 
consistency, shelf life stability, safety, and processability. Ideally, characterizing 
chitosan-alginate nanoparticles with an entrapped lipophilic compound will assist in 
future utility in post-processing and food applications such as the stabilization of 
flavoring agents, inhibitory and bactericidal capabilities, as well as the reduction of 
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unpleasant odors and tastes due to oxidation. Trans-cinnamaldehyde (3-phenylprop-2-
enal) is an essential oil with antimicrobial and antioxidant properties that may degrade 
microbial membranes to cause cell death, but can also scavenge free radicals and prevent 
oxidation in food products.  It is volatile and chemically labile as a result of oxidation, 
chemical interactions, or volatilization. Characterization will also help determine how 
well protected trans-cinnamaldehyde is when entrapped. Encapsulation of lipophilic 
compounds into aqueous-soluble nanoparticle systems could provide solutions to several 
problems in the food industry by improving solubility of active and providing a 
controlled way to deliver and release drug payload with full potential. 
This research is important in determining if it is feasible to entrap lipophilic 
compounds in hydrophilic systems. Subsequently, this study will also show if the 
antimicrobial compounds have potential for improving the effectiveness and efficiency 
of delivery in food systems. Characterization of the system can allow for the 
understanding of the release mechanisms and the antimicrobial efficiency which could 
allow food manufactures to design smart food systems for delivery applications. This 
research is different from previous studies in that two new and unique polymers are used 
in the fabrication of nanoparticles. Trans-cinnamaldehyde was explored as an 
antimicrobial and antioxidant compounds. No current literature utilizes chitosan and 
alginate biopolymers with the essential oil trans-cinnamaldehyde as a combination for 
the assembly of a nano-sized food carrier. Additionally, characterization methods used in 
this study are commonly used methods that are easily repeatable and modifiable for use 
in future studies. This study is unique in that it improves and optimizes a synthesis 
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methodology (e.g. processing parameters and design constrains) followed by several 
characterization studies. Current literature does not attempt to optimize physical 
characteristics (e.g. size and entrapment efficiency) of particles prior to characterization 
studies. 
1.4 Objectives of Study 
This study aimed to explore combinations of alginate and chitosan as an 
entrapment matrix for the essential oil trans-cinnamaldehyde which is poorly soluble in 
aqueous media. This goal was attained by addressing the following specific objectives: 
i. Determine a method to optimally synthesize chitosan-alginate nanoparticles with 
entrapped trans-cinnamaldehyde using the ionic gelation and polyelectrolyte 
complexation technique. 
ii. Determine the physical and thermal characteristics of fully optimized 
nanoparticles. 
iii. Test the optimized nanoparticle antioxidant activity on apple juice. 
iv. Test optimized nanoparticle inhibitory and bactericidal capability on Escherichia 
coli O157:H7 and Listeria monocytogenes. 
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2. LITERATURE REVIEW 
 
2.1 Introduction  
 The development of a working nanoparticle delivery system is crucial to obtain 
efficacy in food applications. Researchers are currently looking for solutions to entrap 
poorly soluble drugs, actives, and proteins. The following offers a review of relevant 
drug delivery systems, synthesis techniques, and characterization assays as well as 
essential information about the polymers, active compounds, preparation methods, and 
characterization methods used in this study.  
2.2 Nanosystems for Drug Delivery 
2.2.1 Polymeric Nanoparticles 
Major food grade structural components that can be utilized to construct delivery 
systems for food applications include lipids, surfactants, and polymers. Polymeric 
nanoparticles are synthesized by a variety of materials such as proteins, lipids, 
polysaccharides, and synthetic polymers to obtain nanospheres or nanocapsules. Matrix 
materials are dependent on the size of nanoparticles required, active encapsulant 
properties and release profile, surface characteristics, charge, permeability, 
biodegradability, and toxicity (Mohanraj and Chen 2006). Nanocapsules represent 
vesicular systems where a drug is entrapped in a cavity surrounded by polymer 
membrane while nanospheres are solid colloidal particles in which an active can be 
entrapped, encapsulated, chemically bound, or absorbed by a polymer matrix (Figure 
2.1). They have hydrophobic surface characteristics and mucoadhesive properties 
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(Sinjan and Robinson 2003; Caban and others 2014). Lipophilic compounds can be 
incorporated into the oily core of nanocapsules or solubilized in nanospheres while 
hydrophilic compounds can be adsorbed on the surface.  
 
 
 
 
Figure 2.1. Nanospheres versus nanocapsules, entrapped versus adsorbed drug. Adapted 
from Thwala (2012). 
 
 
The goals in designing a nanoparticle system are to control particle size, surface 
properties, and release mechanisms to provide good mechanical strength, minimize 
average particle size, and maximize active payload capacity. The advantages of 
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polymeric nanoparticles include small size, sustained drug release, site specific targeting, 
cheaply fabricated via large quantity and several methods, and engineered for specific 
functionality. Nanoparticles have high surface to volume ratio which allows control of 
particle size and surface characteristics, ability to sustain controlled release of 
encapsulant via pH, ion, biodegradation, and temperature treatments, as well as site 
specific targeting (Thwala 2012). However, this also leads to limitations such as particle 
aggregation, difficult handling procedures with potential limited drug loading and burst 
release (Jong and Borm 2008; Mohanraj and Chen 2006).  
The biodegradability that leads to sustained drug release is an advantage over 
solid lipid nanoparticles and nanosuspensions. In comparison to liposomes, these 
polymeric nanoparticles are more stable in vivo and in storage (Tiwari and Takhistov 
2012). However, disadvantages include entrapment capabilities that depend on the 
products water solubility as well as potential polymer related toxicity, organic residues, 
and scaling up difficulties (Tiwari and Takhistov 2012; Mohanraj and Chen 2006). 
Particle aggregation also makes physical handling of nanoparticles difficult in both 
liquid and dry form (Jawahar and Meyyanathan 2012). 
2.2.1.1 Biodegradable Polymers 
Polymers containing one or more functional group that have the ability to be 
hydrolyzed are biodegradable polymers. Examples of biodegradable polymers include 
biopolymers, polysaccharides, and synthetic polymers. These types of polymers are 
effective for use in controlled release studies due to their ability to sustain release of 
active drug molecules (Jawahar and Meyyanathan 2012). Nanoparticles synthesized via 
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polymers are superior to other delivery vehicles such as liposomes and micelles due to 
high shelf life stability, storage stability, site specific targeting abilities, reduced mobility 
leading to less loss of entrapped molecule, and ability to functionalize through coating of 
particle surface (Thwala 2012). 
2.2.1.2 Synthetic Polymers 
Polymers that can be constructed and built with specific functionality are 
considered synthetic polymers. Synthetic polymers can be used to fabricate nanoparticles 
that can be conjugated with functional groups and ligands to change the functionality of 
the particle (Ruo 2012). Polyethylene glycol (PEG) is a common example. PEG can be 
covalently attached to a synthetic polymer. Benefits of attachment include reduced 
immunogenicity and antigenicity while also increasing the size of the particle. 
PEGylation allows for increased water solubility of hydrophobic active molecules, 
increased active stability, reduced toxicity, as well as changing physiochemical 
properties such as conformation and electrostatic binding ability (Davis 2002).  
Synthetic polymers and copolymers examples include poly(cyanoacrylate), 
poly(lactic acid) (PLA), poly(glycolic acid) (PGA), polycaprolactone (PCL), 
poly(alkylcyanoacrylate) (PACA), and poly(lactic-co-glycolic acid) (PLGA). Synthetic 
polymers have the advantage of having high purity and reproducibly over natural 
polymers. The polyester family which includes PLA, PCL, PLGA, and PGA are of 
significant interest to the food industry due to their biocompatibility and 
biodegradability. PLGA has even been approved for human therapy (Anderson and 
Shive 1997). Limitations of synthetic polymers include scale up difficulties, bulk 
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erosion, acidic environment within PLGA matrix, hydrophobicity, immune response to 
foreign bodies, potential toxicity, complicated storage and redispersibility, and high cost 
(Avgoustakis and Konstantinos 2004). 
PLGA and PLA have broad uses in food applications due to their established 
safety profiles. PLGA has low toxicity, low immunogenicity, good mechanical 
properties, and predictable biodegradation mechanisms. PLGA was successfully utilized 
by Gomes and others (2011) to entrap cinnamaldehyde and eugenol for the inhibition of 
Salmonella and Listeria (Hill and others 2013b). PLA has been successfully used as an 
antimicrobial delivery vehicle for Nisin (Abdollahi and Lotfipour 2012). PLA helped to 
overcome the stability and solubility problems associated with Nisin loading. PCL has 
been effectively used as a delivery vehicle for antioxidant applications through the 
encapsulation of α-tocopherol (Byun and others 2011). PLGA nanoparticles have been 
used in poultry meat systems to deliver benzoic acid and inhibit the growth of 
Salmonella Typhimurium and Listeria monocytogenes (Hettiarachchy and Ravichandran 
2012).  
2.2.1.3 Natural Polymers 
Natural polymers are widely used in food grade applications due to their stability, 
safety, high number of reactive groups, high abundance in nature, and low cost. Their 
unique characteristics include wide range of molar masses, molecular conformation, 
varying chemical composition and electropotential, hydrophobicity, and flexibility 
(Huang and others 2009). Natural polymers used in food delivery applications are 
proteins, non-ionic polysaccharides, and ionic polysaccharides. Specifically, polymers 
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such as gelatin, albumin, pectin, starch, chitosan, and sodium alginate have been 
extensively used to assemble food grade nanoparticles.  
Polysaccharides are cost effective, form integral parts of numerous food systems, 
occur in a wide range of polymeric sizes, and have physical properties such as solubility, 
melting, and phase change that are advantageous in encapsulation applications (Lakkis 
2007). They are stable, safe, non-toxic, and hydrophilic. The ability to control particle 
size using polysaccharides is advantageous. The size of nanoparticles will change as pH 
and concentration of solution is changed due to free end groups being available for ionic 
bonding and particle formation. Lower concentrations yield fewer interactions, thus less 
particle formation. Gupta and others (2011) found that particle size of a nanosystem is 
dependent on concentrations of the polysaccharides used. 
Ionic polysaccharides can undergo electrostatic interactions which are largely 
dependent on solution pH conditions (Benita 1998). Also of importance are hydrophobic 
interactions among food constituents. Hydrophobic interactions allow for non-polar 
groups to aggregate with other non-polar groups. Hydrophobic interactions can be 
controlled by altering temperature or changing the polarity of the aqueous solution 
through the addition of a polar solvent. This is important in entrapment procedures 
where hydrophobic or lipophilic constituents need to be entrapped (Li and others 2008; 
McClements 2009). Nanoparticles made from polysaccharides are bioadhesive and can 
increase the absorbance of loaded drugs as well as improve the dissolution rate of poorly 
soluble drugs and control their release.  
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A number of studies have been completed using natural polymers.  Animal based 
polymers such as chitosan, albumin, and gelatin have been used to assemble 
nanoparticles with the following food applications: enhance mechanical and thermal 
stability of fruit puree and carboxymethylcellulose films (Martelli and others 2013; de 
Moura and others 2011), reduce the bacterial count of uncoated psychrophilic bacteria 
coliform bacteria, and proteolytic bacteria on fish fingers coated with commercial edible 
coatings (Abdou and others 2012), encapsulate quercetin to improve antioxidant 
properties for use in manufacturing of functional foods (Marthyna and others 2014), and 
improve the stability of anthocyanins under neutral conditions (Chen and others 2014). 
Algal based polymers such as alginate have been used to assemble nanoparticles with the 
following food applications: encapsulate iron and zinc to be released and enrich ice 
cream without changing sensory effects (Armoon and others 2013), and encapsulate zinc 
oxide to have potential antibacterial properties (Bajpai and others 2012). Plant based 
polymers such as pectin and cellulose have been used in to assemble nanoparticles that 
can entrap lipids in a core-shell matrix by electrostatic deposition of pectin onto protein 
aggregates (Santipanichwong and others 2008), entrap hydrophobic zein (Dhanya and 
others 2012), and entrap ascorbic acid (Liu 2014). Cyclodextrins, or cyclic 
oligosaccharides enzymatically derived from starch, have been utilized as a delivery 
vehicle in the entrapment of black pepper oleoresin, and essential oils for antimicrobial 
applications (Hill and others 2013a; Kamimura and others 2014; Teixeira and others 
2013). Cyclodextrins are active carrier materials due to how easily they can form 
inclusion complexes in solution and in solid state. Within the inclusion complex, 
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molecules are protected from the hydrophobic environment in the cyclodextrins cavity. 
This leads to greater delivery potential due to the enhancement of the physical, chemical, 
and biological properties of entrapped molecule (Thwala 2012). Cyclodextrins can also 
be combined with polymers to offer enhanced delivery systems.  
2.2.2 Liposomes  
Liposomes are spherical shaped vesicles produced by phospholipids and 
cholesterol with size from 30 nm to several microns. An aqueous volume is surrounded 
by this phospholipid bilayer. Liposome properties are controlled by lipid composition, 
size, surface charge, and method of preparation. The biocompatibility of liposomes as 
well as their amphiphilic character and small size make them promising delivery 
systems. Liposomes are easy to modify, are biodegradable, and encapsulate a wide 
variety of active molecules with limited toxicity (Tiwari and Takhistov 2012). 
Liposomes can entrap both hydrophilic and hydrophobic molecules which leave the 
phospholipid bilayer through diffusion.  Limitations of liposomes include interaction 
with lipoproteins, difficulty encapsulating aqueous ingredients, difficulty improving 
stability of entrapped active, limited physical stability, aggregation during storage, and 
lipase degradation destroying the encapsulated material (Thwala 2012). In the food 
industry liposomes have been used to deliver food flavors, enzymes, and nutrients as 
well as delivery antimicrobial compounds for protection against spoilage and pathogenic 
microorganisms (Taylor and others 2005; Mozafari and others 2008). Antimicrobial 
peptides have been successfully entrapment into liposomes for food application (da Silva 
Malheiros and others 2010). 
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2.2.3 Micelles 
Micelles are spherical aggregates of surfactant molecules dispersed in liquid 
colloid. Micelles have unique amphiphilic properties with a core-shell like structure with 
size of 10 to 100 nm. The inner core of a micelle is hydrophobic and can dissolve 
lipophilic drugs. The outside of micelles is hydrophilic. Micelles can enhance solubility 
as well as increase bioavailability of hydrophobic active molecules.  Another advantage 
of using micelles for entrapment of active molecules is the ability to modify the surface 
in order to improve site specific targeting. Micelles can self-assemble due to large 
solubility differences in optimal solvent media (Thwala 2012; Ruo 2012).  
Encapsulation by micelles is a technique that can enhance the solubility of 
slightly soluble active molecules. This technique involves the simple entrapment of a 
hydrophobic active in a hydrophilic shell material thus making the particle soluble in 
aqueous media. The micelle serves as a nanocontainer that allows active to be released 
by diffusional processes. Critical micelle concentration (CMC) is the minimum polymer 
or surfactant concentration required to form a micelle. CMC is unique to micelles in that 
the lower the CMC, the greater the thermodynamic stability of micelles in solution. 
However, this can cause limitations in drug delivery such as dose dumping, or the 
dilution of micelles in solution leading to spontaneous disassembly (Hatefi and Amsden 
2002). Micelle use is limited due to physical and thermodynamic stability (Thwala 
2012). Micelles have been used in food application to improve antioxidant capacity of 
curcumnoids via entrapment (Yu and others 2011), enhance solubility of curcumin for 
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entrapment in beta-casein-micelle nanovehicle (Esmaili and others 2011), and 
incorporate mustard oil in food-grade micelles (Kirchner and others 2009). 
2.2.4 Hydrogels 
Hydrogels are hydrophilic structure networks formed chemically or physically 
through crosslinking of polymer chains with covalent bonds, hydrogen bonds, Van der 
Waals interaction, and physical entangling. They must be functionalized to improve 
biodegradability, drug loading capacity, and drug release.  Drug molecules can be loaded 
by their porous structure which is advantageous over polymeric delivery systems which 
require biocompatible drug to matrix. Hydrogels structure can be controlled through pH 
and temperature changes. This is often referred to as a stimuli-responsive drug delivery 
system (Figure 2.2). Hydrogels can also be prepared from the hybrids of a synthetic 
polymer and a biopolymer, two different biopolymers, or two different synthetic 
polymers. Advantages include the mimicking of structure and functionality of biological 
tissue, improved functionality, improved stability, and biodegradability profile (Lin and 
others 2012). Hydrogel nanoparticles have been used for potential food applications to 
load curcumin (Dandekar and others 2010) as well as incorporate liposomes for 
antimicrobial delivery and inhibition of Staphylococcus aureus (Gao and others 2014). 
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Figure 2.2. Hydrogel formation and stimuli-response for drug entrapment. Adapted from 
(Thwala 2012). 
 
 
2.2.5 Dendrimers  
Dendrimers are monodisperse symmetric macromolecules with highly branched 
structures around an inner core.  They are three dimensional molecules with low 
polydisperity and high functionality.  Dendrimers are built from a starting atom, or the 
central core, which in many cases is a nitrogen atom.  Carbon or other elements are 
added to the nitrogen atom through a series of repeating chemical reactions that produce 
spherical branching structure (Holister and others 2003; Duncan and Izzo 2005) 
Dendrimers provide a number of advantages compared to other linear polymeric 
materials including high concentration of active entrapment, easier passage across 
biological barriers, and internal cavities which can be optimized in order to 
accommodate large or smaller molecules. Thus, encapsulation capacity can be tailored to 
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the molecule of interest in a dendrimer system while linear polymeric structures are 
random and internal cavities cannot be optimized. The ability to customize a dendrimer 
allows for the nanomaterial to be tailored to exact specifications for a food application 
and also allows the dendrimer to be ideal carriers for small molecules.  This high level of 
control and the ability to change inner cavity to polar or nonpolar allows for entrapment 
of hydrophilic and hydrophobic drugs making them an attractive system for drug 
delivery (Astruc and others 2011). However, limitations of dendrimers include the multi-
step chemical synthesis, poor entrapment of large bioactive molecules, and leaking of 
incorporated compounds from the branch structure (Thwala 2012).  
2.2.6 Nanoemulsions 
Nanoemulsions are non-toxic lipid droplets in the scale of 50 to 100 nm in 
continuous phase and fabricated from surfactants that are generally approved for human 
consumption. Nanoemulsions are synthesized by mixing two immiscible liquids with 
one of the liquids dispersed as a small spherical droplet in the other (Tiwari and 
Takhistov 2012). Nanoemulsions are stabilized by surfactants or alcohol. Lipophilic 
cores are separated from aqueous phase by a monomolecular layer of surfactant thus 
allowing for nanoencapsulation potential. Nanoemulsions are advantageous for food 
applications due their broad-spectrum antimicrobial activity against bacteria, fungi, 
protozoa and spores, as well as its lysing ability. The active ingredient and the high 
energy are essential for the antimicrobial mechanisms of action. Nanoemulsion particles 
are thermodynamically driven to fuse with lipid containing organisms. Upon fusion, 
energy from the emulsion is released into the pathogen with the active ingredient 
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destabilizing the lipid membrane (He and others 2011). Nanoemulsions are 
biocompatible, kinetically stable, increase bioavailability of lipophilic components, and 
can entrap hydrophobic active molecules. On the other hand, limitations include 
potential toxicity of certain fabrication components during long-term drug dose release, 
thermodynamic instability, and poor storage stability (McClements and Rao 2011; 
Tiwari and Takhistov 2012). 
Current studies with potential food application include: nanoemulsion fabrication 
with proteins such as soybean isolate, whey isolate, and ß-lactoglobulin for delivery 
systems with poorly water-soluble drugs (He and others 2011), and nanoemulsions with 
basil oil incorporated using surfactants for antibacterial activity against E. coli (Ghosh 
and others 2013). Nanoemulsions fabricated from food-grade ingredients are being 
increasingly utilized in the food industry to encapsulate, protect, and deliver lipophilic 
functional components. These include ω-3 fatty acids, conjugated linoleic acid, 
lipophilic flavors, vitamins, and preservatives (McClements and Rao 2011). 
2.2.7 Lipid and Solid Lipid Nanoparticles 
Solid lipid nanoparticles consist of spherical particles with size of 10 to 100 nm 
dispersed in water or in an aqueous surfactant solution. They consist of a lipid core and 
have the ability to solubilize lipophilic molecules which is a fundamental problem in 
food nanotechnology (Ruo 2012).  These particles are solid at room temperature and are 
very much like nanoemulsions, differing in lipid nature. Solid lipid nanoparticles are 
bioavailable, can incorporate lipophilic and hydrophilic molecules, avoid use of organic 
solvents, control drug release and drug targeting, and can be scaled up allowing for 
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functionality enhancement, site specific targeting, and low toxicity (Üner and Yener 
2007). Solid lipid nanoparticles combine the advantages of lipid emulsion and polymeric 
nanoparticle systems while overcoming stability issues. Limitations include high 
pressure induced drug degradation, lipid crystallization, drug incorporation implied 
localization, coexistence of different lipid modifications and colloidal species, low drug 
loading capacity, storage stability difficulties, and particle burst concerns. Studies with 
potential relevance to food application include the solid lipid nanoparticles encapsulation 
of vitamin D2 stabilized with Tween 20 (Patel and San Martin-Gonzalez 2012),  
synthesis of transparent dispersions of milk fat based solid lipid nanoparticles for 
delivery of beta-carotene bioactive (Zhang 2013). Disadvantages include cost and 
complexity (Tiwari and Takhistov 2012).   
2.2.8 Inorganic Nanoparticles, Carbon Nanotubes, Nanocrystals 
Inorganic nanoparticles consist of metal oxide particles or particles that are 
comprised of at least one metallic composition at the nanoscale. They have small particle 
size and have been used in drug delivery, controlled release studies, and as nanosensors 
for microorganism detection (Caban and others 2014; Safari and Zarnegar 2013). 
Biocompatible materials such as silica, alumina, and titanium have been formulated for 
ceramic nanoparticles with specific targeting moieties (Ruo 2012). Inorganic 
nanoparticles are suited for food packaging systems as well as water filtration systems. 
Inorganic particles in food applications silver nanoparticles have been incorporated in 
hydroxypropyl methylcellulose for food packaging applications and were 
antibactericidal against E. coli and Staphylococcus aureus  (de Moura and others 2012). 
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Titanium dioxide nanoparticles have been used as effective antimicrobials against 
Salmonella choleraesuis, Vibrio parahaemolyticus, and L. monocytogenes (Kim and 
others 2003). Silver, gold and copper oxide nanoparticles have shown considerable 
antimicrobial activity against Gram negative bacteria as well as microbial detection and 
screening (Duncan 2011).  
Carbon nanotubes are cylindrical carbon nanostructures with the size of 
approximately 1 to 50 nm. They have great mechanical strength, electrical, and surface 
properties. The advantage of using carbon nanotubes is the ability to functionalize and 
facilitate transmembrane penetration. Although carbon nanotubes can be used in drug 
delivery, their need to be functionalized and potential cytotoxicity create problems when 
being applied to food applications.  Carbon nanotubes are currently being utilized in 
nanosensor applications. They have been shown to detect staphylococcal enterotoxin B, 
cholera toxin, and bind to the surface of the cyanobacteria toxin Microcystin-LR 
(Duncan 2011).  
Nanocrystals are nanoparticles aggregates composed of atoms in a single or poly-
crystalline arrangement synthesized via nanosuspensions. They are drug powder 
dispersed in aqueous surfactant solution. Nanocrystals are capable of entrapping poorly 
soluble drugs, increasing bioavailability, and improving solubility of hydrophobic active 
molecules (Tiwari and Takhistov 2012). Nanocrystals have been shown to be useful in 
rapid microorganism detection as fluorescent tags of E. coli (Duncan 2011). 
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2.3 Nanoparticle Synthesis Methodologies 
Production of nanoparticles has been limited by the difficulties and complexities 
of preparation methods. Conventional approaches used to prepare nanoparticles have 
noteworthy disadvantages including: relative high cost, long synthesis time, scaling up 
difficulties; unknown toxicity of solvents and reagents used for fabrication; rigorous 
processing such as interfacial polymerization, high torque mechanical shearing, and 
homogenization which may be damaging to entrapped molecules; inability to easily 
reproduce stable particles; and low encapsulation efficiency of many types of drugs.  
Various materials and methods have been utilized for nanoencapsulation 
purposes, as no individual encapsulation method is adaptable to all product applications 
or core materials (Table 2.1 and Table 2.2). Different nanoparticle preparation methods 
will result in particles of different size, shape, and morphology.  Selection of the proper 
technique is based on the physical and chemical properties of the wall and core 
materials, as well as the desired functional properties of the nanoparticles. Nanoparticles 
with electrostatic potential are prepared most frequently by three methods: dispersion of 
preformed polymers, polymerization of monomers, and ionic gelation complex 
coacervation of hydrophilic polymers (Mohanraj and Chen 2006). Methods of preparing 
polymeric nanoparticles generally includes two main steps; the preparation of an 
emulsification system followed by the precipitation or gelation of the polymer or 
copolymers (Thwala 2012). Ionic gelation followed by polyelectrolyte complexation 
(IG-PEC) of hydrophilic polymers was utilized in this research. The goal of this method 
is to form polyelectrolyte complexes by interactions of molecules that carry oppositely 
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charged ionizable groups. This method was chosen over emulsion evaporation methods 
due to its simplicity, reproducibility, and mild nature. Additionally, crosslinking by 
electrostatic interactions avoids toxicity that would otherwise result from chemical 
bonding. The emulsion cross linking method has several drawbacks which include 
overall tedious procedures and harsh cross linking agents which can induce chemical 
reactions with active agents. Additionally, complete removal of the unreacted cross 
linking agent can also be difficult (Agnihotri and others 2004). 
The ionotropic gelation method should develop stable, nontoxic complexes of 
ionic cross linked chitosan-alginate nanoparticles. One of the key factors in 
encapsulating trans-cinnamaldehyde in a chitosan-alginate matrix is the hydrophobicity 
of trans-cinnamaldehyde.  The ionotropic gelation technique can help overcome this 
obstacle (Thwala 2012; Li and others 2008). 
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Table 2.1. Polymeric nanoparticles: Advantages and Limitations of Preparation Methods. Adapted from Pinto Reis and others 
(2006). 
 
Method 
Simplicity 
of 
Procedure 
Need for 
Purification 
Facility 
Scaling-up 
EE (%) Compound Safety 
Polymerization of monomers 
Emulsion polymerization 
Organic 
Aqueous 
Interfacial Polymerization 
- 
- 
Low 
High 
Low 
- 
- 
High 
High 
High 
- 
- 
- 
High 
Medium 
- 
- 
Low 
High 
High 
- 
- 
Low 
Medium 
Low 
Preformed Polymers 
Synthetic 
Emulsification Evaporation 
Solvent Displacement 
Salting Out 
Solvent Diffusion 
- 
- 
High 
High 
High 
Medium 
- 
- 
Low 
- 
High 
Medium 
- 
- 
Low 
- 
High 
High 
- 
- 
Medium 
High 
High 
High 
- 
- 
Medium 
Medium 
Low 
Medium 
Preformed Polymers 
Natural 
Albumin 
Gelation 
Alginate 
Chitosan 
Agarose 
- 
- 
NR 
NR 
High 
High 
Medium 
- 
- 
High 
High 
Medium 
Medium 
High 
- 
- 
- 
- 
High 
High 
- 
- 
- 
Medium 
Medium 
High 
High 
- 
- 
- 
Low 
Low 
High 
High 
High 
Preformed Polymers 
Desolvation 
- 
- 
- 
High 
- 
- 
- 
Low 
- 
Low 
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Table 2.2. Examples of Preparative Methods, Polymers, and Encapsulants. Adapted from Pinto Reis and others (2006). 
 
Polymer Encapsulant Size [nm] 
Interfacial polycondensation α-Tocopherol < 500 
Solvent Evaporation 
     Poly(lactic acid) 
     Poly(lactic acid)-poly(glycolic acid) copolymer 
- 
Albumin 
Cyclosporin A 
- 
100 or 120 
~300 
Solvent Displacement 
     Poly(lactic acid)-poly(glycolic acid) copolymer 
 
     Poly(lactic acid) 
- 
Doxorubicin 
Insulin 
Vitamin K 
- 
274 
~105-170 
~270 
Interfacial Deposition 
     Poly(lactic acid) 
- 
Indomethacin  
- 
230 
Salting Out 
     Poly(lactic acid) 
- 
Savoxepin 
- 
<1000 
Emulsion/Solvent Diffusion 
     Poly(lactic acid)-poly(glycolic acid) copolymer 
      Poly(lactic acid) 
- 
Doxorubicin 
DNA 
- 
<1000 
<300 
Nanoparticles Produced From Natural Macromolecules 
     Serum Albumin 
     Gelatin  
     Polysaccharides 
- 
Doxorubicin 
Mitomycin C 
Oligonucleotides 
Insulin 
Doxorubicin 
- 
200-1500 
280 
<1000 
<1000 
<1000 
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2.3.1 Ionotropic Gelation Polyelectrolyte Complexation  
Ionotropic gelation (IG) is based on the ability of polyelectrolytes to cross link in 
the presence of counterions to form hydrogels or spherical particles that can undergo 
precipitation. Polysaccharides are first dissolved in weak acidic solutions to form ionic 
solutions. An anionic solution is cross-linked with a counterion (e.g. calcium chloride) to 
form a hydrogel (IG step). Polyelectrolyte complexation (PEC) consists of dropping an 
aqueous solution of polyvalent cations into a drug loaded anionic polymeric solution (i.e. 
hydrogel) to form PEC.  The cations will diffuse into the drug-loaded polymeric drops 
forming lattice structures of ionically cross linked moieties (Berger and others 2004). 
This is the stage of fabrication where nanoparticles are formed (Figure 2.3)  
Ionotropic gelation and polyelectrolyte complexation (IG-PEC) should develop 
stable, nontoxic complexes of ionic cross linked chitosan-alginate with entrapped trans-
cinnamaldehyde (TC).  Ideally, a calcium-alginate core will be bounded by a membrane 
which itself is surrounded by a complexed layer of precipitated chitosan. 
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Figure 2.3. Schematic representation of the ionic gelation and polyelectrolyte complexation method. 
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2.3.1.1 Ionotropic Gelation (IG) 
There are two IG methods, external and internal. In external IG, the cross linking 
cation is positioned externally while in the internal IG method the cross linking cation is 
incorporated within the polymer solution (Figure 2.4). External cross-linking produces 
nanoparticles with greater matrix strength, encapsulation efficiency, and slower active 
release (Ahirrao and others 2013, Ruo 2012). The quality and mechanical strength of 
hydrogel beads prepared by ionotropic gelation method can be improved by PEC 
technique (Patil and others 2012). For instance, addition of polycations to the IG pre-gel 
allows a membrane of polyelectrolyte complex to form on the surface of alginate beads 
(Patil and others 2010).  
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Figure 2.4. External Ionotropic Gelation Technique. Adapted from Ahirrao and others (2013). 
 
 
2.3.1.2 Polyelectrolyte Complexation (PEC) 
The driving force of PEC is the strong electrostatic interactions between 
oppositely charged polyelectrolytes which leads to inter-polymer ionic condensation and 
formation of aggregates in the nanosized range called nanospheres (Challa and others 
2005).  PEC is due to the carboxyl residues of alginate and the amino groups of chitosan 
ionically interacting (Figure 2.5 (a) and Figure 2.5 (b)). PEC reduces porosity of alginate 
beads and decrease leakage of encapsulated drug (Thwala 2012).  
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Figure 2.5 (a). Representation of oppositely charged poly-ions interacting to form a PEC. 
Adapted from Thwala (2012). 
 
 
 
 
 
Figure 2.5 (b). Additional representation of PEC formation. Adapted from Thwala 
(2012). 
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2.3.1.3 Application to Research 
IG-PEC is a two stage procedure. The first stage is the preparation of calcium-
alginate pre-gel via ionotropic gelation followed by cross linking with CS via PEC. In 
the first stage polyguluronate units of alginate molecules form a chelated structure with 
the cation calcium chloride thus packing into spherical structures. Calcium ions have 
unequal affinity for the guluronic (G) and mannuronic units (M) of alginate and will 
form an egg box structure (Figure 2.6) with the repeating G units of alginate. Any 
additional calcium ions will interact with unreacted G and M acid residues forming a 
stacked calcium-alginate complex in a planar two dimensional manner (Sinjan and 
Robinson 2003). Upon stacking of G groups, the alginate chains will dimerize with other 
chains and form a gel network. The ability of alginates G acid residues to complex with 
divalent ions such as calcium allows the pre-gel to form (Racovita and others 2009). 
Continuous stirring of this state results in formation of a pre-gel and avoids the gelling 
point (Leonard and others 2004; Sarmento and others 2006).  
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Figure 2.6. Egg-box structure of an alginate gel formed by chelating of calcium chloride 
ions. GG blocks represented by zig-zag portions and MM and MG blocks represented by 
smooth parts of polymer chains.  Adapted from Thwala (2012). 
 
 
The second stage of the process is PEC. This is the addition of aqueous chitosan 
solution.  Upon chitosan addition the pre-gel is stabilized and PEC is formed into sponge 
like particles.  A nanoparticle matrix is created with a core composed of complexed 
calcium-alginate segments while any unreacted polymer in the PEC are segregated in the 
outer shell. This increases colloidal stabilization of particles thus reducing potential 
coagulation and aggregation (Leonard and others 2004; Thwala 2012).  Under acidic 
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conditions the ionizable amino group in chitosan molecules are protonated and have 
affinity for the deprotonated carbonyl groups of alginate.  Thus, carbonyl residues of 
alginate undergo ionic interactions with the amino groups of chitosan to form 
nanoparticles. Essentially, chitosan stabilizes the calcium-algiante pre-gel nucleus into 
individual sponge-like nanoparticles.  
2.3.2 Emulsification-Solvent Evaporation 
Emulsification evaporation is the process where polymer solutions are dissolved 
in volatile solvents and emulsions are formulated with a stabilizer. Emulsions are 
formulated with polymer solutions prepared in volatile solvents such as 
dichloromethane, chloroform, and ethyl acetate. The evaporation of the polymer solvent 
through diffusion of the continuous phase converts the emulsion into a nanoparticle 
suspension under vacuum (Thwala 2012).  Emulsions can be prepared via single-
emulsions or double emulsions and utilize homogenization, ultrasonication, and solvent 
evaporation. Thus, each emulsion droplet forms one polymer particle when the solvent is 
removed. The advantages of this technique include the obtaining of small nanoparticles 
with high encapsulation efficiency, reproducibility, and incorporation of lipophilic active 
molecules. Limitations include the use of ultrasonication which can induce 
chemical reactions, scaling difficulties, and harsh solvent use (Nagavarma and others 
2012). 
2.3.3 Emulsification-Solvent Diffusion 
Emulsification diffusion is similar to emulsification evaporation with the caveat 
that extraction of the polymer solvent from the emulsion occurs in milliseconds leading 
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to nanoparticles. The encapsulating polymer is partially dissolved in a water soluble 
solvent and saturated with water to ensure thermodynamic equilibrium. This organic 
phase is then emulsified in an aqueous solution containing a stabilizer leading to solvent 
diffusion to the external phase thus forming nanoparticles (Nagavarma and others 2012). 
The solvent is then eliminated through evaporation or filtration. Nanoparticles are 
formed because of a physicochemical instability produced by solvent transport. The 
diffusion of the solvent carries molecules into the aqueous phase from supersaturated 
regions where new polymer aggregates form. Once stabilized, nanoparticles are formed 
following diffusion of the solvent. The advantages of this technique include high 
encapsulation efficiencies, no homogenization, reproducibility, ease of scaling up, 
simplicity, and narrow size distribution. Limitations include high volumes of water to be 
eliminated from the suspension, leakage of water-soluble molecules into the saturated-
aqueous external phase, and the process cannot be freeze-dried because of the presence 
of residual benzyl alcohol (Mohanraj and Chen 2006; Pinto Reis and others 2006). 
2.3.4 Complex Coacervation 
Coacervates from complex coacervation are formed as a result of electrostatic 
interactions between two aqueous phases whereas ionic gelation involves the material 
undergoing transition from liquid to gel due to ionic interactions at room temperature 
(Nagavarma and others 2012).  Complex coacervation is a liquid/liquid phase separation 
that occurs when two oppositely charged polyelectrolytes are mixed under suitable 
conditions forming enclosed solid particles.  Thus, PEC is formed. In complex 
coacervation two liquid phases are formed which include the coacervate phase and the 
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supernatant phase.  The coacervate phase is the phase where the capsule forms. Capsules 
or particles are often held together by hydrophobic forces. The supernatant phase is a 
dilute polymer solution that acts as the continuous phase where capsule formation 
occurs. Core materials that are suitable for complex coacervation include water-insoluble 
actives that will not dissolve in the aqueous phase. Coacervation offers high payload 
potential and is versatile and adaptable (Astete and others 2009; Nagavarma and others 
2012).  
2.3.5 Salting Out  
Salting out is a technique based on the separation of a water-miscible solvents 
from an aqueous solution. The salting out procedure can be considered a modification of 
the emulsification evaporation and diffusion processes. Acetone is commonly chosen as 
the water-miscible solvent due to its solubilizing properties and its separation from 
aqueous solutions by salting out with electrolytes. The encapsulating polymer and the 
active drug are dissolved in acetone and emulsified in aqueous gel containing a salting 
agent and a colloidal stabilizer (Nagavarma and others 2012). Electrolyte salting agents 
include magnesium acetate or magnesium chloride. The selection of the salting out agent 
is important due to the effect on encapsulation efficiency of the drug. The emulsion is 
then diluted with sufficient water increasing the diffusion of acetone into the aqueous 
phase. The diffusion of acetone from the droplets is the most important step. This 
diffusion, which takes place on dilution with excess water, can generate interfacial 
turbulence leading to polymer aggregation in the form of nanoparticles. This signifies 
the formation of nanoparticles. The solvent and salting out agent can then be eliminated. 
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Advantages of salting out include high incorporation of drug, high yield, 
protection of heat susceptible molecules, and ease of scaling up for industrial 
manufacturing. Limitations of this technique are that it is limited to lipophilic drugs, 
high processing times, extensive purification to remove salting agents, and potential 
salting without precipitation (Rodriguez and others 2004; Nagavarma and others 2012) 
2.3.6 Nanoprecipitation  
Nanoprecipitation, or solvent displacement, is the precipitation of a polymer 
from an organic solution and the diffusion of that organic solvent in the presence or 
absence of a surfactant.  A polymer is dissolved in a water miscible organic solvent and 
added to an aqueous solution in which the organic solvent diffuses. As the solvent 
diffuses out, the polymer precipitates and the organic solvent is typically evaporated 
with the help of a vacuum. Nanoparticle formation is spontaneous due to the polymer 
precipitating in the aqueous environment. Diffusion and surface tensions at the interface 
of the organic solvent and the aqueous phase cause abruptions, which form small 
particles containing the polymer. Surfactants or stabilizers can modify the size and the 
surface properties of nanoprecipitate particles as well as ensure the stability of the 
nanoparticle dispersion (Nagavarma and others 2012; Fessi and others 1989).  
Advantages of this method include its simplicity, no homogenization, ability to 
enhance encapsulation by changing pH, and ease of scale up. However, drawbacks of 
this technique include difficulty in choosing the active molecule to be entrapped, 
polymer building blocks, and solvents in delivery system. Other disadvantages include 
poor encapsulation efficacy of hydrophilic drugs, because the drug can diffuse to the 
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aqueous outer phase during polymer precipitation (Fessi and others 1989; Rodriguez and 
others 2004). 
2.4 Assembly Components of Loaded Chitosan-Alginate Nanoparticles 
The selection of nanoparticle wall materials, synthesis methods, and 
characterization methods in published research has be made primarily through empirical 
knowledge, processing conditions and advantages (Table 2.3), as well as a general trial 
and error basis (Zuidam and Nedović 2009). Polymeric wall materials can be used 
independently or in combination. Combining wall materials enhances stability and 
increases functionality (Forssell 2004; Liu 2014).  Cost and toxicity are two parameters 
to consider when choosing wall materials.  Risks of toxicity can be minimized by using 
naturally occurring dietary polysaccharides such as chitosan and alginate, which is 
particularly important for food applications (Liu 2014)
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Table 2.3. Properties of common used wall materials for encapsulation process. Adapted from Fang and Bhandari (2012). 
 
Wall Material Properties 
C
ar
bo
hy
dr
at
es
 Hydrolyzed starches: corn syrup solids, 
maltodextrins, etc. 
Modified starches: acetylated starch, 
monostarch phosphate, etc. 
Gums: agar, Arabic gum, sodium 
alginate, etc. 
Cyclodextrins: α-, β- cyclodextrins 
Good oxygen barrier, low viscosity at high solids; 
no/limited emulsion stabilization; economical 
Good emulsion stabilization; sometimes varying 
quality; not universally usable; economical 
Good emulsions; good retention of volatiles; varying 
quality; price depends on availability; some impurities 
Good inclusion of volatiles; excellent oxygen barrier; 
relatively expensive 
P
ro
te
in
s Milk Proteins: whey protein caseinates 
skim milk powders, etc. 
Other Proteins: soy protein, egg 
proteins, etc. 
Good emulsions; being dependent on other factors such 
as pH and ionic strength; allergenic potential; expensive 
L
ip
id
s 
Food fats: milk fat, soybean oil, cocoa 
butter, etc. 
Polar Lipids: monoglycerides, 
phospholipids, glycolipids, etc. 
Waxes: Beeswax, carnauba wax, etc. 
Good colloidal stability, rheological properties and 
moisture barrier properties; economical 
Amphiphilic properties; good surface activity and 
emulsion stability; self-assembly behavior; expensive 
Excellent moisture barrier properties; ideal for spray 
cooling or chilling (melting > 45°C); low viscosity at 
melt state; economical 
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2.4.1 Chitosan  
Chitosan is a polysaccharide, hydrophilic colloid, and a product of the N-
deacylated chitin (Figure 2.7). Commercially available chitosan has an average 
molecular weight of 3,800 to 20,000 Daltons and is 66 to 95% deacylated. It has a 
similar chemical structure to 2-aminocellulose. Chitosan is composed of linear beta-(1-
4)-linked monosaccharaides (Figure 2.13). These monosaccharaides include 2-amino-2-
deoxy-beta-D-glucan in combination with glycosidic linkages (Risch and Reineccius 
1995; Bansal and others 2012). 
Chitosan is protonated at acidic conditions making it a good candidate for 
coacervation and ionic gelation reactions. At acidic pH ranges, amino groups undergo 
protonation thus becoming soluble in water.  Thus, chitosan is a cation which allows for 
unique bonding characteristics due to its electrostatic potential.  Chitosan has a ridged 
crystalline structure built through inter- and intra-molecular hydrogen bonds. The 
cationic nature of chitosan in acidic solution allows chitosan to adhere to negatively 
charged molecules such as alginate (Agnihotri and others 2004). This is a key point as 
chitosan can be manipulated to be useful in food pH ranges. Solubility of chitosan 
depends on the free amino and N-acetyl group distribution. Literature shows that 1-3% 
acetic acid is sufficient to solubilize chitosan in solution (Sinjan and Robinson 2003; 
Sarmento and others 2006; Li and others 2008).  
Recent advances in nanoparticle research has proposed chitosan to be used in gel 
forming systems with multivalent anionic counterions like polyphosphate and sodium 
alginate by ionic cross linking methods, coacervation, or ionic gelation methods 
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(Agnihotri and others 2004). Chitosan nanoparticles prepared via ionic gelation have 
been examined in the past decade as delivery media for drugs with low molecular weight 
(Koukaras and others 2012). Chitosan is efficient in the entrapment of drugs and has 
been shown in literature to reinforce nanoparticle structure by creating impermeability 
and preventing rapid diffusion out of particle (Risch and Reineccius 1995). Chitosan 
allows nanoparticles to enlarge their surface area via swelling to compensate for osmotic 
differences between interior and exterior nanoparticle environments (Ruo 2012). 
Chitosan is advantageous for use in nanoparticle systems due to its ability to 
control the release of active agents, nontoxic nature, ability to avoid use of organic 
solvents, readily available free amine groups for cross linking, and good electropotential 
(Agnihotri and others 2004). Chitosan also possesses antimicrobial properties, good 
adhesive properties, coagulation abilities, and absorbs toxic metals (Berger and others 
2004; Kong and others 2010). Chitosan is also effective in releasing water soluble drugs 
and enhancing the bioavailability of poorly water soluble compounds (Peniche and 
others 2003). This is a key issue as the active encapsulant in this research, trans-
cinnamaldehyde (TC), is hydrophobic. 
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Figure 2.7. Conversion of chitin to chitosan. Adapted from Ahirrao and others (2013). 
 
 
2.4.2 Alginate  
Sodium alginate is an anionic polysaccharide and hydrocolloid which forms ionic 
mediated gels. Alginates are widely used natural polymers in the preparation of micro 
and nanoparticles with sustained release dosage. Alginates are obtained primarily from 
Laminaria hyperborean, Ascophyllum nodosum, and Macrocystis pyrifera species of 
brown algae. They are widely abundant in nature and can easily form nanoparticles due 
to its ability to form hydrogels upon cross-linking. This ability to gel under mild 
conditions makes alginate the polymer of choice in food applications (Peniche and 
others 2003; Thwala 2012). Alginate has the unique property of forming water insoluble 
gels through IG. Formation of alginate gel is simple, mild, and eco-friendly with the 
main function of entrapping active molecules rapidly (Ahirrao and others 2013; Peniche 
and others 2003). 
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Sodium alginate is water soluble sodium salt of alginic acid (Figure 2.8). Alginic 
acid is a linear unbranched copolymer composed of D-mannuronic acid (M) and L-
guluronic acid (G).  The M and G monomers are 1, 4 linked by glycosidic bonds, 
forming homopolymeric M or G blocks and heteropolymeric MG blocks (Figure 2.13). 
The functional properties of alginate are strongly associated with the composition and 
sequence of M and G acids. Alginates polyanionic character is a result of carboxyl 
groups along its polymeric chain. Every sugar on the chain contains a carboxyl group. 
The degree of ionization of carboxyl groups is a function of pH and decreases as the pH 
decreases.  Alginate maintains a negative charge under acidic conditions which is ideal 
for forming complexes with polyvalent cations such as chitosan, calcium, or aluminum. 
The cations act as bridges between the anionic polymer chains, constituting junction 
zones, forming a hydrogel network (Daemi and Barikani 2012).  
Advantages of using sodium alginate include the ability to encapsulate lipophilic 
drugs, utilized in a multiplicity of techniques, high stability, simplicity, non-toxicity, 
biocompatibility, and low cost. Also, alginate has the highest mucoadhesive strength  
compared to other natural and synthetic polymers (Thwala 2012). Drawbacks of use are 
that the porous structure without addition of membrane coating to reduce permeability as 
well as the low viscosity of alginate solutions cause lack of mechanical and physical 
stability. Therefore, the use of alginate is limited due to its low physical stability and 
subsequent degradation at acidic pH ranges causing faster release of entrapped active 
ingredients. In order to add mechanical strength to alginate, coating alginate beads with 
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polycations has been suggested in literature. Chitosan can be utilized in this fashion 
(Sinjan and Robinson 2003; Thwala 2012; Patil and others 2010). 
 
 
 
 
Figure 2.8. Structure of alginic acid. Adapted from Ahirrao and others (2013). 
 
 
2.4.3 Calcium-Alginate Complex 
Calcium chloride plays a key role in nanoparticle synthesis in the pre-gelation 
step.  Calcium chloride is a commonly used cross-linker that interacts with G blocks of 
alginate due to structurally favorable chelation sites to form insoluble meshwork pre-gels 
(Figure 2.9 and Figure 2.10)(Ahirrao and others 2013). Calcium chloride was chosen for 
this study because it has been highly reported to be optimal for encapsulation efficiency 
of several active drugs with high mechanical strength and low toxicity (Khazaeli and 
others 2008; Thwala 2012; Joshi and others 2012). Literature shows that the pre-gel state 
is essential in enabling ionic interaction between calcium-algiante and chitosan in the 
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PEC step. Thus, stability of the trans-cinnamaldehyde loaded chitosan-alginate 
nanoparticles (LCA-NP) can be increased by incorporating calcium chloride in the 
gelation of alginate step.  As the concentration of calcium chloride increases the rate of 
chitosan binding increases (Patil and others 2012). Sinjan and Robinson (2003) found 
the optimal mass ratio of alginate to calcium chloride to chitosan to be 100:17:10. Many 
researchers have reported calcium cross linked alginate beads for different controlled 
release applications and delivery applications (Thwala 2012; Daemi and Barikani 2012; 
Mumper and others 1994; Rajaonarivony and others 1993). These studies use the 
calcium–alginate cross-linking step as a cross-linking step and not as a final nanoparticle 
formation step.  
 
 
 
 
Figure 2.9. Electrostatic interaction between carboxyl groups of alginate and calcium 
ions. Adapted from Ahirrao and others (2013). 
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Figure 2.10. Cross linked structure of sodium alginate and calcium ions. Adapted from 
Ahirrao and others (2013). 
 
 
2.4.4 Trans-cinnamaldehyde (TC) 
Active encapsulants or molecules can include flavors, antimicrobial agents, 
nutraceuticals, vitamins, minerals, colors, nutrients, enzymes, cross-linking agents, and 
yeast among many others (Figure 2.11).  Core materials are normally in the form of 
either solid, liquid, or gas and are used in the form of a solution, dispersion, or emulsion.  
Size of the core material effects permeability, diffusion, and controlled-release 
applications. Hydrophobicity is one of the critical attributes that play a significant role in 
determining encapsulants entrapment efficiency as well as controlled release into a food 
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system. The major problem in this research was determining the correct method to 
encapsulate hydrophobic TC with two hydrophilic polymers; chitosan and alginate.   
Trans-cinnamaldehyde (Figure 2.12) or cinnamic aldehyde (3-phenyl-2-
propenal) is a component in cassia oils, cinnamon bark oils, and is also a Generally 
Recognized as Safe substance based on 21 CFR part 172.515 (CFR 2009). It is a cyclic 
terpene alcohol with low water solubility (Gomes and others 2011). It is viscous, liquid, 
organic compound that is responsible for the flavor and odor associated with cinnamon 
and naturally present in the bark of cinnamon trees. It is an essential oil with great 
antimicrobial and antioxidant properties which makes it ideal for the use in food systems 
(Chia-Wen and others 2009; Yen and Chang 2008; El-Baroty and others 2010; Kong and 
others 2010). TC has been shown to be one of the most effective antimicrobials against 
foodborne pathogens and also shows more inhibitory action in comparison to purified 
oils (Gomes and others 2011; Beuchat 1994). Although it has low solubility in water, 
entrapping TC can prevent loss of volatility and improve solubility of the oil, thus 
improving delivery to an aqueous system.  Water soluble polymers have been used in 
pharmaceutical research to increase drug solubility. The polymers can interact with drug 
molecules via electrostatic bonds such as ion to ion, dipole to dipole, or other forces such 
as Van der Waal and hydrogen bridges. These interaction participate in drug-polymer 
complex formation (Thwala 2012). 
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Figure 2.11.  A brief illustration of the aim of encapsulation along with some examples 
of core materials. Adapted from Fang and Bhandari (2012). 
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Figure 2.12. Structure of trans-cinnamaldehyde. Adapted from ColeParmer (2014). 
 
 
2.4.5 Active Molecule Entrapment  
Entrapment is the trapping of active encapsulant molecules within or throughout 
a matrix. Encapsulation with semi-permeable membranes has been used to attain slow 
and prolonged release of active molecules. A successful nanoparticle system should have 
a high active substance loading capacity (Ruo 2012). Various methods of loading have 
been developed to improve the efficiency of loading which is dependent on the method 
of preparation as well as the physical properties of the drug and the polymer. Active-
substance loading is normally achieved by two methods: incorporation or absorption. In 
these systems the drug is physically embedded into the matrix or adsorbed onto the 
surface. Incorporation is the loading of active molecules at the time of nanoparticle 
production. Absorption is loading of drug after formation of nanoparticles by incubating 
the carrier with a concentrated drug.  Incorporation gives a low initial burst effect and 
better sustained release characteristics in comparison to absorption methods. The 
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biopolymer membrane layer will control the diffusion out of the nanoparticle while also 
protecting the particle from environmental stressors (Mohanraj and Chen 2006; Patil and 
others 2012). 
Maximum loading can be achieved through incorporation. Ford and others 
(1999) found that hydrophobic peptides dissolved in water miscible organic solvents can 
be precipitated in the aqueous phase as discrete spherical particles. Li and others (2008) 
also found the same precipitation to occur by dissolving a hydrophobic drug in a mixture 
of dehydrated alcohol and water before the addition of calcium chloride. This resulted in 
the Tyndall effect, or light scattering by particles in a colloid or fine suspension. This 
procedure can be used to allow for trans-cinnamaldehyde entrapment (Sarmento and 
others 2007; Sarmento and others 2006; Gupta and others 2011; Li and others 2008; 
Thwala 2012). 
2.4.6 Chitosan-Alginate Complexation 
Alginate has been mixed with other polymers to form PEC to solve problem of 
drug leaching and instability. Likewise, chitosan will form nanoparticles on its own but 
the matrix is often to permeable.  Alginate shrinks in low pH and dissolves in high pH 
ranges while chitosan dissolves in low pH and is insoluble at high pH ranges. The high 
solubility of chitosan at low pH ranges is prevented by the alginate network due to 
alginate being insoluble in the low pH range. Similarly, dissolution of alginate at high 
pH is prevented by stable chitosan at high pH. Thus, complexation of oppositely charged 
polyelectrolytes has been used to strengthen alginate particles and reduce porosity 
(Leonard and others 2004). 
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The strong electrostatic interaction of the amine groups (NH2
+) of chitosan with 
the carboxyl groups (COO-) of alginate in acidic pH ranges leads to the formation of 
chitosan-alginate nanoparticles (Figure 2.13). Amino groups on chitosan become 
protonated and carboxyl groups on alginate become ionized leading to chitosan binding 
onto the surface of alginate. As chitosan solution is dropped into alginate solution, the 
spreading of alginate particles decreases as the chitosan viscosity increases. This leads to 
decreased maneuverability and freedom resulting in the production of small and uniform 
particles. Alginate‘s function is to entrap TC while chitosan‘s function is to add 
mechanical strength to the nanoparticle (Thwala 2012; Sezer and Akbuga 1999; Mumper 
and others 1994). Chitosan-alginate complex nanoparticles are stabilized through 
Brownian motion, or the thermal motion of particles in the colloidal size range. 
Gravitational forces normally would cause particles to sediment. However, Brownian 
motion and gravitational forces oppose each other, but at small particles sizes Brownian 
forces dominate leading to suspended particles (Abdelwahed and others 2006).  
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Figure 2.13. (a) Representative structure of sodium alginate with G unit residues, and M 
unit residues, and glycosidic linkages (b) Representative structure of chitosan. Adapted 
from Lertsutthiwong and others (2009) and Wang and others (2006). 
 
 
2.4.7 Surfactant Choice 
Essential oils can be emulsified in an ―oil in water‖ emulsion using surfactants. 
Surfactants are compounds having active hydrophilic and lipophilic reactive groups on 
the same surfactant molecule.  Thus, surfactants are able to arrange themselves to lower 
interfacial tension leading to formation of water based emulsion. Tween 20 (Polysorbate 
20) is a non-ionic and food permitted solubilizing agent. 
  Surfactants such as Tween 20 may bind strongly to both hydrophilic and 
hydrophobic sites of polymers, forming high energy links between chains. These links 
can be formed in C-A polyelectrolyte complexation where the stronger and tighter 
structures lead to smaller particle size.  Li and McClements (2013) showed that mean 
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droplet diameters in ―oil in water‖ emulsions prepared using a homogenizer were 
considerably larger if polymer is used without combination of a surfactant.  Edris and El-
Galeel (2010) presented that the best surfactant to solubilize large amounts of cinnamon 
oil in a surfactant water system was Tween 20. The study also showed Tween 20 would 
solubilize more pure cinnamic aldehyde and cinnamon oil at different surfactant to water 
ratios in comparison to Tween 80. Tween 20 has a lower hydrophilic-lipophilic balance 
(HLB value) versus Tween 80 meaning that Tween 20 has higher strength of the 
lipophilic groups of the surfactant molecule hence stronger lipophilic nature. If an 
essential oil and a surfactant have similar polarity or HLB, maximal solubilization takes 
place (Edris and El-Galeel 2010). The HLB value of Tween 20 is 16.7 which in the HLB 
region appropriate for solubilization of oils. Tween 20 is also a simple, economical, and 
feasible solution to create an emulsion for the solubilization of TC in this study.  
2.4.8 Solvent Choice 
 The selection of organic solvent is important in developing a successful 
nanoparticulate formulation. The miscibility of the solvent with water and its ability to 
dissolve the chitosan, alginate, and entrapped TC impacts overall encapsulation 
efficiency of TC and particle size. Generally, solvent should have low solubility in water 
to yield a more stable emulsion and formulate high-quality nanoparticles (Bala and 
others 2004). Other important aspects of solvent choice are toxicity and purification 
method. Acetonitrile was chosen for this study due to its polar, aprotic nature (i.e. 
solvent that will dissolve many salts but lacks an acidic hydrogen, thus can accept 
hydrogen bonds). It is a medium polarity solvent which is miscible in 
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water.  Acetonitrile is more polar than common solvents used in nanoparticle 
formulation such as acetone and ethyl acetate. In a study by Galanakis and others (2011) 
it was found that cinnamic aldehyde generally solubilized easiest in polar aprotic 
solvents such as dichloromethane and acetone. The dielectric constant of TC is 16.9 
while the dielectric constant of acetonitrile is 37, higher than that of acetone (i.e. 20.7). 
Thus, acetonitrile should allow higher dissolution of TC. 
2.5 Nanoparticle Treatment Post Assembly 
2.5.1 Introduction 
Nanoparticles should be free from impurities and the degree of purification 
depends upon the final purpose of the formulation developed.  All impurities were 
attempted to be removed in this study through the use of filtration. The most commonly 
used procedures in literature are gel filtration, ultracentrifugation, centrifugal filtration, 
dialysis, and cross-flow filtration. 
2.5.2 Stability 
Homogenization and sonication are utilized to reduce particle size and 
aggregation as well as improve uniformity of nanoparticles. Homogenization is a fluid 
mechanical process that involves shearing of particles to create a stable evenly 
distributed dispersion or emulsion. Increasing shear or energy input can reduce size of 
particles and disrupt aggregates (Harte and Venegas 2012).  A reduction in the mean 
diameter of the particles increases the number of individual particles. This leads to a 
reduction of the average particle diameter and increases the particle surface area. Ahmed 
and others (2012) found that increasing homogenization speed produced smaller solid 
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lipid nanoparticles with a small polydisperity index and homogenous distribution of 
particle size. However, downfalls of homogenization include tearing and stretching of 
nanoparticles. 
Sonication is the act of applying ultrasonic frequencies to agitate particles in a 
sample to speed up dissolution by breaking intermolecular interactions and prevent 
aggregation of particles. In addition, sonication is useful for evenly dispersing 
nanoparticles in liquids. A study by Al-Kaysi and others (2005) demonstrated that 
sonication provides an approach to exert control over particle size, morphology, and 
colloidal stability. Sonicators are commonly used for dispersing, deagglomerating, 
particle size reduction, particle synthesis, precipitation, and surface functionalization 
applications (Qsonica 2014). 
2.5.3 Purification 
 A rotary evaporator is utilized to remove any remaining volatile solvents. This 
instrument can remove acetonitrile under evaporation at reduced pressure. Removal of 
solvent is essential to eliminate toxicity concerns and interference during freeze drying. 
By lowering the pressure of the nanoparticle solution, the boiling point of incorporated 
acetonitrile is lowered allowing for simple extraction. The boiling point of acetonitrile is 
179.6°C. Thus, lowering the pressure of the acetonitrile solution reduces the boiling 
temperature.  
2.5.4 Filtration  
Tangential filtration, also called cross flow filtration is utilized to filter 
nanoparticles and remove excess aggregates, unreacted polymer, or foreign materials. In 
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tangential filtration, the sample being filtered travels tangentially across the surface of 
the filtration membrane, and two exiting streams are generated. The permeate stream is 
the portion of the fluid that passes through the membrane. This filtered fluid will contain 
some percentage of soluble and/or insoluble components from the initial feed stream that 
are smaller than the membrane removal rating (50 kDa cutoff). The remainder of the 
feed stream, which does not pass through the membrane, is the retentate stream (Koros 
and others 1996; Pall 2013).  
Advantages of using tangential filtration include ability to set molecular weight 
cutoff, a higher overall liquid removal rate, and continuous operation at relatively high 
solid loads without blinding due to trapped particles on the filter surface to be rubbed 
off. Membrane filters can have pore sizes between 0.001 and 0.1 microns. Tangential 
filtration has greater throughput capacity compared to traditional cartridge direct flow 
filtration. Limitations include long processing times, difficult cleaning procedures, short 
membrane life, and pH and temperature sensitive membranes (Pall 2013).  
2.5.5 Lyophilization  
Lyophilization, or freeze-drying, is a process used to preserve and improve 
storage stability of nanoparticles that would normally degrade or become contaminated 
in suspension by microorganisms.  Lyophilization works through the freezing of a 
material and reducing pressure to allow sublimation of ice to gas. Essentially, the solvent 
is removed from the system. In the case of nanoparticle assembly, the solvent is 
commonly water as harsh solvents are removed via evaporation.  Freeze drying is a 
commonly accepted method to remove water from nanoparticles formulations (Hirsjärvi 
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2008). Freeze drying is affected by freezing rate, temperature, pressure, cryoprotectant 
use, and changes in pH or ionic strength. Ideally, nanoparticles should be easily 
resuspended after lyophilization without physical changes. 
Nanoparticles are normally isolated by freeze-drying using cryoprotective agents 
such as trehalose or mannitol.  Trehalose, utilized in this research, will help protect the 
physical integrity of purified nanoparticles and from any freeze drying and desiccation 
related stresses. Trehalose aids in the redispersibility of nanoparticles and helps prevent 
aggregation of nanoparticles during the freeze-drying process (Liu 2014). Trehalose is 
best utilized in a trehalose to polymer mass ratio of 1:1 (Abdelwahed and others 2006). 
The protective mechanism of trehalose is due to its amorphous matrix. Protection arises 
when the amorphous matrix forms hydrogen bonds with the nanoparticles. Trehalose 
will act as a substitute to water inhibiting the destructive effect of ice crystals. Thus, the 
use of trehalose enables a wider temperature scale for drying (Hirsjärvi 2008; 
Abdelwahed and others 2006).  Trehalose is a preferred cryoprotectant compared to 
other sugars due to its low hygroscopicity, absence of internal hydrogen bonds which 
allows for more flexible formation of hydrogen bonds with nanoparticles, low chemical 
reactivity, and high glass transition temperature (Abdelwahed and others 2006; Astete 
and others 2009). 
Advantages of freeze drying nanoparticles include improved reconstitution and 
redispersibility characteristics, reduced foreign matter, and enhanced sterility. In 
comparison to spray drying, freeze drying is accomplished at low temperatures and is 
less destructive to nanoparticles. Disadvantages of the process include cost, high purity 
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of solvents needed, difficult handling procedures, and potential aggregation in lag time 
before nanoparticles are dry (Hirsjärvi 2008). 
2.6 Design Constraints and Processing Parameters 
2.6.1 Introduction 
Processing parameters such as stirring time, droplet size, and equilibration time 
affect the formation of nanoparticles thus affecting particle size, shape, size distribution, 
and entrapment efficiency.  The average size and uniformity of nanoparticles impacts the 
encapsulation ability and release kinetics.   
2.6.2 Processing Parameters 
Optimization of nanoparticle size during assembly is an important phase of this 
research in regards to assembling a delivery system with optimal TC entrapment.  To do 
this, processing parameters must be optimized. Processing parameters include stirring 
time, homogenization time, sonication time, equilibration time (time elapsed from post-
assembly to freezing), and concentration of drug to polymer. Gupta (2011) optimized 
stirring rate at 800 RPM and optimal stirring time at 90 minutes.  In the same study, the 
optimal drug to polymer mass ratio was determined to be 5:75 for TC:alginate and 5:50 
for TC:chitosan. The optimal concentration of cross linking agent used was determined 
to be 2 ml. With optimal parameters considered, the entrapment efficiency was on 
average 91% while particle size was 245 nm.  Droplet size of chitosan and alginate as 
well as homogenization rate and time, and sonication time will affect the size of loaded 
chitosan alginate nanoparticles. A number of studies use differing processing 
parameters, thus it is important to consolidate these methods into one standard method 
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(Thwala 2012; Sarmento and others 2007; Gupta 2011; Li and others 2008; 
Rajaonarivony and others 1993). 
2.6.3 Particle Size  
Particle size and size distribution are critical characteristics of nanoparticle 
systems. The average size and uniformity of nanoparticles impacts the mechanical 
stability, permeability, handling ease, encapsulation ability, and diffusion kinetics. 
Smaller particles have larger surface area to volume ratio therefore most of the 
encapsulant material is located near or at the particle surface leading to faster drug 
release (Li. and others 2008). Although small particles have greater risk of aggregation 
and gelation, small particles form faster leading to higher entrapment efficiency.  Larger 
particles have larger cores and the encapsulant can diffuse out of nanoparticles over 
longer formation times.  Larger particles also degrade and erode at a more rapid rate than 
smaller particles (Berkland and others 2004; Ghosh 2006). 
Chitosan molecular weight has a direct effect on properties of nanoparticles.  In a 
study by Honary (2009) involving low, medium, and high molecular weight chitosan, it 
was found that increasing molecular weight of chitosan decreased the diameter of 
particles. It was also determined that higher concentration chitosan solution formed 
larger size particles.  Thus, polymer molecular weight and concentration has a direct 
effect on size and encapsulation potential. Fortunately, chitosan and alginate‘s final 
particle size is easily changed as concentration dependence on biopolymers relates 
directly to particle size.  
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2.7 Characterization of Assembled Nanoparticles  
2.7.1 Particle Size Analysis 
The most routine and current method for determining particle size is through the 
use of dynamic light scattering (DLS).  DLS has been a vital probe into the structure and 
dynamics of nanoscale materials. Results from DLS can be verified though the use of 
transmission electron microscopy (Mohanraj and Chen 2006).  Laser diffraction sizing is 
highly efficient and repeatable compared to other sizing methods.  
DLS relies on the superposition of a scattered light field. Nanoparticles exist in 
aqueous suspension and are not stationary. These particles are undergoing Brownian 
motion which brings upon frequency and phase changes of scattered light. Nanoparticles 
block a laser beam that the DLS instrument emits. A scattered wave is generated from 
the path that is blocked and reaches the DLS detector at a fixed position. Thus, the 
detector accumulates the signal and the superimposition of the electrical field is 
calculated. Each particle in solution carries its own phase determined by its relative 
position.  The intensity, angular distribution, and polarization of the scattered light carry 
data about the particles size, shape, and electrical character.   
2.7.2 Encapsulation Efficiency  
Encapsulation efficiency, also known as drug loading efficiency, is a measure of 
the amount of entrapped active compound in nanoparticles. It is expressed throughout 
literature as the amount of active compound entrapped relative to the initial active 
compound amount.  In this study, encapsulation efficiency is the amount of TC 
entrapped relative to the initial TC added during incorporation into alginate solution. 
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Encapsulation efficiency is one of the critical properties of nanoencapsulation and its 
applications. Nanosystems with high loading efficiency often use less wall material and 
need less net amount of encapsulated compound to deliver the required amount of core 
material (Liu 2014). 
Generally, steps for encapsulation efficiency include completely dissolving 
resuspended lyophilized nanoparticles and determining concentration of active 
compound via spectroscopy methods or high-performance liquid chromatography.  
2.7.3 Cumulative Controlled Release 
Controlled release is the modification of the rate or place at which an active 
substance is released. This modification can be made using materials with certain barrier 
properties for manipulating the release of an active substance to provide sensory or 
functional benefits (Lakkis 2007) . Functional benefits could include antioxidant, 
antimicrobial, or nutrient properties.  
Controlled release can be broken down into two modes: delayed release or 
sustained release. Delayed release is the release of an active substance being delayed to a 
point where the release is favored. Sustained release is designed to release an active and 
maintain constant concentration of that active to the target site. Release of TC from 
trans-cinnamaldehyde loaded chitosan-alginate nanoparticles (LCA-NP) in this research 
will be initiated through the use of phosphate buffered saline (PBS) stressor at pH 7.4. 
Stressors can include temperature, moisture, pH, enzymes, and shear (Li and others 
2008). The release profiles are expected to show two phases. The first phase is from the 
initial burst release followed by a second phase of uniform controlled release.  This 
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effect is primarily based on the fact that a large concentration of TC may be attached 
close to the surface of the particle allowing for rapid release as well as permeability of 
thin polymeric membrane coating.  The second release phase, uniform release, is due to 
the diffusion of the drug molecules from the inner compartment and core. In the first 
several hours of the release phase, higher pH levels should correlate with a higher 
concentration of TC release (Sinjan and Robinson 2003). 
 In vitro release testing is one of the most important analyses to assure the 
functionality of an encapsulated ingredient due to the estimation of the behavior of 
nanoparticles in actual applications, by using similar environmental conditions. 
Controlled release also evaluates the sensitivity of the diffusion release mechanism.  
Release tests are referred to as release profiles where cumulative concentration or 
percentage release of the TC is plotted against time, as in this study. The release rate of 
the TC in this study is dependent on its solubility, nanoparticle morphology, size, pH of 
media, polarity, density of the particulate system, desorption of any surface-bound 
active, active diffusion through the nanoparticle matrix, and the combination of erosion 
and diffusion processes (Mohanraj and Chen 2006; Liu 2014; Wise 2000). 
The pH dependent behavior of alginate and chitosan allows for the modification 
of release profiles (Thwala 2012). The release medium used in this research is PBS. PBS 
is an isotonic water based buffer solution containing sodium phosphate and sodium 
chloride. Over time, PBS degrades LCA-NP to release TC. This release involves the 
following three steps: PBS penetration into loaded nanoparticle system, swelling of the 
matrix, conversion of the glassy polymer into a rubbery matrix, and diffusion of the drug 
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from the rubbery matrix (Liu 2014). If the diffusion of TC out of nanoparticle is faster 
than matrix erosion, the mechanism of release is primarily diffusion. The membrane 
polymer acts as a barrier to release and is therefore the most important parameter in 
active substance release. The diffusion mechanism of controlled release acts to limit the 
release of TC by controlling the diffusion of TC from its location in the particle to the 
surface of the particle. Diffusion is controlled by the solubility of a component in the 
matrix and the permeability of the component through the matrix.  The true driving force 
for diffusion is the activity or chemical potential as related to the vapor pressure on each 
side of the membrane(Mohanraj and Chen 2006; Liu 2014; Wise 2000). 
Literature shows drug release kinetics as being primarily first order as well as 
swelling and erosion being the main causes of drug release. Based on work done by Li 
and others (2008), it is expected that the mechanism of active release may follow non-
Fickian behavior after initial burst release. Other controlled release methods found in 
literature include side-by-side diffusion cells with an artificial or biological membrane, 
dialysis bag method, ultracentrifugation, and centrifugal ultrafiltration (Jawahar and 
Meyyanathan 2012). 
2.7.4 Spectroscopy 
Ultraviolet spectroscopy will be utilized in this study as a quantitative analysis 
method to determine the concentration of TC in solution as a result of encapsulation 
efficiency and in vitro release tests (Rajaonarivony and others 1993). Ultraviolet 
radiation interacts with matter causing electrons to move from a grounded state to a high 
energy state. The ultraviolet region falls in the range of 190-380 nm. UV absorption 
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spectroscopy measures the radiation that is absorbed by a compound at that wavelength. 
Absorption is dependent on the compound, concentration, and molecular structure. TC 
absorbs radiation at 280 nm (Čeppan and others 1993; Gomes and others 2011). Beer's 
Law can be utilized to find the unknown TC concentration from absorbance readings at 
280 nm. This is done through the use of a standard curve, where TC concentrations are 
accurately known and experimental absorbance is read.   
2.7.5 Differential Scanning Calorimetry  
 Differential scanning calorimetry (DSC) will be utilized as a thermal 
characterization tool for trans-cinnamaldehyde loaded chitosan-alginate nanoparticles 
(LCA-NP). Thermal characterization assists in understanding structural properties, 
hydrophilic properties, and associate state of nanoparticles.  A complete thermal profile 
will also validate thermal oxidative stability, loss of water in polymers, depolymerization 
at high temperature, and confirm inclusion of active compound in nanoparticle formation 
(Hill and others 2013a; Thwala 2012).  This information is used to characterize 
materials, design products, predict performance, optimize processing conditions, and 
improve quality.  Shifts in endothermic and exothermic peaks show polymer-polymer 
interactions as well as active compound-polymer interactions. 
 DSC works on the thermodynamic concept of heat flow differences between 
sample and a reference. Thus, calorimeters measure the amount of heat absorbed or 
released during material transformation (Thwala 2012).  DSC outputs a plot of heat flow 
as a function of temperature. Heat flow is determined by measuring the temperature 
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difference over an accurately known thermal resistance. The difference of heat flow of 
reference to the heat flow of the sample is final heat flow.  
DSC will be used to study complex formation between TC and LCA-NP 
(Sarmento and others 2006; Hill and others 2013a; Kamimura and others 2014). TC is 
liquid at room temperature and can be confirmed to be included in the inclusion complex 
indirectly by comparing the thermal stability of the free TC with the encapsulated 
TC. The boiling point of TC should disappear in the LCA-NP thermogram confirming 
that TC has been included into the nanoparticle inclusion complex. The energy change 
associated with water loss and depolymerization at high temperatures along with 
exothermic and endothermic peak shifts will help indicate interaction of entrapped TC 
with the wall forming biopolymers chitosan and alginate.  
DSC diagrams should show two peaks. It was expected that an endothermic peak 
would arise at 80ºC to 120ºC and an exothermic peak would arise at 146°C. The first 
peak should be attributed to the loss of water from the nanoparticles while the second 
peak attributed to the partial crystallization of TC after the loss of water at 120ºC 
(Honary 2009). DSC curves should show a broad endothermic peak as the nanoparticle 
becomes anhydrous as well as exothermic region at high temperatures corresponding to 
depolymerization and decarboxylation of polymers. The broader endotherm is associated 
with the loss of bound water.  
The advantages of DSC include rapid measurements, both solids and liquid can 
be tested, programmability, and functionality. Hermetically sealed aluminum pans with a 
pinhole for pressure reduction are used to incinerate samples. Aluminum pans allow for 
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a highly conductive capsule distributed in a thin layer reducing internal resistance of the 
sample. This allows for superior temperature control and maximized heat transfer (Elmer 
2014).  
2.7.6 Transmission electron microscopy 
Surface characteristics will be evaluated using transmission electron microscopy 
(TEM). An electron beam will be transmitted through an ultra-thin nanoparticle 
specimen under vacuum and will interact as it passes through the sample. An image is 
formed from the transmitted electrons to a phosphorescent screen or camera. The TEM 
will interact with nanoparticles through transmission rather than absorption. This test 
will also allow nanoparticle size to be estimated. TEM should confirm nanoparticle 
shape; spherical with smooth surfaces.  TEM is a versatile sizing and morphology 
characterization method. However, TEM is limited by its stringent sample requirements 
as well as its laborious and time-consuming sample preparation. Advantages of TEM in 
comparison to a scanning electron microscope (SEM) include less electron interaction 
with specimen, cheaper and less sample contamination (Bala and others 2004; Thwala 
2012).  
2.8 Applications of Assembled Nanoparticles 
2.8.1 Antioxidant Capacity 
 Free radical reactions are a common occurrence in food systems. Free radicals 
can be in the form of reactive oxygen and nitrogen species. Free radical production is 
initiated through oxidative stresses (Singh and others 2007). They are generated as a 
result of normal metabolic processes or from extraneous stressor. They can initiate 
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peroxidation or the accumulation of lipid peroxides.  Polyunsaturated fats are easily 
oxidized by molecular oxygen and are a major cause of oxidative deterioration, 
nutritional loses, and sensory changes.  Antioxidants have been used in the food industry 
to prolong shelf life of foods prone to oxidation. Antioxidants provide a way to scavenge 
these free radicals in food products thus maintaining sensory parameters of foods and 
increasing shelf life stability.   Essential oils have potential to act as natural food 
preservatives. They are being increasingly used as antioxidants in food applications due 
to their safe status, acceptance by consumers, and high functionality (Chia-Wen and 
others 2009; Yen and Chang 2008). Cinnamon bark has been shown to have free radical 
scavenging potential (Singh and others 2007). Chia-Wen and others (2009) found 
cinnamon bark at 5 mg/ml showed highest DPPH free-radical scavenging activity of 
about 91.4%. TC is a large component of cinnamon bark and is an important antioxidant 
compound (Chia-Wen and others 2009; Shimada and others 1992; El-Baroty and others 
2010). Cinnamon extracts in ethanol or methanol have been reported to show 
considerable antioxidant activities at a 1:1 mass ratio (Rao and Gan 2014). 
 Scavenging of DPPH free radical is the basis of a common antioxidant assay 
(Sharma and Bhat 2009). 2,2-Diphenyl-2-picrylhydrazyl (DPPH) (Figure 2.14) is a 
stable free radical with an unpaired valence electron at one atom of its nitrogen bridge. 
DPPH shows absorption at 517 nm on a spectrophotometer due to presence of hydrogen 
free radical. When it encounters proton radical scavengers, DPPH‘s innate purple color 
fades to a yellow. Thus, the concentration of DPPH lost gives an indication of 
scavenging power. Decreased absorbance of DPPH indicates increased rate of 
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antioxidant effect. This antioxidant test will determine the ability of LCA-NP to reduce 
oxidation, inhibit fatty acid oxidation, and lipid peroxidation in vitro with potential food 
application (Sharma and Bhat 2009; Chien and others 2007; Shimada and others 1992) 
The DPPH assay is simple, rapid, inexpensive, and will yield a radical 
scavenging activity profile for nanoparticles. The DPPH method can be used for solid or 
liquid samples and is not specific to any particular antioxidant component. However, it 
applies to the overall antioxidant capacity of the sample. Measuring the total antioxidant 
capacity will determine functional properties of foods or in the case of this research the 
nanoparticles. Essentially, DPPH solution was added to apple juice containing LCA-NP. 
LCA-NP release TC where TC acts as an antioxidant scavenging free radicals. The 
antioxidant effect (%) = (1-Absorbancesample, 517nm/Absorbance control, 517nm)*100.  
Apple juice is an important food commodity because of its nutritional value and 
its ability to inhibit the oxidation of low density lipoprotein in humans. It is widely 
consumed in  many countries and is a relatively cheap product (Chien and others 2007). 
Apple juice can also be purchased as a transparent medium which is convenient for 
spectrophotometric studies.  
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Figure 2.14. Structure of DPPH. Adapted from (Sharma and Bhat 2009). 
 
 
2.8.2 Antimicrobial Effectiveness  
2.8.2.1 Introduction 
International and domestic outbreaks of pathogens such as Listeria 
monocytogenes and Escherichia coli O157:H7 justifies the continuous search for ways to 
inhibit these microorganisms and improve food safety without sacrificing quality. The 
majority of foodborne illness associated with fresh produce are caused by Salmonella 
enteritidis, E. coli O157:H7, L. monocytogenes, and Campylobacter jejuni (Kong and 
others 2010). E. coli O157:H7 and L. monocytogenes are of particular importance due to 
their detection in a high variety of foods as well as their ability to affect 
immunocompromised individuals. Increasing consumer demands for high-quality and 
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microbial safe foods paralleled with longer product shelf life are continuously forcing 
researchers to develop novel food preservative strategies (Jin and Zhang 2008). 
Recently, natural antimicrobials such as essential oils have been of research 
interest due to low toxicity, biodegradability, and consumer perception (Kalemba and 
Kunicka 2003). Minimum inhibitory concentration and minimum bactericidal 
concentration analysis were used to determine effectiveness of LCA-NP on inhibiting 
the growth of L. monocytogenes and E. coli O15H7:H7.  This section of the study aimed 
to show the potential for antimicrobial nanoparticles to inhibit the growth of two 
microorganisms that are of principal food safety concern. This data can not only provide 
a better idea of nanoparticle antimicrobial efficacy, but also may assist researchers 
bridging the gap between microbiological safety and stability of foods through the use of 
polymeric nanoparticles that encapsulate essential oils.  
2.8.2.2 Microorganisms 
 Listeria monocytogenes and Escherichia coli O157:H7 are two common 
foodborne pathogens that are of concern in food safety. L. monocytogenes is Gram 
positive, facultative anaerobe, nonspore-forming, motile, rod-shaped bacterium. It is 
catalase positive and oxidase negative and expresses beta-hemolysin for the destruction 
of red blood cells (Mead and others 1999). It is capable of surviving in the presence or 
absence of oxygen. It is present in raw foods with ready to eat meats, poultry products, 
soft cheeses, and seafood commodities. Listeria can live in food processing plants and 
can grow at refrigeration temperatures (FoodSafety 2013). Listeriosis is the serious 
infection caused by L. monocytogenes and is associated with such conditions as 
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gastroenteritis, stillbirth, meningitis, septicemia, and death in immunocompromised 
individuals (Brandt and others 2010). L. monocytogenes can grow and replicate inside 
host cells and is considered one of the most virulent foodborne pathogen with 20-30% of 
clinical infections leading to death (Ramaswamy and others 2007). The CDC estimates 
approximately 1600 illnesses and 260 deaths due to listeriosis annually in the United 
States. This amounts to 0.29 cases per 100,000 people from 2009 to 2011 and is the third 
leading cause of death amongst foodborne bacterial pathogens (CDC 2014; Mead and 
others 1999). Recent domestic and international listeriosis outbreaks and death totals 
include: multistate outbreak in 2011 originating from whole cantaloupes in Colorado (33 
total deaths), multistate outbreak linked to imported Ricotta Cheese in 2012 (2 deaths), 
and outbreaks linked to contaminated product lines in Ontario (6 deaths) (CDC 2014). 
The Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA) 
(e.g. Food Safety Inspection Service (FSIS)) maintain a zero-tolerance policy for L. 
monocytogenes in ready to eat food products (FDA 2003). 
 Escherichia coli O157:H7 is an enterohemorrhagic serotype of E. coli and a 
major food safety concern.  It is a Gram-negative, rod shaped bacterium.  E. coli is a 
facultative anaerobe, is nonspore-forming, and is motile. It is catalase positive and 
oxidase negative. Many E. coli strains are harmless and can be found within the 
intestines of mammals. However, E. coli O157:H7 can produce a Shiga-like toxin and 
cause severe illness and even death.  E. coli O157:H7 is often referred to as ―Shiga 
toxin-producing‖ (STEC). Shiga-toxins are iron-regulated toxins that inactivate 
ribosomal subunits of eukaryotic cells which block mRNA production leading to 
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eventual cell death. Infection is progressive and could lead to gastroenteritis, 
hemorrhagic colitis, diarrhea, kidney failure, and possibly death. E. coli O157:H7 is 
often transferred via fecal to oral route through undercooked contaminated ground beef 
or ground pork (FDA 2013; Mead and others 1999). Recent domestic E. coli O157:H7 
Shiga toxin-producing outbreaks and hemolytic uremic syndrome (HUS) totals include: 
multistate outbreak linked to ground beef (0 HUS), multistate outbreak linked to ready-
to-eat salads (2 HUS), and multistate outbreak linked to frozen food products (2 HUS) 
(CDC 2013). The USDA declared a zero tolerance policy for E. coli O157:H7 in 1994. 
This bacterium is considered an adulterant if detected in raw ground beef, its 
components, and tenderized steaks (USDA 2011).  
2.8.2.3 Minimum Inhibitory and Bactericidal Concentration  
 Agar dilution and broth dilution are the most commonly used techniques to 
determine minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) of antimicrobial compounds, including substances that kill 
(bactericidal) or inhibit the growth (bacteriostatic) of bacteria (Wiegand and others 
2008). The broth dilution method was utilized in this study. Broth dilution uses a liquid 
growth medium containing LCA-NP antimicrobial, which is inoculated with E. coli or L. 
monocytogenes. Following incubation into a microplate well, the presence of turbidity or 
sediment (measured via optical density at 630 nm) indicates growth of microorganisms.  
A limitation of MIC/MBC is that it is a poor predicator of drug efficacy in vivo. The test 
does not give an indication of the mode of action (bactericidal or bacteriostatic) of the 
LCA-NP.  
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Minimum inhibitory concentration is the lowest concentration (mg/L) of an 
antimicrobial that will inhibit the visible growth of a microorganism after 24 h 
incubation at 35°C. MIC is important in analytic test to confirm resistance of 
microorganisms to LCA-NP and also to monitor the activity of new antimicrobial agents.  
A MIC is generally regarded as the most basic laboratory measurement of the activity of 
an antimicrobial agent against an organism (Burt 2004; Wiegand and others 2008).   
The minimum bactericidal concentration (MBC) is the lowest concentration of an 
antibacterial agent required to kill a particular bacterium.  It can be determined from 
broth dilution MIC tests by subculturing to agar plates that do not contain the test agent. 
The MBC is identified by determining the lowest concentration (mg/L) of antibacterial 
agent that reduces the viability of the initial bacterial inoculum by ≥ 3.0 log10  CFU/ml. 
MBC tests use colony-forming units (CFU) as a measure of bacterial viability. This 
means the test can be confounded by antibacterial agents which cause aggregation of 
bacterial cells (Wiegand and others 2008).  
Previous studies with solubilized chitosan, chitosan nanoparticles, and copper 
loaded chitosan nanoparticles against E. coli showed MIC to be highest for solubilized 
chitosan and lowest for copper loaded chitosan particles (Kong and others 2010). MBC 
showed similar results. These conclusions should be reconfirmed in this study as 
components of loaded nanoparticles should work synergistically to inhibit microbial 
growth lowering MIC and MBC. 
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2.8.2.4 Antimicrobial Mechanisms 
2.8.2.4.1 Chitosan 
Small nanoparticles can penetrate through the cell wall of bacteria and combine 
with DNA to inhibit synthesis of mRNA and DNA transcription (El-Baroty and others 
2010). Larger nanoparticles may interact with cell surfaces instead and alter cell 
permeability forming an impermeable layer around the cell which blocks the transport of 
essential solutes into the cell. Age of the cell can influence antimicrobial efficiency due 
to changes in cell surface electronegativity, leading to susceptibility of cells towards 
chitosan and other antimicrobials compounds. Once the cells lose their protection of the 
cell wall, the cell membrane is left unguarded with membrane permeability altered. 
Additional interactions will denature membrane proteins and initiate penetration into the 
phospholipid bilayer. Thus, increased membrane permeability leads to destabilization of 
cell membrane and leakage of intracellular substances and ultimately, death of cells. The 
sequence of events that leads to antimicrobial efficacy by chitosan and chitosan 
nanoparticles is as follows: adsorption onto the bacterial cell surface, diffusion through 
the cell wall, adsorption onto the cytoplasmic membrane, disruption of the cytoplasmic 
membrane, leakage of the cytoplasmic constituents, and cell death (Kong and others 
2010).   
Chitosan and its derivatives can act as antimicrobials against both Gram-negative 
and Gram-positive bacteria as well as fungi and yeasts (Sadeghi and others 2008; Kong 
and others 2010). Chitosan nanoparticle prepared by ionic gelation showed high 
antibacterial activity against Gram-positive organisms. Particularly, E. coli had the 
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highest MIC and MBC of all organisms at 0.25 μg/ml and 1 μg/ml, respectively (Qi and 
others 2004).  
2.8.2.4.2 Trans-cinnamaldehyde  
In vitro studies have demonstrated antibacterial activity of essential oils such as 
TC against L. monocytogenes and E. coli O157:H7. Overall, Gram-negative organisms 
are less susceptible than Gram-positive bacteria to essential oils having MICs of 0.05–5 
μl/ml. Gram-negative organisms are less susceptible to antimicrobials due to their outer 
hydrophilic membrane surrounding the cell wall which limits diffusion of hydrophobic 
compounds through its lipopolysaccharide covering (Hyldgaard and others 2012). A 
higher concentration of antimicrobial is needed to achieve the same effect in foods. 
Studies with fresh meat, fish, dairy products, vegetables, and fruit have shown that the 
concentration needed to achieve a significant antibacterial effect is around 0.5–20 μl/g in 
foods and about 0.1–10 μl/ml in solutions for washing fruit and vegetables (Burt 2004). 
Cinnamon bark has also shown significant inhibitory activity against selected strains of 
bacteria and fungi with MIC from 20 to 120 μg/ml (El-Baroty and others 2010). Overall, 
the essential oil from cinnamon is more potent than other tested plant extracts, such 
as Azadirachta indica and Syzygium aromaticum (Rao and Gan 2014). Gomes and others 
(2011) found the MIC of PLGA-TC on Salmonella and Listeria to be 10 mg/ml and 20 
mg/ml respectively.  The test concentration per well ranged from 20,000 to 20 μg/ml of 
nanoparticle. 
The mode of antibacterial action of TC likely involves action against several 
targets in the bacterial cell. The hydrophobicity of TC enables it to partition in the lipids 
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of the cell membrane and mitochondria, rendering them permeable and leading to 
leakage of cell contents. Extensive loss of cell contents or the exit of critical molecules 
and ions will lead to eventual death (Burt 2004). 
Additional studies have shown that TC does not necessarily disintegrate the outer 
membrane or deplete the intracellular ATP pool. Thus, researchers believe the carbonyl 
group of TC may bind to proteins and prevent the action of amino acid decarboxylases 
in microorganisms. These reactive aldehyde groups will cross-link covalently with DNA 
and proteins through the amine groups disturbing normal function. Hyldgaard and others 
(2012) describe cinnamaldehyde‘s antimicrobial mechanism as inhibiting enzymes 
involved in cytokinesis and cellular functions, acting as an ATPase inhibitor, and 
perturbing cell membranes.  
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3. METHODOLOGY 
 
3.1 Introduction 
This chapter focuses on the methodologies used to synthesize and characterize 
trans-cinnamaldehyde loaded chitosan-alginate nanoparticles. Nanoparticles were 
optimized for smallest particle size and maximum encapsulation efficiency by evaluating 
several processing parameters in a ―preliminary‖ stage study. Upon completion of this 
stage, a parent methodology was developed with optimized processing parameters and 
design constrains. Trans-cinnamaldehyde loaded chitosan-alginate nanoparticles (LCA-
NP) were synthesized with this final methodology and further characterized.  
3.2 Materials  
The essential oil trans-cinnamaldehyde (TC) (93%) was of food grade quality 
and purchased from Sigma Aldrich Co. (St. Louis, MO). Low molecular weight chitosan 
(10-120 kDa, 90% deacetylation) and low viscosity sodium alginate (10-100 kDa, M/G 
= .6) were ordered from Spectrum Chemical (New Brunswick, NJ). Tryptic soy agar 
(TSA), tryptic soy broth (TSB), peptone water (PW), modified oxford medium (MOX), 
and tryptose phosphate broth (TPB) for bacterial growth and enumeration were ordered 
from Becton, Dickinson and Co. (Sparks, MD). 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
for free radical scavenging potential tests was purchased from VWR (Chicago, IL). 
HPLC grade acetonitrile (99.8%, FW 41.05) was purchased from VWR (West Chester, 
PA). All other chemicals including Tween 20®, acetic acid, trehalose, calcium chloride, 
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sodium phosphate dibasic, sodium phosphate monohydrate, and sodium chloride were of 
analytical grade.  
3.3 Preliminary Study  
The framework used to build a final nanoparticle synthesis methodology was 
based primarily on observational stability testing, particle size analysis, and entrapment 
efficiency (EE) tests. Through these tests, the best overall processing parameters and 
design constraints were determined. All testing was carried out at varying concentrations 
and combinations of alginate, chitosan, and TC at different pH ranges to determine a 
base model formulation. All initial model parameters were adapted from existing 
literature (Gupta 2011; Manish and Kulkarni 2012; Mohanraj and Chen 2006; 
Rajaonarivony and others 1993; Sinjan and Robinson 2003). Once the base model for 
alginate to chitosan mass ratio was identified at the proper pH range (highest EE and 
lowest particle size), additional processing parameters such as syringe gauge size, 
homogenization time, equilibration time, calcium chloride concentration, and TC 
loading volume were improved and optimized (Das and others 2010).   
3.3.1 Observational Stability Study 
Observational tests were simple, rapid lab techniques used to determine stability 
of a nanoparticle sample. Observational methods were graded in three distinct 
categories: transparency, precipitation, and aggregation. Transparency was recorded as 
opaque (O), translucent (TL), or transparent (TP).  A 5 mW laser was passed through 
samples in a dark room. Nanoparticle samples with good stability were recorded as 
translucent or some light being refracted through the sample. Nanoparticle samples with 
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poor stability were recorded as opaque or transparent (Li and others 2008).  Aggregation 
(A) was considered to be white cloudiness or clumping of particles normally centralized 
in a sample. Precipitation (P) was considered the cloudy or clumped particles which had 
fallen out of suspension to the bottom of the sample solution. Any solution showing 
aggregation or precipitation was considered a poor working sample. Thus, in order for a 
nanoparticle sample to be considered stable and workable, the sample must have shown 
translucence and no signs of precipitation or aggregation at 0 and 24 h post synthesis.  
Laboratory trials showed that a stable and workable sample will have an increased shelf 
life, will not obstruct expensive filtration membranes, will not lose particles and 
entrapped TC during filtration, will have lower average particle size, and will have more 
homogenous morphology.  
3.3.1.1 pH Testing 
The first design parameter tested was the pH value of alginate and chitosan at 
varying mass ratios of alginate to chitosan. Initially, the pH of alginate was set to 5.5 
while chitosan pH was set to 5.3 (Sinjan and Robinson 2003; Li and others 2008).  
Observations about clarity, precipitation, and aggregation of final nanoparticle solution 
helped to determine formulation stability. Stable nanoparticle (TL) formulations would 
continue to be optimized while nanoparticle formulations showing O, TP, P, or A would 
be eliminated from future synthesis. The pH of alginate and chitosan was changed to 4.9 
and 4.6 respectively for varying mass ratios of alginate to chitosan to determine pH 
effect on stability (Gupta 2011; Thwala 2012; Sarmento and others 2007; Sarmento and 
others 2006).  Observational tests were completed at this pH range. The three most 
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stable mass ratios (TL, no A, no P) were then tested for particle size and EE to determine 
the best overall mass ratio. This mass ratio formulation (smallest particle size/highest 
EE) was considered the most stable, workable formulation and would undergo further 
process modification and optimization (Figure 3.1). 
 
 
 
 
Figure 3.1. Example of observational stability roadmap to determine best combination 
of chitosan-alginate mass ratio at different pH ranges. 
 
 
 83 
 
3.3.2 Processing Parameters 
 The following processing parameters were modified for the best working 
formulation from the observational stability and pH testing: (1) calcium chloride 
concentration, (2) TC encapsulant volume, (3) stirring time, (4) syringe size, (5) 
homogenization time, and (6) equilibration time. The initial methodology was adapted 
from Rajaonarivony and others (1993) and Sinjan and Robinson (2003). Only one 
variable was changed per formulation with all other processing constraints held constant 
(Figure 3.2).  Changing one processing parameter yielded one unique nanoparticle 
formulation. Particle size and EE tests were carried out to compare formulations within 
batches. The best formulation from within a processing parameter batch (smallest 
particle size/highest EE) was considered an optimal formulation (Figure 3.3). All 
modified/optimized processing parameters from discrete batches were then consolidated 
and extrapolated into one final working formulation.
 84 
 
 
 
Figure 3.2. Schematic representation of processing parameter modification and optimization with respect to constant parent 
formulation.
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Figure 3.3. Example of observational stability/processing parameter roadmap to determine pH, alginate to chitosan mass ratio, 
and optimized processing parameters for use in final synthesis methodology.
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3.4 Final Methodology 
The following methodology was based on work from Sinjan and Robinson 
(2003), Rajaonarivony and others (1993), Gupta (2011), Li and others (2008), Das and 
others (2010) and modified accordingly (Figure 3.4). 
3.4.1 Sample Preparation 
3.4.1.1 Alginate 0.06% (w/v)        
0.15 g of sodium alginate (Food Grade, (C6H7NaO6)n, low viscosity, M/G = .6) 
were added to 250 ml volumetric flask. Added slightly less than 250 ml of 0.2 µm 
filtered water (Nalgene Filtration Products, 50 mm filter) and stirred for 4-6 h until fully 
dissolved to obtain a 0.06% (w/v) alginate solution. Filtered sodium alginate solution 
using vacuum filtration unit (VWR, Filter Flask 1000 ml, 40/35 inner joint) and 
qualitative filter paper (VWR, Filter Paper 5.5 cm, 10 µm particle retention). Added 
approximately 1.25 ml of Tween 20® (Fischer Scientific, Polyoxyethylene-20 sorbitan 
monooleate) and stirred 4-6 h until solution appeared homogenous. Volume and pH were 
adjusted to 250 ml and 4.9, respectively, in volumetric flask by adding 4-8 drops 
(transfer pipette) of 0.5 N HCl and 0.2 µm filtered water. This method was a 
combination of methods as stated previously.  
3.4.1.2 Chitosan 0.05% (w/v) 
0.1 g of chitosan (Food Grade, (C6H11NO4)n, 90% deacetylated) were added to 
200 ml volumetric flask. Added slightly less than 200 ml of 0.2 µm filtered water and 
stirred for 1 h to obtain a 0.05% chitosan solution. Added 0.952 ml acetic acid (Glacial, 
FW 60.05) and stir for 4-6 h. Filtered chitosan solution using vacuum filtration unit and 
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qualitative filter paper. Volume and pH were adjusted to 200 ml and 4.6 respectively in 
volumetric flask by adding 6-8 drops of 5N NaOH and 0.2 µm filtered water. This 
method was a combination of methods as stated previously.  
3.4.1.3 Calcium Chloride 0.2% (w/v)     
0.2 g calcium chloride (Food Grade, Anhydrous, FW 110.98) were added to 100 
ml volumetric flask.  Added 100 ml of 0.2 µm filtered water and stirred for 2-4 h to 
obtain 0.2% (w/v) calcium chloride solution. This method was a combination of methods 
as stated previously.  
3.4.2 Ionotropic Gelation and Polyelectrolyte Complexation    
Trans-cinnamaldehyde (93%, FW 132.16) was dissolved in an acetonitrile/water 
mixture (1:1, 2 mg/ml) and vortexed for 10-20 s (Das and others 2010; Zohri and others 
2011; Li and others 2008). Two ml of this solution was added drop-wise with adapted 
burette-syringe (PrecisionGlide, 18 gauge syringe attached to 50 ml burette with stopper) 
into the previously prepared 250 ml pH adjusted (4.9) sodium alginate solution and 
stirred for 90 min. 15.625 ml of 0.2% (w/v) calcium chloride solution (i.e. previously 
prepared) was then added drop-wise with adapted burette-syringe into TC-incorporated 
sodium alginate to form pre-gel (ionotropic gelation) (Figure 3.4). Pre-gel was stirred for 
90 min and sonicated (Cole Parmer 8890, Vernon Hills, Ill., USA) for three cycles of 5 
min (Zohri and others 2011). 200 ml of pH adjusted (4.6) chitosan solution (i.e. 
previously prepared was added drop-wise with adapted burette-syringe into the TC-
incorporated calcium-alginate pre-gel (PEC) (Figure 3.5). Resulting solution was stirred 
for 90 min (Figure 3.6).  
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Figure 3.4. Diagram illustrating the preparation of calcium alginate pre-gel with 
incorporated trans-cinnamaldehyde by ionotropic gelation. 
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Figure 3.5. Diagram illustrating the addition of chitosan to calcium-alginate pre-gel with 
incorporated trans-cinnamaldehyde to form nanoparticles by polyelectrolyte 
complexation.
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Figure 3.6. Schematic representation of final methodology. 
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3.4.3 Homogenization, Purification, and Filtration  
 Nanoparticles were homogenized at high RPM (21500 RPM, Ultra-Turrax T25 
Basic IKA-Works Inc., Wilmington, NC) in five 3 min cycles to prevent suspension 
overflow due to shearing of Tween 20®. Any sample remaining on the homogenizer 
shaft was rinsed into sample using 0.2 µm filtered water. Sonicate sample for three 
cycles of five minutes using ultrasonic bath (Cole Parmer 8890, Vernon Hills, Ill., USA). 
Any trace acetonitrile was then removed from sample by a rotary evaporator. 
Nanoparticle suspension was heated to 28°C under vacuum (40-50 torr, Heidolph 
Laborota 4001 with Lauda K-4R Heating/Cooling System, Elk Grove Village, IL). 
Suspension was allowed to settle and equilibrate overnight allowing full PEC to take 
place (24 h).  
Following volatile evaporation, nanoparticle suspensions were purified via ultra-
filtration to remove excess of surfactant Tween 20®, large aggregates, and TC. Samples 
were sonicated in three cycles of 5 min prior to ultrafiltration. Sample volume to be 
filtered was recorded. A Millipore-Labscale™ TFF system equipped with a 50 kDa 
cutoff Pellicon XL-Millipore (Biomax 50, 50 cm2 membrane, Millipore Co., Kankakee, 
Ill., U.S.A.) was used. Inlet pressure was 40 psi and outlet pressure was maintained 
below 10 psi. Ultrafiltration took place with an initial 300 ml volume and sample was 
collected when approximately 50 ml was remaining in the retentate column. Retentate 
was transferred to a 100 ml beaker and 0.2 µm filtered water was used to gather all 
remaining retentate in column. Trehalose (Calbiochem, Dihydrate, FW 378.3) was added 
to retentate nanoparticle suspension at a ratio of 1:1 (w/w) relative to the amount of 
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nanoparticles and stirred for 1 h. Sample was then transferred into a 250 ml glass Pyrex 
container and sealed with lid. Post ultrafiltration, nanoparticles were frozen overnight at 
-20°C in a freezer (Frigidaire FRT21, Electrolux Home Products, Augusta, GA) (Hill 
and others 2013a).   
3.4.4 Lyophilization 
After retentate was frozen, the Pyrex lid was replaced with permeable cloth and 
wrapped with an elastic band.  Frozen retentate was placed into a freeze dryer (Labconco 
Freeze Dry-5, Kansas City, MO) at -50°C under 5-7 mtorr (9.67 x 10-5 psi) for 48 -72 h 
to sublimate all moisture from nanoparticles. Samples were removed from the freeze 
dryer and weighed out. Lyophilized samples were stored in an air tight container in a 
freezer (-20°C) (Frigidaire FRT21) until further use (Astete and others 2009; Hill and 
others 2013a).  
3.5 Characterization Methodologies  
3.5.1 Introduction 
Food nanotechnology is an expanding field in which new technologies are being 
used to characterize nanostructures. Physical characterization such as visualization, 
scaling, and morphology are now possible due various techniques and instruments for 
imaging and detecting. Similarly, new and conventional thermal and chemical 
characterization techniques are available to characterize nanostructures. Thus, the advent 
of new techniques and instruments in tandem with new nanostructures makes the 
selection of these instruments and methods critical to allow for standardization of 
methods across this field (Tiwari and Takhistov 2012). The following tests were 
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conducted to physically characterize the LCA-NP: (1) particle size analysis, (2) physical 
yield percentage, (3) encapsulation efficiency, (4) thermal analysis, (5) a controlled 
release test, (6) and surface characterization.  
3.5.2 Particle Size Analysis 
Particle size measurements were obtained for LCA-NP by dynamic light 
scattering (DLS) in a Malvern Nanoseries ZetaSizer (Nano–ZS90, 633 nm He-Ne 200). 
For measurements, 200 μg of resuspended lyophilized LCA-NP in 2 ml of 0.2 µm 
filtered water was allowed 3-6 hours to fully dissolve large aggregates. Resuspended 
particles were vortexed for 20 s, sonicated for 15 min, vacuum filtered (10 µm particle 
retention), and sonicated again for 5 min immediately before transferring to plastic 
cuvettes (1 cm path length, disposable polystyrene) and placed in analyzer. Analysis was 
performed at a scattering angle of 90°, refractive index of 1.590, and temperature of 
25°C. For each LCA-NP sample, the mean diameter and standard deviation of 100 
iterations was performed in triplicate. Particle size was read in terms of z-average size 
(intensity) (Gomes and others 2011; Hill and others 2013a; Sinjan and Robinson 2003). 
3.5.3 Yield Analysis  
All nanoparticle samples were weighed after lyophilization. Physical percent 
yield (w/w) of nanoparticles was calculated from the weight of dried nanoparticles 
recovered (W1) and the sum of the initial dry weight of starting materials (W2). This yield 
of LCA-NP was determined according to the following equation (Dudhani and Kosaraju 
2010): 
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      (3.1) 
 
 
3.5.4 Encapsulation Efficiency 
 For each nanoparticle sample, 5 mg of LCA-NP was dissolved in 5 ml of 95 
g/100 ml acetonitrile and mixed thoroughly. The suspension was left for 48 h under 
constant agitation in dark area to allow for enough time for all entrapped TC to be 
available in solution. Samples were vortexed for 10 s, filtered with 0.2 μm membrane, 
and measured in a UV-Visible spectrophotometer (Genesys 10S UV-Vis, Thermo 
Scientific, Madison, WI) at 280 nm in triplicate. Encapsulation efficiency (EE) was 
determined according to the following equation (Gomes and others 2011; Hill and others 
2013a): 
 
   ( )   
                                   
                             
      
 
(3.2) 
where the ―amount of active compound entrapped‖  is the compound (TC) amount 
present in the particles and the ―initial active compound amount‖ indicates the 
compound (TC) amount initially used to manufacture the particles (Hill and others 
2013a).   
A standard calibration curve was obtained for TC between 0.93 μg/ml and 4.65 
μg/ml and followed the equation y = 4.294x (R2 = .975) (Appendix 1). ―Amount of 
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active compound entrapped‖ was determined by substituting the absorbance value of the 
LCA-NP read from the spectrophotometer into the x-value of the calibration equation. 
This yields the y-value (i.e., TC concentration). Samples were diluted with acetonitrile 
for proper spectrophotometric readings when necessary. 
3.5.5 Controlled Release  
0.15M phosphate saline buffer (PBS, .85% NaCl) was prepared by mixing two 
separate stock solutions. Solution 1 was dibasic composed of 21.3 g/L sodium phosphate 
dibasic (Na2HPO4, anhydrous, FW 141.96) and 8.5 g/L sodium chloride (NaCl, 
crystalline, FW 58.44) while solution 2 was monobasic composed of 20.7 g/L sodium 
phosphate monohydrate (NaH2PO4*H2O, anhydrous, FW 137.99) and 8.5 g/L sodium 
chloride. Solution 2 was added to solution 1 until pH 7.4 was obtained. 
36 mg of LCA-NP was weighed in a beaker and 36 ml of phosphate buffer (pH 
7.4) was added. The suspension was stirred with a magnetic stirrer until homogenized. 
From this suspension, 1 ml was added to an eppendorf vial (in triplicate). Eppendorfs 
were placed in a 35°C bath with constant agitation. Eppendorfs were removed from the 
bath, vortexed for 10 s and filtered with 0.2 μm membrane measured in a UV-Visible 
spectrophotometer (model Genesys 10S UV-Vis, Thermo Scientific, Madison, WI) at 
280 nm in triplicate at predetermined times of 15 min, 30 min, 45 min, 1 h, 1.5 h, 2 h, 4 
h, 8h, 12 h, 24 h, 48 h, and 72 h. Samples were diluted with acetonitrile for proper 
spectrophotometric readings when necessary. Release at preset times was determined 
using the same calibration curve as entrapment efficiency testing (Appendix 1). 
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Cumulative release percentage was calculated using the equation below (Das and others 
2010; Xing and others 2010): 
 
                   ( )   
            
        
      (3.3) 
 
3.5.6 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) was performed using a Perkin-Elmer 
DSC 6 with ISOTEMP 1028P (Fischer Scientific, Pittsburg, PA) with an integrated 
cooling system (Pyris 5 Software, Boston, MA). Lyophilized samples (~2 mg) and 
control samples (i.e. empty crimped pan) were weighed to the nearest 0.1 mg and were 
added into hermetically sealed and crimped 20 μl aluminum pans with one hole in the 
lid.  Scanning of samples was completed at a rate of 10°C/min from 25°C to 350°C with 
temperature maintained for 1 min at 350 °C with nitrogen purging at 20 ml/min. An 
empty loosely covered aluminum pan was used as the reference or blank. Calibration 
was completed using zinc and indium metals prior to sample testing. Each sample was 
run twice (Sarmento and others 2006; Hill and others 2013a). 
3.5.7 Transmission Electron Microscopy 
Surface morphology of particles was visualized using a FEI Morgagni 
Transmission Electron Microscope (FEI Company, Hillsboro, OR) at the School of 
Veterinary Medicine and Biomedical Sciences at Texas A&M University (College 
Station, TX) using a negative staining technique. 100 μg of lyophilized nanoparticles 
were resuspended in 2 ml of 0.2 μm filtered water and sonicated for 10 min. Samples 
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were kept at 4°C for about 3 hours. 600 μl of this sample in ethanol was mixed with 600 
μl water. 1.4 μl of suspension was applied directly to carbon film (300 mesh Cu/Ni grid 
filmed with carbon) and incubated for 4 min in humid area. Stains were cleaned with a 
60 s glow at 5 mA. Excess fluid was wicked off slowly with filter paper. 180 μl of 2% 
phosphotungstic acid (pH 7, FW 2880.05) or 0.2% uranyl acetate (FW 424.14, EMS, 
Hatfield, PA) was dripped onto grid surface tilted at 45°. Excess stain was wicked off 
slowly with filter paper and grids were air dried. Backs of grids were washed off with 
water, wicked again, and dried a final time. Viewing took place at 2,200 to 140,000 x 
magnification, 32 to 2024 pixels per μm, and 80 kV (Astete and others 2009; Hill and 
others 2013a; Hill and others 2013b; Dudhani and Kosaraju 2010). 
3.5.8 Antioxidant Capacity in Apple Juice 
The method used to measure antioxidant capacity in this study was the 1,1-
Diphenyl-2-picrylhydrazyl (DPPH) test (Chien and others 2007; Fathi and others 2013). 
Clear, ultra-high-temperature processed, shelf stable apple juice with no additional 
preservatives was purchased from a local retailer (HEB, College Station, TX). 5 ml of 
resuspended LCA-NP was added to 45 ml of apple juice in a 250 ml Erlenmeyer flask to 
obtain working concentrations of 0.1 to 1 g/L of LCA-NP in apple juice. A control flask 
was prepared using 5 ml of water instead of LCA-NP or ULCA-NP in apple juice. 100 
μM DPPH solutions in methanol were prepared and 1 ml of this solution was added to 4 
ml of the LCA-NP working concentrations in apple juice. Samples were agitated and 
incubated for 30 min at room temperature in a dark area. Samples were vortexed for 20 s 
and filtered with a 0.2 μm filter. The absorbance of the resulting solution was read at 517 
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nm against a blank. The inhibitory percentage of DPPH was calculated according to the 
following equation (Chien and others 2007): 
 
                  ( )  (  
                
                 
)       (3.4) 
 
3.5.9 Minimum Inhibitory and Bactericidal Concentration  
Escherichia coli O157:H7 (ATCC 43894) and Listeria monocytogenes (ATCC 
15313) were obtained from Texas A&M University Food Microbiology Laboratory 
culture collection (Department of Animal Science, College Station, TX). These strain 
selections are representative of typical Gram-negative and Gram-positive pathogenic 
microorganisms commonly occurring in various food products. Both microorganisms 
were resuscitated in tryptic soy broth (TSB) by identical duplicate transfers and 
incubated aerobically for 24 h at 35ºC. The bacterial cultures were maintained on tryptic 
soy agar (TSA) slants at 4ºC for no more than 3 months. Transfers from slants were 
conducted similarly to the resuscitation method to prepare microorganisms for analysis 
(Figure 3.7). Pathogen isolates were maintained, revived, and handled under biosafety 
level (BSL) 2 containment at all times according to Texas A&M University System 
Institutional Biosafety Committee (IBC) policy. 
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Figure 3.7: Representation of resuscitation and revival of microorganisms from TSA 
slant. 
 
 
Minimum inhibitory concentrations (MIC) for nanoparticles and pure TC were 
determined using an adapted broth dilution assay (Wiegand and others 2008; Brandt and 
others 2010; Pendleton and others 2012; Gomes and others 2011). Overnight culture (24 
h) of E. coli O157:H7 and L. monocytogenes were individually subjected to serial 
dilution in 9.0 ml of 0.1% (w/v) peptone water (PW) and then transferred to 9.0 ml of 
double strength broth (TSB for E.coli and TPB for Listeria) to obtain 5.0 log10 CFU/ml 
final concentration for use as inoculum (concentration per well on 96 well plate). E. coli 
O157:H7 and L. monocytogenes in double strength broth were serially diluted in 0.1% 
peptone water (PW) and spread on surfaces of Petri dishes containing sterile TSA and 
TSA-YE for enumeration of inoculum of each pathogen, respectively. Inoculated TSA 
and TSA-YE plates were then incubated for 24-48 h at 35°C prior to colony enumeration 
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(Figure 3.8). Aliquots of 100 µl of all antimicrobial solutions and solvents blanks were 
spread plated to ensure sterility (Hill and others 2013a; Hill and others 2013b). 
 
 
 
 
Figure 3.8. Representation of enumeration of selected microorganisms. 
 
 
MIC analyses were conducted in a 96 well microliter plate (sterilized 300μl 
capacity, MicroWell, NUNC, Thermo-Fisher Scientific, Waltham, MA). The 
antimicrobial inclusion complexes were added to the wells as aqueous suspensions, 
while the TC was added as an aqueous microemulsion containing 1.0 g/100 g 
acetonitrile and 0.01 g/100 g Tween 20® (Hill and others 2013b). The concentration of 
LCA-NP added to the test wells ranged from 3,515 – 28,125 µg/ml (365 – 2,920 µg/ml 
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of TC concentration based on the entrapment efficiency (73%), while the concentration 
of free TC ranged from 6.25 – 2,000 µg/ml for both pathogens (Figure 3.9). Chitosan 
concentration ranged from 31.25 - 500 μg /L. Alginate concentration ranged from 18.75 
- 600 μg /L. The test compound concentration in literature ranges from 20,000 to 20 
μg/mL of nanoparticles (Kalemba and Kunicka 2003; Hill and others 2013b; Hill and 
others 2013a). 
 
 
 
 
Figure 3.9. Example of 96 well plate setup. 
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200 μl of double strength antimicrobial solution was loaded into the first well of 
the specified row. 100 μl of sterile water was added to all remaining wells on specified 
row (not added to first well) and lastly 100 μl of bacterial inoculum in 2XTSB/TPB was 
added to all wells on specified row (added to first well) using a multichannel pipette 
(Brandt and others 2010; Wiegand and others 2008; Pendleton and others 2012). The 
first well on row (antimicrobial and inoculum) was mixed ten times with a multichannel 
pipette and 100 μl of this solution was added into the second well of the specified row 
and mixed ten times (Figure 3.8). Dilutions were completed in this manner for all 
remaining wells on the row. This transfer procedure continued for 10 of the 12 rows of 
wells (Gomes and others 2011). Along with each antimicrobial tested, sterilized water 
blank was used in the same fashion to ensure that the sterilized water (where 
nanoparticles were suspended) did not have an antimicrobial effect.  
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Figure 3.10. Diagram presenting the composition of sample wells with initial 
components, dilution factor, and final concentration. Positive controls were prepared 
containing inoculum and sterile distilled water. 
 
 
Tween 20, free TC, and acetonitrile at test concentrations (combined and singly) 
to guarantee solvents and additives had no effect on optical density values at 630 nm 
(OD630) or antimicrobial effect (Hill and others 2013a). The last column acted as a 
growth control. Negative controls were also prepared with antimicrobial solutions and 
sterile 2X broth to ensure they were not contaminated. Negative control wells were 
prepared in the same manner as the treatment wells. Once plates were prepared, they 
were covered with Mylar plate sealer (Thermo-Fisher Scientific) and OD630 of the wells 
was read (0 h) in Epoch BioTek UV/Vis range spectrophotometer (Bio-Tek® 
Instruments, Inc., Magellan™ software, Winooski, VT). Plates were incubated at 35ºC 
and after 24 h another OD630 was measured (24 h).  Plates were normalized (baseline 
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adjustment) using the OD630 values of the negative controls with the following 
equations: 
 
(0hrOD630, Treatment) - (0hrOD630, Negative Control) = 0hrOD630, Normalized (3.5) 
  
(24hrOD630, Treatment) - (24hrOD630, Negative Control) = 24hrOD630, Normalized (3.6) 
  
(24hrOD630, Normalized)  - (0hrOD630, Normalized) = ∆OD630 (3.7) 
 
Any antimicrobial sample well that showed ≤ 0.05 change in OD630 was 
considered ―inhibited‖ by the antimicrobial. The lowest concentrations of antimicrobial 
TC containing nanoparticles  producing pathogen inhibition across triplicate identical 
replications (n=3) were identified as the MIC (inhibited visible growth) for nanoparticle 
system (Figure 3.9) (Brandt and others 2010; Hill and others 2013b; Gomes and others 
2011).  
To study the bactericidal activity of nanoparticle solutions after identification of 
MIC levels of TC-containing nanoparticles, 100 μl of solution from pathogen inhibitory 
wells were spread on TSA containing Petri plates for E. coli and TSA-YE containing 
Petri plates for Listeria (1 TSA/TSA-YE plate prepared per test well) incubated for 24 h 
at 35ºC. The concentrations of nanoparticles that produce > 3.0 log10 CFU/ml reduction  
of the E. coli or L. monocytogenes (plate count of the inoculum minus the plate 
count on the TSA plate for bactericidal assay) from initial inoculum (5.0 log10 CFU/ml) 
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were classified as bactericidal. The lowest concentration of nanoparticles over all 
replications (n=3) were deemed the minimum bactericidal concentration (MBC) (Figure 
3.9) (Brandt and others 2010; Hill and others 2013b; Gomes and others 2011). E. coli 
O57:H7‘s identity was confirmed using MacConkey-Lactose agar. L. monocytogenes 
identity was confirmed using MOX and RAPID‘L.Mono™(Bio-Rad Laboratories, Inc., 
Hercules, CA, USA) for L. monocytogenes. 
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Figure 3.11. Schematic representation of MIC and MBC procedures and 96 well plate setup.
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3.6 Statistical Analysis 
All experiments were performed in triplicate as independent experiments and 
data is expressed as mean values ± the standard deviation (SD). Statistical analysis were 
performed using SigmaPlot v. 11 software (San Jose, CA) with p-value less than .05 
considered as an indication of statistical significance. Differences between variables 
were tested for significance by one-way analysis of variance (ANOVA). Significantly 
different means (p < 0.05) were separated by the Tukey‘s Honestly Significant 
Differences (HSD) test. Linear regression and analysis of covariance with 95 % 
confidence interval were used when appropriate.  
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4. RESULTS 
 
4.1 Introduction  
Encapsulation of lipophilic compounds such as trans-cinnamaldehyde (TC) into 
aqueous-soluble nanoparticle systems (i.e. chitosan-alginate) can provide solutions to 
several problems in the food industry by both improving solubility and providing a 
controlled way to deliver and release drug payload with full potential. The ionotropic 
gelation polyelectrolyte complexation method (IG-PEC) is a mild nanoparticle 
preparation method that was optimized in this research to produce nanoparticles with the 
highest payload potential at the smallest size.  
This chapter focuses on the characterization of loaded chitosan-alginate 
nanoparticles (LCA-NP) and a brief discussion and interpretation of the findings. This 
chapter is broken down into the following parts: (1) preliminary study results including 
(a) observational studies and pH testing, and (b) process parameter optimization 
(entrapment efficiency and particle size); and (2)characterization results using new 
extrapolated methodology including (c) cumulative controlled release tests, (d) 
differential scanning calorimetry, (e) transmission electron microscopy, (f) antioxidant 
capacity in apple juice, and (g) minimum inhibitory and bactericidal concentration tests. 
Optimizing processing parameters of the IG-PEC method will increase the 
significance of characterizing polymeric nanoparticles. Optimized particle preparation 
and formulation will assist in future utility of post-processing and food applications such 
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as the stabilization of lipophilic flavoring agents, shelf life stability, antioxidant and 
antibacterial potential, and the reduction of unpleasant odors and tastes. 
4.2 Preliminary Study  
4.2.1 Observational Stability and pH Testing  
Table 4.1 and Table 4.2 show the observational results of assembled nanoparticle 
solutions at varying mass ratios of alginate to chitosan at different pH values.  Different 
nanoparticle samples were recorded by their visible appearance: translucence (TL), 
precipitation (P), aggregation (A), or opaque coloration (O). The mass ratios of alginate 
(AG) to chitosan (CS) of 1.5:1 and 1:1 (samples 5a and 6a; pH dispersion 5.4) yield the 
best observational results due to solution showing TL at 0 h (Table 4.1). However, at 24 
h post synthesis, the same nanoparticle solutions showed P, A, and O suggesting that 
these solutions are only stable for 24 h. Table 4.2 shows nanoparticle solutions of 
AG:CS mass ratios of 5:1, 2:1, and 1.5:1 (samples 3b, 4b, 5b; pH dispersion 4.7) that are 
TL at both 0 h and 24 h post synthesis. Thus, these mass ratios were considered the most 
stable formulations. Examples of unstable formulations post synthesis are shown in 
Figure 4.1. Laboratory trials revealed that samples that were stable at 24 h post synthesis 
would remain stable (TL, no A, no P) in solution for up to six weeks (Figure 4.2). 
Samples that were unstable at 0 or 24 h post synthesis would show substantial P and A 
after 6 weeks of storage in solution.  
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Table 4.1. Observational results of varying mass ratios of alginate to chitosan (alginate: 
CaCl2 mass ratio = 4.8:1, pH alginate = 5.3 pH, chitosan = 5.5). 
 
Sample 
Number** 
Mass Ratio Alginate : Chitosan 
(AG:CS)1 
0 h 24 h 
1a 30:1 O/P/A* O/P/A 
2a 7 :1 O/P/A O/P/A 
3a 5:1 O/P/A O/P/A 
4a 2:1 O/P/A O/P/A 
5a** 1.5:1 TL* O/P/A 
6a 1:1 TL O/P/A 
7a 1:1.5 O/P/A O/P/A 
8a 1:2 O/P/A O/P/A 
9a 1:5 O/P/A O/P/A 
10a 1:7 O/P/A O/P/A 
*O = opaque coloration   P =precipitation   A = aggregation   TL =translucence  
1Represents the mass ratio (w:w) of alginate to chitosan powder used to formulate nanoparticles. 
**Values in red text correspond to the best working formulation (translucent and stable). Processing 
parameters based on parent methodology: mass ratio alginate: calcium chloride (4.8:1), mass ratio 
alginate: oil (50:1), stirring time (90 min), syringe size (pipette/burette tip), homogenization time (5 
min), and equilibration time (24 h).   
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Table 4.2. Observational results of varying mass ratios of alginate to chitosan (alginate: 
CaCl2 mass ratio = 4.8:1, pH alginate = 4.6, pH chitosan = 4.9). 
 
Sample 
Number** 
Mass Ratio Alginate : Chitosan 
(AG:CS)1 
0 h 24 h 
1b 30:1 O/P/A* O/P/A 
2b 7 :1 O/P/A O/P/A 
3b 5:1 TL* TL 
4b 2:1 TL TL 
5b 1.5:1 TL TL 
6b 1:1 TL O/P/A 
7b 1:1.5 TP TL 
8b 1:2 O/P/A O/P/A 
9b 1:5 O/P/A O/P/A 
10b 1:7 O/P/A O/P/A 
*O = opaque coloration   P =precipitation   A = aggregation   TL =translucence  
1Represents the mass ratio (w:w) of alginate to chitosan powder used to formulate nanoparticles. 
**Values in red text correspond to the best working formulation (translucent and stable). Processing 
parameters based on parent methodology: mass ratio alginate: calcium chloride (4.8:1), mass ratio 
alginate: oil (50:1), stirring time (90 min), syringe size (pipette/burette tip), homogenization time (5 
min), and equilibration time (24 h).   
 
 
 
Figure 4.1. Examples of unstable formulations post synthesis (24 h); rapid precipitation 
(P) and aggregation (A). Disregard sample labels.  
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Figure 4.2. Example of fresh retentate stability after 6 weeks in solution. 
  
 
 The most stable mass ratio formulations (3b, 4b, 5b) were then analyzed for 
particle size and encapsulation efficacy (EE) (Table 4.3).  From this table, it can be 
concluded that the best working formulation was 5b with average particle size of 294.78 
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nm and 60.61% EE (smallest particle size/highest EE). Average particle size was 21.4% 
smaller while EE% was 4.9% larger than the next best formulation (4b). All means for 
particle size of different treatment groups (AG:CS) were statistically significant (p < 
0.05) while means for EE%, and physical yield percentage were significantly different 
only for the 5b formulation likely due to wall forming components being in 
stoichiometric proportion (i.e. no excess polymer forming large particle aggregates). 
Additionally, means for polydisperity index (PDI) were statistically significant (p < 
0.05) for formulations 4b and 5b. There is an inverse relationship between particle size 
and encapsulation efficiency as AG:CS mass ratio decreased (Figure 4.3).  This is likely 
due to water making up the bulk of the nanoparticle matrix at higher concentrations of 
biopolymer creating an environment that is not favorable to entrap a hydrophobic active 
molecule. The matrix is also permeable and porous leading to loss of entrapped TC 
(Singh and others 2007).   
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Table 4.3.  Particle size, encapsulation efficiency (EE), polydisperity index (PDI), and 
physical yield results for nanoparticles at the three best alginate to chitosan mass ratios 
at pH alginate = 4.6, pH chitosan = 4.9. 
 
Mass 
Ratio 
(AG:CS)1  
Observations 
(0 h/24 h) 
 
Particle Size 
* [nm] 
 
EE%* 
 
Yield%* 
 
PDI 
5:1   (3b) TL/TL 648.08a(28.44) 40.17a(6.55) 51.25a(9.58) 0.84a(0.09) 
2:1   (4b) TL/TL 375.29b(29.91) 57.60b(5.19) 83.36b(5.30) 0.69b(0.03) 
1.5:1 (5b) TL/TL 294.78c(26.30) 60.61b(4.34) 78.86b(2.93) 0.66b(0.04) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts (within columns) indicate significantly different values (p < 0.05). 
Values in parenthesis are the standard deviation.  
1Represents the mass ratio (w:w) of alginate to chitosan powder used to formulate nanoparticles. 
Processing parameters based on parent methodology: mass ratio alginate: calcium chloride (4.8:1), 
mass ratio alginate: oil (50:1), stirring time (90 min), syringe size (pipette/burette tip), 
homogenization time (5 min), and equilibration time (24 h).   
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Figure 4.3. Effect of alginate to chitosan mass ratio on particle size, encapsulation 
efficiency, and physical percent yield at 25°C. 
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These results are consistent with results found throughout literature. Particle size 
distributions become wider as pH increases  (i.e. PDIpH 5.4  =  .91) resulting in 
aggregation likely due to weaker ionic interactions (Ruo 2012). For instance, for 
dispersions with pH of 4.7, other studies found nanoparticles to be in the 190-300 nm in 
size and have 70-92% EE within AG:CS range of  1:1 to 6.3:1 to encapsulate Nisin, 
turmeric oil, chloramphenicol, and insulin  (Zohri and others 2011; Thwala 2012; Gupta 
2011; Sarmento and others 2006). In particular, Zohri and others (2011) produced 205 
nm particles with 70% EE of protein with a similar mass ratio of AG:CS used in this 
study (AG:CS 1:1).  Further increasing the pH of the dispersion saw an increase in 
particle size and a decrease in EE. For instance, for dispersions with pH of 5.2, Douglas 
and Tabrizian (2005) produced 323 nm particles with 60% EE of DNA (AG:CS 1.5:1). 
On the other hand, results from studies by Sinjan and Robinson (2003) and 
Cegnar and Kerc (2010)  directly contradict results from this study as the smallest 
particles were found to be in the range of 10:1 AG:CS mass ratio with average particle 
size of 506 nm. Particle size increased as the AG:CS mass ratio decreased to 7:1 which 
is the opposite effect that occurred in this study. Potential causes for this discrepancy 
between studies are the differences on pH which affect size and the driving forces that 
control spontaneous formation of nanoparticles as the ratio of AG:CS increases. Particle 
size significantly decreased  when pH decreased from 5.5 to 4.2 for chitosan (Ruo 2012). 
Additionally, reports of increased EE at higher pH ranges may be due to an increase in 
particle size which could increase the potential drug loading volume.  Differences in 
particle size and EE values within the same pH range can be attributed to polymer 
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molecular weight, polymer concentration, deacetylation of chitosan, mass ratio of 
polymer to calcium chloride, processing parameters (i.e. syringe size, stirring time, 
filtration time), and hydrophobicity of active drug to be entrapped (Li and others 2008; 
Gupta and others 2011).  
 Studies by Manish and Kulkarni (2012) and Gupta (2011) found increasing AG 
and CS concentrations led to increased particle size (Ruo 2012). This outcome was also 
seen in this study as an increase on the relative proportion of AG or CS increased 
particle size and ultimately decreased stability. This can be seen at a macro scale in 
Figure 4.4 where precipitation and aggregation were observed as polymer concentrations 
increased either independently or in combination. High CS concentration yielded a 
turbid cloudy precipitate while high AG concentrations yielded a gel like solution with 
high amounts of aggregation and precipitation.  High concentrations of combinations of 
both AG and CS yielded a gel-like solution with high flocculation, aggregation, and 
large microstructures that appeared structurally weak. Excess chitosan changed the 
turbidity of the dispersion of the polyelectrolyte complex into a two phase system 
consisting of a clear supernatant and sediment (Cegnar and Kerc 2010). Low amounts of 
AG and CS produced transparent solutions meaning there was little to no nanoparticle 
formation.   
The present study revealed that the size of loaded chitosan-alginate nanoparticles 
(LCA-NP) was highly dependent on the mass ratio of alginate to chitosan with a higher 
ratio producing larger particles. These results may ultimately prove that smaller particles 
were a result of functional groups being available in stoichiometric proportion (Gaumet 
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and others 2008). As alginate concentration increased the availability of negatively 
charged carboxylate groups increased. Thus, the higher electric charge on the surface of 
particles produced repelling forces that prevented aggregation and provided stability. 
However, as charge continued to increase, polymer chains became further apart 
producing larger and less dense particles. Blank particles (i.e. no entrapped TC) were 
larger in size due to adjacent polymer chains remaining further apart due to high electric 
charge and strong repellent forces (Appendix 2) (Mohanraj and Chen 2006; Berger and 
others 2004; Kong and others 2010). 
Additionally, the pKa of chitosan is well known to be 6.5. Addition of alginate 
solution at higher pH regions would have resulted in the majority of amine groups being 
deprotonated and unable to become involved in ionic interaction while any that would be 
readily available would result in weaker interactions leading to larger particle sizes 
(Douglas and Tabrizian 2005). This is likely the reason for larger particles assembled at 
the pH dispersion of 5.4. Lowering the pH of the dispersion to 4.7 resolved the 
aforementioned issue by allowing stronger interactions between CS and AG leading to 
more compact particle formation. At lower pH regions the carboxyl groups of AG are 
ionized and the amine groups of CS are protonated (hydrogen ions give a high charge 
density) leading to more polyionic complex formation. CS chains open up at acidic pH 
ranges while at basic pH rages CS chains fold up and become deprotonated. Thus, fewer 
amino groups are exposed for crosslinking at basic pH ranges which resulted in a 
sparsely cross linked polymer matrix and larger particle sizes. Thus, increasing the 
protonation of chitosan chains allowed the formation ionic linkages with calcium 
 118 
 
chloride resulting in small particle formation (Mohanraj and Chen 2006; Sinjan and 
Robinson 2003; Rajaonarivony and others 1993).  
Overall, evidence suggests that increasing the amount of extended polymer 
chains at low pH values form smaller, more compact particles (24% smaller).  It is 
important to note, however, that in the lower pH regions, the alginate pH may reach its 
pKa value of 3.5 and precipitate into alginic acid. In theory, this could lead to larger 
particles with less entrapment capability (Ruo 2012; Thwala 2012; Gaumet and others 
2008).
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Figure 4.4. Visual representation of the effect of chitosan and alginate concentration on physical stability and 
appearance of nanoparticle solutions. 
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4.2.2 Processing Parameter Results  
The preliminary observational stability and pH tests helped determine the best 
working formulation at a pH dispersion of 4.7 and the AG:CS mass ratio to be 1.5:1 (i.e. 
sample 5b). This formulation was further optimized using several processing parameters 
to reduce particle size and increase EE. Table 4.4 summarizes the optimized processing 
parameters by batch. Results elucidated that the syringe size was the processing 
parameter with the largest effect (p < 0.05) on particle size, PDI, and EE. Nanoparticles 
produced with an 18 gauge syringe were 19% smaller than the next best optimal batch 
formulation (homogenization time 15 min) and 27.7% smaller than the original parent 
formulation (5b). All other variables were not statistically significant (p > 0.05) between 
treatment groups (with the exception of PDI value for mass ratio alginate:oil). This result 
suggests that the methodology is well-designed and processing parameters only have a 
small impact on overall assembly of nanoparticles. 
It is important to note that only one discrete processing parameter was modified 
and optimized per batch from the parent methodology (i.e. all other parameters held 
constant). The parent methodology utilized the following processing parameters: mass 
ratio alginate: calcium chloride (4.8:1), mass ratio alginate:oil (50:1), stirring time (90 
min), syringe size (pipette/burette tip), homogenization time (5 min), and equilibration 
time (24 h).  For example, if the mass ratio (w/w) of alginate to calcium chloride, (e.g. 
1.6:1) was the parameter being improved and optimized, all other parameters would 
remain constant from the parent methodology (mass ratio alginate:oil (50:1); stirring 
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time (90 min); syringe size (pipette/burette tip); homogenization time (5 min); 
equilibration time (24 h). Refer to Figure 3.2 for additional clarification.  
 
 
Table 4.4. Particle size, encapsulation efficiency (EE), and polydisperity index (PDI) of 
nanoparticles with modified methodology (alginate:chitosan mass ratio 1.5:1; pH 
alginate = 4.6, pH chitosan = 4.9). 
 
Batch** Processing Parameter (Optimized) Particle Size*[nm]  EE%* PDI 
1 Mass Ratio Alginate: CaCl2 (4.8:1) 294.78
a,x(26.30) 60.62a,x(4.34) 0.66a,x(0.04) 
2 Mass Ratio Alginate: Oil (37.5:1) 303.93a,x(7.79) 65.58a,x(1.14) 0.81b,x(.07) 
3 Stirring Time (90 min) 294.78a,y(26.30) 60.61a,x(4.34) 0.66a,x(0.04) 
4 Syringe Size (18 gauge) 213.01b,y(4.47) 65.18a,x(1.48) 0.61c,y(0.03) 
5 Homogenization Time (15 min) 263.23a,x(7.07) 60.48a,x(2.68) 0.67a,x(0.08) 
6 Equilibration Time (24 h) 294.78a,y(26.30) 60.61a,x(4.34) 0.66a,x(0.04) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05). Values in parenthesis are the standard deviation. 
**Only one parameter modified and optimized per batch. All other processing parameters held constant 
based on parent methodology. Constant parameters from parent methodology: mass ratio alginate: 
calcium chloride (4.8:1), mass ratio alginate: oil (50:1), stirring time (90 min), syringe size 
(pipette/burette tip), homogenization time (5 min), and equilibration time (24 h).   
a,x Means within a column not followed by a common superscript letter are significantly different between 
treatment groups (a) and within treatment groups (x) (p  < 0.05). ‗Within treatment groups‘ refers to a 
comparison of variables within the same processing parameter batch. ‗Between treatment groups‘ 
refers to comparison of two different processing parameters.  
 
 
4.2.2.1 Calcium-Alginate Complex  
Table 4.5 shows the results of nanoparticles synthesized with modified mass 
ratios of alginate to calcium chloride (CaCl2) (constant AG:CS 1.5:1; sample 5b). The 
optimal mass ratio of AG:CaCl2 was 4.8:1 due to minimal particle size and relatively 
high EE. No means were statistically significant (p < 0.05) for particle size, EE, or 
physical yield.  AG:CaCl2 mass ratio of 4.8:1 was the ratio used in the initial parent 
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formulation (AG:CS 1.5:1). This means no further optimization of amount of calcium 
chloride was needed. Particle size was 7.3% smaller while EE was 2.9% smaller than the 
next best AG:CaCl2 mass ratio (2.4:1). Additionally, AG:CaCl2 mass ratio and particle 
size show an inverse relationship. The AG:CaCl2 mass ratio had less of a predominant 
effect on particle size in comparison to pH. As the alginate to calcium chloride mass 
ratio increased, the size distribution became wider. Lower calcium chloride 
concentration resulted in more compact particulate matrices (PDI Ag:CaCl1.6:1 = .84) and 
more entrapped trans-cinnamaldehyde.  As LCA-NP became larger in size, less alginate 
was cross linked by calcium chloride. This phenomenon was also observed in studies by 
Cegnar and Kerc (2010) and  Thwala (2012) where high AG:CaCl2 mass ratios (1.75:1 
and 1.59:1) resulted in larger particles  due to excess calcium ions likely encountering a 
higher degree of ionic interaction causing rapid gelation.  
The results from this are consistent with those found in literature. Rajaonarivony 
and others (1993) and Sarmento and others (2006) triggered pre-gelation with a 
AG:CaCl2 mass ratio of 5:1.  Li and others (2008), Gupta (2011), and Sinjan and 
Robinson (2003) utilized AG:CaCl2 mass ratios of 4.47:1, 4.9:1, and 5.88:1 to obtain 20-
50, 230, and 282 nm particles, respectively. In fact, Sinjan and Robinson (2003) stated 
the optimal region of AG:CaCl2 mass ratio to be between 2.85:1 and 12.5:1. 
Additionally, Lertsutthiwong and others (2009) found the physical yield to be in the 
same range as this study (70%).  
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Table 4.5. Particle size, encapsulation efficiency (EE), and physical yield of 
nanoparticles assembled with modified mass ratios of alginate to calcium chloride 
(alginate:chitosan mass ratio 1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
Mass Ratio (AG:CaCl2)
1 Particle Size* [nm] EE%* %Yield* 
1.6 325.11a(7.11) 53.00a(4.80) 61.78a(11.12) 
2.4 317.99a(32.60) 62.48a(4.73) 67.93a(5.59) 
4.8 294.78a(26.60) 60.62a(4.34) 78.86a(2.93) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05). Values in parenthesis are the standard deviation. 
1Represents the mass ratio (w:w) of alginate to calcium chloride powder used to formulate nanoparticles. 
All other processing parameters held constant and based on parent methodology: mass ratio alginate: 
oil (50:1), stirring time (90 min), syringe size (pipette/burette tip), homogenization time (5 min), and 
equilibration time (24 h).   
 
 
4.2.2.1.1 Effects of Added Calcium Chloride  
Sinjan and Robinson (2003) suggested that calcium chloride is essential for 
nanoparticle formation because it provides alginate beads with a nucleus for nanoparticle 
growth.  High concentrations of calcium chloride may not be essential for particle 
formation, but calcium chloride addition is necessary for pregel formation below 
AG:CaCl2 mass ratios of 5:1. This statement is consistent with findings in this study as 
AG:CaCl2 was necessary at 4.8:1 ratio to form smallest particles. There was no 
significant difference in lower mass ratios tested suggesting that this mass ratio is 
sufficient for nanoparticle production.  However, results by Douglas and Tabrizian 
(2005) show that the absence of calcium chloride only produced marginally larger 
particles in comparison with the standard AG:CaCl2 mass ratio of 4.5:1. Different 
analysis methods as well as different guluronic acid contents of alginate could be the 
reason for this difference. Low guluronic acid (G) content alginate is crucial to create a 
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nanoparticle nucleus without causing gelation. Higher G content will see a higher ionic 
interactions in same alginate chain form beads and result in larger particles. The effect of 
calcium chloride on polymeric nanoparticle formation should be further evaluated to 
determine if calcium chloride addition is necessary above the AG:CaCl2 ratio used in 
this study with different G content alginates.  
4.2.2.1.2 Effects of Chitosan Addition  
 Rajaonarivony and others (1993) found that formation of AG nanoparticles is 
influenced by the first compound added. If calcium chloride was not added first, the 
protonated amino groups of chitosan would have high affinity for the mannuronic 
residues of AG causing random interactions leading to large particle formation. Sinjan 
and Robinson (2003) confirmed that the size of chitosan-alginate nanoparticles were 
larger than alginate (i.e. no chitosan addition) and also suggested that particle size 
increases as CS and AG attach to the surface of TC. Furthermore, any increase in 
particle size post CS addition may indicate that a large CS concentration is localized on 
surface of the alginate polymer due to electrostatic interaction which may help stabilize 
the nanoparticle core. Respective concentrations of AG and calcium chloride allow 
pregel formation and small nanoparticles to form which are further strengthened by 
chitosan complexation.  
In the pH range of this study, positively charged CS competes with calcium 
chloride to electrostatically interact with AG.  The shielding effect of the CS counter ion 
can disturb the polymeric framework formed by AG and calcium chloride which will 
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reduce the monodisperity of LCA-NP and could significantly increase particle size (i.e. 
bimodal size distribution) (Ruo 2012).   
4.2.2.1.3 Bimodal Size Distributions  
Rajaonarivony and others (1993) explained the pregel phenomenon as a 
reduction of polymer size due to individual AG chains shrinking into a more compact 
coiled structure where the guluronic (G) regions in the same AG chain are linked by 
calcium ions. Ruo (2012) showed that nanoparticles form at a distinct polymer to cross 
linking ratio (4.8:1) which affects whether particle size follows a unimodal or bimodal 
distribution. This was observed in this study‘s preliminary methodology as several size 
distribution curves where bimodal, thus increasing average particle sizes (Appendix 2). 
Bimodal distributions in this study are likely due to processing difficulties at lab-scale 
(i.e. stirring rate and droplet rate inconsistencies) as well as the lag time before 
ultrafiltration and freeze drying where particles formation can be affected. Further work 
needs to be completed to understand bimodal size distribution occurrences.  
4.2.2.2 Trans-Cinnamaldehyde  
Table 4.5 shows the results of nanoparticles synthesized with modified mass 
ratios of alginate to trans-cinnamaldehyde (TC). The optimal mass ratio of AG:TC was 
37.5:1 due to small particle size (303.93 nm) and maximum EE (65.58%). No means 
were statistically significant (p < 0.05) for particle size, EE, or physical yield.  Particle 
size was 3% larger while EE was 7.6% greater than the next best AG:TC mass ratio 
(50:1). Both particle size and EE had a direct relationship with AG:TC mass ratio. The 
AG:TC mass ratio has a less predominant effect on particle size in comparison to pH but 
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just as significant of an effect on EE. Particle size and EE results were consistent with 
literature values. However, many studies do not divulge both the concentration of active 
drug incorporated and the stage of incorporation during synthesis.  Thwala (2012), 
Gupta (2011), Sinjan and Robinson (2003), and Li and others (2008) used AG:TC 
concentrations of 10:1, 15:1, 15:1, and 100:1 to produce 20-230 nm particles with 83-
92% EE of turmeric oil, chloramphenicol, methylene blue, and nifedipine, respectively. 
Manish and Kulkarni (2012) also used a polymer to drug 15:1 to achieve particle size of 
230 nm and entrapment 72-92% of azelastine hydrochloride.  Additional ratios (15:1 and 
10:1) were tested in this study, however, resulting solutions showed white opaqueness 
and were considered unstable formulations. 
 Rajaonarivony and others (1993) found that increasing the concentration of an 
active drug increases the drug loading capacity. However, limitations do exist as the size 
of the nanoparticles could increase due to the presence of the active drug having affinity 
for AG and its G residues. Both scenarios were directly observed in this study as EE and 
particle size both increased as incorporated TC in AG solution increased.  TC was added 
directly into AG solution in this study to avoid steric hindrance or a conformational 
arrangement that would lead to large particle formation through structure formation with 
calcium chloride (Das and others 2010). However, this could be a potential flaw in the 
methodology of this study, as it is difficult to completely solubilize and evenly disperse 
TC for entrapment in the pregel. Further work needs to be completed on the stage of TC 
addition in synthesis methodology. 
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Table 4.6. Particle size, encapsulation efficiency (EE), and physical yield percentage of 
nanoparticles assembled with modified mass ratios of alginate to trans-cinnamaldehyde 
(alginate to chitosan mass ratio 1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
(Mass Ratio AG:TC)1 Particle Size*[nm] EE%* %Yield* 
75:1 279.66a(34.71) 57.98a(9.28) 65.37a(7.67) 
50:1 294.78a(26.3) 60.62a(4.34) 78.86a(2.93) 
37.5:1 303.93a(7.79) 65.58a(1.14) 70.47a(3.90) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05).Values in parenthesis are the standard deviation. 
1Represents the mass ratio (w:w) of alginate to trans-cinnamaldehyde powder used to formulate 
nanoparticles. All other processing parameters held constant and based on parent methodology: mass 
ratio alginate: calcium chloride (4.8:1), stirring time (90 min), syringe size (pipette/burette tip), 
homogenization time (5 min), and equilibration time (24 h).   
 
 
4.2.2.3 Syringe Size, Stirring, Homogenization, and Equilibration Time 
Table 4.7 (a) to Table 4.7 (d) show the results of nanoparticles synthesized with 
modified processing parameters. It can be concluded that the optimal syringe size is 18 
gauge. Particle size was 27.7% smaller while EE was 6.9% larger in comparison to the 
burette/pipette tip. Means for particle size and PDI were statistically significant (p < 
0.05) between the two tip sizes (Table 4.6 (a)). Means for entrapment efficiency were 
not significantly different regardless of tip size. This suggests droplet size has a larger 
effect on size in contrast to EE. In addition, smaller droplets at a constant rate means that 
less physical material (i.e. calcium chloride or chitosan) is available for complexation 
resulting in particles being formed with only the physical material that is present (i.e. 
limit excess material).  
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Table 4.7 (a). Particle size, entrapment efficiency (EE), polydisperity index (PDI), and 
physical yield percentage of nanoparticles assembled with different droplet/syringe sizes 
(alginate to chitosan mass ratio 1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
Syringe Size [Gauge]1 Particle Size* [nm] EE%* %Yield* PDI 
Burette/Pipette Tip (ID 
=1.50/0.6 mm)** 
294.78a(26.30) 60.62a(5.34) 78.86a(3.93) 0.66a(0.04) 
18 G (ID = 0.83 mm) 213.01
b(4.47) 65.18a(1.48) 81.92a(3.46) 0.61b(0.03) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis.  
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05). Values in parenthesis are the standard deviation.  
1All other processing parameters held constant and based on parent methodology: mass ratio alginate: 
calcium chloride (4.8:1), mass ratio alginate: oil (50:1), stirring time (90 min), homogenization time 
(5 min), and equilibration time (24 h).   
** ‗ID‘ refers to internal diameter of syringe needle and pipette.  
 
 
The optimal total stirring time was 90 min. Particle size was 23.3% smaller while 
EE was comparably larger than the next best stirring time (180 min) (Table 4.7 (b)). 
Means for particle size were statistically significant (p < 0.05) when stirring time was 
increased or decreased. Means for entrapment efficiency were not significantly different 
regardless of stirring time increase or decrease. This result likely indicates that 
equilibrium of polyelectrolyte complexation was achieved during this time. Shorter 
times possibly lead to fewer larger assembled particles while longer stirring times likely 
lead to aggregation of assembled particles.  Additionally, no substantial change in EE is 
probably due to chitosan addition only affecting particle size. TC is entrapped in the 
ionotropic gelation step through the addition of calcium chloride. Chitosan addition only 
adds to the external structure to the nanoparticle which consequently increases size 
(Thwala 2012; Mumper and others 1994; Mohanraj and Chen 2006). Gupta (2011) 
results were similar to this study as 90 minutes stirring time was optimal to obtain 
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particles of 236 nm and 90.9% EE for entrapment of chloramphenicol. Manish and 
Kulkarni (2012) observed different results as stirring time was optimal at 15 min for size 
(245 nm) and 30 minutes for EE (91%) of azelastine hydrochloride; significantly less 
stirring time in comparison to this study.   
 
 
Table 4.7 (b). Particle size, entrapment efficiency (EE), and physical yield percentage of 
nanoparticles assembled with modified stirring times (alginate to chitosan mass ratio 
1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
Total Stirring Time [min]1 Particle Size* [nm] EE%
* %Yield* 
45 401.53
a(45.30) 58.58a(7.37) 65.077a(11.56) 
90 294.78
b(26.30) 60.62a(4.34) 78.86a(2.93) 
180 384.41
a(23.46) 60.16a(6.13) 63.66a(7.50) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05). Values in parenthesis are the standard deviation. 
1All other processing parameters held constant and based on parent methodology: mass ratio alginate: 
calcium chloride (4.8:1), mass ratio alginate: oil (50:1), syringe size (pipette/burette tip), 
homogenization time (5 min), and equilibration time (24 h). 
 
 
The optimal total homogenization time was 15 min. Particle size was 10.8% 
smaller while EE was comparable to homogenization time of 5 min (Table 4.7 (c)). 
Means for particle size, EE, and PDI were not statistically significant (p > 0.05) 
regardless of homogenization time. Similar to stirring time, this suggests 
homogenization only affects the physical characteristic of the nanoparticles. TC loading 
is not effected by mechanical shearing likely due to the fact that homogenization takes 
place after nanoparticle formation is complete (i.e. all TC is already entrapped).  Longer 
homogenization times were also tested (e.g. 30 and 45 min), but nanoparticle destruction 
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resulted. This was likely due to an overload of mechanical shearing and heat from the 
homogenizer shaft which lead to tearing and stretching of assembled nanoparticles 
reducing storage life in suspension (Ahmed and others 2012). 
 
 
Table 4.7 (c). Particle size, entrapment efficiency (EE), polydisperity index (PDI), and 
physical yield percentage of nanoparticles assembled with modified homogenization 
times (alginate to chitosan mass ratio 1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
Total Homogenization Time 
[min]1 
Particle Size* [nm] EE%* %Yield* PDI 
5 294.78
a(26.30) 60.62a(4.34) 78.86a(2.93) 0.66a(0.04) 
15 263.23
a(7.07) 60.48a(2.68) 67.08b(2.91) 0.67a(0.08) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis.  
Values with differing subscripts letters within columns indicate significantly different values (p < 
0.05).  
1Values in parenthesis are the standard deviation. All other processing parameters held constant and based 
on parent methodology: mass ratio alginate: calcium chloride (4.8:1), mass ratio alginate: oil (50:1), 
stirring time (90 min), syringe size (pipette/burette tip), and equilibration time (24 h).   
 
 
Optimal equilibration time prior to ultrafiltration was 24 h. Particle size was 
5.9% smaller while EE was 4.9% larger than next best equilibration time (48 h) (Table 
4.7 (d)). Means for particle size were statistically significant (p < 0.05) for equilibration 
times greater than 24 h. Means for entrapment efficiency were not significantly different 
(p > 0.05) regardless of equilibration time. This likely indicates equilibrium of 
polyelectrolyte complexation was achieved after 12 h post CS addition. Shorter 
equilibration times result in fewer large particles or nanoparticles that have not 
completely assembled in solution.  Equilibration times (e.g. filtration after 12 h) result in 
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a higher concentration of CS complexing with the calcium-alginate pregel forming 
smaller compact particles.  
 
 
Table 4.7 (d). Particle size, entrapment efficiency, and physical yield percentage of 
nanoparticles assembled with varying equilibration times (alginate to chitosan mass ratio 
1.5:1; pH alginate = 4.6, pH chitosan = 4.9). 
 
Equilibration Time [h]1 Particle Size*[nm] EE%* %Yield* 
12 406.12
a(20.15) 48.03a(9.40) 60.08a(11.98) 
24 294.78
b(26.30) 60.62a(4.34) 78.86a(2.93) 
48 310.56
b(30.33) 57.62a(8.74) 61.41a(10.01) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis.  
Values with differing subscripts letters within columns indicate significantly different values (P < 
0.05). 
 1Values in parenthesis are the standard deviation. All other processing parameters held constant and based 
on parent methodology: mass ratio alginate: calcium chloride (4.8:1), mass ratio alginate: oil 
(50:1), stirring time (90 min), syringe size (pipette/burette tip), and homogenization time (5 min). 
 
 
4.2.3 Final Methodology Results  
Preparation of trans-cinnamaldehyde loaded chitosan-alginate nanoparticles was 
successfully carried out through the ionotropic gelation polyelectrolyte complexation 
method. The dispersion of TC in aqueous alginate with Tween 20 surfactant and calcium 
chloride cross linking agent created hydrogel nanoparticles. Particles were then 
solidified with calcium chloride as a cross linking agent followed by chitosan for 
structural support. This occurs as electrostatic interactions between carboxylate groups 
on alginate and positively charged calcium ions and protonated amine groups on 
chitosan. Toxic acetonitrile solvent was removed from nanoparticle solution via 
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evaporation at reduced pressure. The final solution was lyophilized for long term storage 
and ease of handling.  Final design constraints of methodology are briefly displayed in 
Table 4.8.  All values were based on optimal modified mass ratios from preliminary 
study (AG:CS 1.5:1; AG:CaCl2 4.8:1; AG:TC 37.5:1). 
Particle size and EE were optimized with 18 gauge syringe needle, stirring times 
of 90 minutes, 15 minutes of high RPM homogenization, and equilibration time of 24 
hours (Table 4.4). The final nanoparticle system formulated with these optimal 
processing parameters showed increased shelf life (9 weeks at 3°C) and translucency 
(TL) in solution.  Average particle size was 43.6% smaller while 17.2% more trans-
cinnamaldehyde was entrapped in comparison with the suboptimal AG:CS 1.5:1 mass 
ratio (Table 4.9). Means for particle size, PDI, and EE of optimal to suboptimal 
treatment groups were statistically significant (p < 0.05) while overall physical yield of 
nanoparticle post lyophilization was not significantly different.  In conclusion, particle 
size was more drastically affected by processing parameters in comparison to EE within 
processing parameter treatment groups. Specifically, mass ratio of AG to CS, droplet 
size, and equilibration time had the greatest effect on particle size. However, 
nanoparticles formulated with all optimized processing parameters had a great effect on 
EE.  This can be explained as a synergistic effect. No independent processing parameter 
had statistical significance on EE but there was statistical significance in combination   
(p < 0.05).   
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Table 4.8. Final design constraints for optimal nanoparticle synthesis (alginate to chitosan mass ratio 1.5:1; pH alginate = 4.6, 
pH chitosan = 4.9). 
 
AG* 
(.06% w/v) [ml] 
CaCl2  
(.2% w/v) [ml] 
TC [μg] 
CS 
(.05% w/v) [ml] 
AG [g] CaCl2 [g] CS [g] AG:TC AG:CaCl2 AG:CS 
250 15.625 4000 200 0.15 0.031 0.1 37.5 4.8 1.5 
*All processing parameters based on final optimized processing: mass ratio alginate: calcium chloride (4.8:1), mass ratio alginate: 
oil (37.5:1),  stirring time (90 min), syringe size (18 Gauge), homogenization time (15 min), and equilibration time (24 h). 
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Table 4.9. Effect of optimization of nanoparticles on particle size, entrapment efficiency 
(EE), polydisperity index (PDI), and percent yield (alginate to chitosan mass ratio 1.5:1; 
pH alginate = 4.6, pH chitosan = 4.9). 
 
Sample Type Particle Size* [nm] EE%
* %Yield* PDI 
Suboptimal Particles1 294.78a(26.30) 60.61a(4.34) 78.86a(2.93) 0.66a,(0.04) 
Optimized Particles2 166.26b(5.86) 73.24b(3.55) 75.77a(3.70) 0.57b(0.03) 
*Values given are averages of three replicate samples; standard deviations are displayed in parenthesis. 
Values with differing subscripts (within columns) indicate significantly different values (P < 0.05). 
Values in parenthesis are the standard deviation. 
1Suboptimal refers to particles produced with initial parent methodology: mass ratio alginate: calcium 
chloride (4.8:1), mass ratio alginate: oil (50:1), stirring time (90 min), syringe size (burette/pipette 
tip), homogenization time (5 min), equilibration time (24 h).   
2Optimal refers to particles produced with final modified methodology. All optimized processing 
parameters from preliminary study are incorporated into final methodology: mass ratio alginate: 
calcium chloride (4.8:1), mass ratio alginate: oil (37.5:1), stirring time (90 min), syringe size (18 
Gauge), homogenization time (15 min), and equilibration time (24 h).   
 
 
4.3 Characterization Results 
It is critical to analyze nanosystems and nanotechnologies in order to properly 
characterize these systems as nanoscale, homogenous, bioactive, or stable and 
understand structural and functional relationships. Characterization can yield substantial 
data for further research and design applications into food products because it will help 
determine nanoparticles efficacy, interactions and mechanisms involved, types of 
interactions that are occurring, unforeseen impacts, and undesired interactions. 
Ultimately, this will allow for new product research and design as well as data 
submission to federal authorities such as the Food and Drug Administration and the 
Environmental Protection Agency which could expedite the process of legally using 
nanoparticles as food additives. 
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The ionotropic pre gelation method produced chitosan-alginate nanoparticles 
with optimal particle size and entrapment of trans-cinnamaldehyde.  Particle size and 
entrapment efficiency were successfully optimized through the manipulation of 
processing parameters and fundamental design constraints. Further characterization can 
be carried forward using the optimal nanoparticle formulations (Table 4.8). Particle size 
was established through the use of transmission electron microscopy.  Microscopy also 
presented surface characteristic and morphology. Controlled release tests offered results 
on nanoparticle stability, burst mechanics, storage stability, and breakdown. Differential 
scanning calorimetry (DSC) confirmed TC in LCA-NP inclusion complexes as well as 
an attempt to clarify other thermal characteristics.  Antioxidant and antimicrobial testing 
were rapid, mild testing techniques that signified potential use of LCA-NP in future food 
applications.   
4.3.1 Cumulative Controlled Release 
The temperature used for controlled release (35°C) in this study was chosen as an 
ideal case for microbial growth and worst case scenario for food safety (Hill and others 
2013b). Release of TC from chitosan-alginate (CS-AG) inclusion complexes involved 
the following process: (1) diffusion of water into nanoparticles; (2) swelling and 
loosening of compact nanoparticle structure; (3) desorption and escape of TC entrapped 
at nanoparticle surface; and (4) diffusion of internalized TC through surface pores of the 
polysaccharide matrix (Zohri and others 2011).  
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Cumulative release percentage was calculated using the equation below (Das and 
others 2010; Xing and others 2010): 
 
                   ( )   
            
        
      (4.1) 
 
Figure 4.5 shows the cumulative controlled release results of TC from LCA-NP 
in vitro as a function of time. From this curve, it can be concluded that the release rate 
and total amount of TC release decreased after 10 h (32.5%).  This is likely attributed to 
TC that is located in or near the external surface of nanoparticles desorping into PBS 
solution (i.e. possibly by weak interactive forces between CS and AG at the surface of 
particles) (Li and others 2008; Mohanraj and Chen 2006; Liu 2014; Wise 2000). Initial 
burst release may also be attributed to the charge of the polymer matrix. If the surface 
remains charged and hydrophilic, the polymer network (i.e. ―egg box structure‖) will 
show a greater tendency for adsorption of PBS to the nanoparticle network displacing 
TC. Additionally, size, surface charge, pH, and hydrophobicity also play large roles in 
release of TC from polymeric nanoparticles (Zohri and others 2011).  
Following initial burst release, another stage of controlled release was observed 
from 10 to 72 h with final release of 62.31%. Nanoparticles had to dissociate from the 
swollen state to allow internalized TC to escape. However, the rate of TC escape 
continued to decrease which is likely due to the formation of hydrogen bonds along the 
chitosan polymer chains as well as additional physical barriers from polymeric matrix. 
Hydrogen bonds may need to be broken before internalized TC can be released from 
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nanoparticles (Zohri and others 2011; Xing and others 2010; Li and others 2008). 
Overall, burst release was followed by more uniform release after 10 h. Thus, release 
rate decreases after initial burst release because internalized TC has to travel further 
distance and takes longer time to diffuse (Gomes and others 2011). Through 
extrapolation of the controlled release graph it would take approximately 115 hours to 
release all TC based on EE (73.24%).  This value signifies the slow prolonged release of 
TC over time and may be attributed to the previously described mechanisms. 
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Figure 4.5. Cumulative release of trans-cinnamaldehyde in phosphate buffer saline at pH 
7.4 and the bioexponential model at 35°C. 
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TC release from LCA-NP in this study best followed a bioexponential model (R2 
=  .981) or power law model (R2 = .975) (Table 4.10; Equation 4.1 and Equation 4.2) 
when compared to the following zero order (R2 = .830), first order (R2 = .906), and 
Higuchi models (R2 = .791) based on the coefficient of determination (R2) (Equation 4.3 
to Equation 4.5)(Shicheng and Clive 2005): 
 
Bioexponential:    
  
   (     (     )       (    )) 
(4.2) 
   
Power Law:    
  
     
(4.3) 
   
Zero Order:             (4.4) 
   
First Order:        
     (4.5) 
   
Higuchi:    
  
    
   
(4.6) 
   
where  ‗Mt‘ is the amount of TC released at time ‗t‘, ‗Mo‘ is the initial TC content, ‗n‘ is 
the diffusional exponent and  ‗k‘ (ko, k1, k2, kH) represent the rate constant (h
-1) of the 
respective equation.  
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From the results, it can be concluded that the LCA-NP likely follows fickian 
diffusion. The bioexponential model is just a modified empirical equation that is the 
generalized form of the Fickian model (Equation 4.7 and Equation 4.8) employing only 
the first two terms (Gomes and others 2011). The fact that release follows the 
bioexponential model suggest that TC release consists of a rapid (burst phase) and slow 
function (sustained release) as previously discussed. Gomes and others (2011) and Hill 
and others (2013b) obtained similar results for the release of eugenol, cinnamaldehyde, 
and cinnamon bark extract from PLGA that followed the bioexponential model (i.e. two-
term exponential model). 
The value of the diffusion release coefficient was determined from the linear 
regression of log(Mt/Mo) versus log(t) where Mt/Mo represents the fraction of TC 
released at time ‗t‘ (amount of TC released at time ‗t‘/total amount of TC in dosage 
form).  This value (n = .303; Table 4.10) indicated that release was due to Fickian 
diffusion (Equation 4.6 and Equation 4.7) (Li and others 2008; Takka and others 1998; 
Siepmann and Peppas 2001; Nagarwal and others 2012; Shicheng and Clive 2005).  
 
  
  
    
 
  
∑
 
  
 
   
    (      ) (4.7) 
 
where dimensionless time, τ, is given by: 
 
   
  
  
 
(4.8) 
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‗D‘ is the diffusion coefficient of TC in the nanoparticles and ‗r‘ is the radius of 
nanoparticles. This model provides a steep initial release rate in comparison to one term 
exponential models (Shicheng and Clive 2005). 
Release curves for different mass ratios of AG:CS (5:1, 2:1) were completed but are 
not shown in this study due there being no statistical significance (p < 0.05) between 
treatment groups for cumulative release after 10 h. Similar to this study, Das and others 
(2010) determined release of curcumin from CS-AG nanoparticles to follow the Higuchi 
model (i.e. modified power law; n = .5).  
Results in this study are consistent with other recent studies. Thwala (2012) 
found tagetes oil to release in PBS (pH 7.4) in a controlled manner from CS-AG NP 
following initial burst effect (30%; 12 h). Zohri and others (2010) also revealed a burst 
release effect of Nisin from CS-AG NP (30%, 7h). Das and others (2010), Gupta and 
others (2011), and Nagarwal and others (2012) showed similar controlled release curves 
of CS-AG NP with high cumulative release of curcumin (75%), chloramphenicol (90%), 
and 5-fluorouracil (81%) respectively. The higher cumulative release found by the 
aforementioned studies could be a result of higher alginate concentrations used which 
would increase the degree of cross linking the alginate core.  
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Table 4.10. Mathematical representation of trans-cinnamaldehyde release kinetics. 
Zero Order* First Order* Higuchi* Power Law Bioexponential Model* 
                    
     
  
  
    
   
  
  
     
  
  
   (     (     )       (    )) 
ko = .736 μg/h
 k1 = .012 h
-1 kH = 8.53 h
-1 k = 17.6 h-1 
(A = 25.6 ; B = 31.7)*** ; 
    = 1.390 h
-1 ; k2 = .040 h
-1 
(R2  = .830)** R2 = .906 
R2 = .791 
n = .5 
R2 = .975 
n = .303 
R2 = .981 
*‗k‘ represents rate constant; ko = rate constant for zero order; k1 = rate constant for first order; kh = rate constant for Higuchi model;    ,k2 = rate 
constants for bioexponential model 
**‘R2‘ represents the coefficient of determination indicated how well experimental data fit statistical model 
*** ‗A‘ and ‗B‘ represent coefficients of bioexponential model  
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4.3.2 Differential Scanning Calorimetry (DSC) 
DSC was the thermo-analytic technique used to obtain thermal profiles, observe 
fusion and crystallization events, and confirm the entrapment of TC in CS-AG inclusion 
complexes. The thermal curves of TC, LCA-NP, and ULCA-NP are presented in Figure 
4.6. Table 4.11 displays the endothermic and exothermic peaks for the respective curves.  
Isolated AG displayed the highest endothermic peak temperature followed by ULCA-
NP, LCA-NP, and isolated CS.  The highest exothermic temperature was seen for CS 
followed by ULCA-NP, LCA-NP, and isolated alginate. Similar results were observed 
by Sarmento and others (2006) for CS-AG NP with entrapped insulin. Low temperature 
endothermic peaks (70-80°C) were likely due to the water loss associated with 
hydrophilic groups while exothermic peaks (>300°C) were a result of degradation of 
polyelectrolytes through dehydration, decomposition, and depolymerization (e.g. 
decarboxylation of carboxylic groups and deteriorative oxidative reactions) (Hill and 
others 2013a; Sarmento and others 2006; Hedges Allan and others 1995; Teixeira and 
others 2013). 
ULCA-NP show a broader endotherm in comparison to CS and AG, but display 
more narrow endothermic and exothermic regions in comparison to LCA-NP. The 
higher exothermic peak of ULCA-NP may represent slightly weaker electrostatic 
interactions. Lower temperature endothermic peaks of ULCA-NP probably represent 
weaker AG to calcium chloride linkages (Ruo 2012). The broadness of the LCA-NP 
endotherm can be explained by the complexation/coalescence (i.e. new chemical bonds) 
of CS to AG and can be observed through the endothermic peak at 69.67°C and the 
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exothermic peak at 278.5°C (Cegnar and Kerc 2010). The narrow endothermic and 
exothermic regions of ULCA-NP in comparison to LCA-NP are likely due to the lack of 
structural integrity of the nanoparticles. LCA-NP are dense and stable in comparison to 
hollow labile ULCA-NP (Figure 4.6).  
 
 
 
 
Figure 4.6. Thermograms associated with alginate, chitosan, trans-cinnamaldehyde, 
loaded nanoparticles (LCA-NP), and control nanoparticles (not loaded; ULCA-NP). 
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Table 4.11. Peak temperatures associated with DSC thermograms for alginate, chitosan, 
trans-cinnamaldehyde, loaded nanoparticles (LCA-NP), and control nanoparticles 
(ULCA-NP). 
 
 
 
 
 
 
 
 
 
The slight exothermic peak of LCA-NP at 252.3°C in comparison to the large 
exothermic peak of 278°C of ULCA-NP was possibly due to the complexation of 
polyelectrolytes CS and AG and the corresponding interaction between TC and the 
polymer mixture (Zohri and others 2010). Profile changes and peak shifts are usually a 
result of drug and polymer interaction (Cegnar and Kerc 2010).  Results from this study 
compare well to a studies completed by Sarmento and others (2006), Thwala (2012), 
Zohri and others (2011) and Cegnar and Kerc (2010) where loaded CS-AG NP were 
successfully synthesized through ionic gelation.  Thermograms obtained for alginate, 
chitosan, LCA-NP, and ULCA-NP were all comparable to the aforementioned studies 
(Figure 4.6).  
TC showed a sharp endothermic peak at 247°C corresponding to its boiling point 
and potential hydrolysis and oxidation (Teixeira and others 2013; Hill and others 2013a). 
Sample 
Temperature [°C] 
Peak 
Alginate (pH 4.9) 
73.6 
248.2 
Chitosan (pH 4.6) 
71.6 
296.4 
Trans-Cinnamaldehyde 247.1 
ULCA-NP  
69.67 
278.5  
LCA-NP 
79.1 
252.3 
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Thus, its inclusion into LCA-NP was confirmed using DSC indirectly by comparing 
thermal stability (i.e. broad heat flow stress response) of free TC with the encapsulated 
TC in LCA-NP. Disappearance of the endothermic peak at 247°C indicted molecular 
encapsulation of TC in CS-AG inclusion complex (TC was protected within the cavity of 
LCA-NP) (Zhang and others 2008). This finding is consistent with Hill and others 
(2013a) who observed the same results with TC and eugenol entrapment in beta-
cyclodextrin inclusion complexes. Similar results have also been reported in studies by 
Gomes and others (2011), Kamimura and others (2014), and Thwala (2012) with 
entrapped volatile oils.  
An additional DSC study was completed on different mass ratio of AG:CS 
(AG:CS mass ratio of 5:1 and 2:1 are suboptimal formulations) (Figure 4.7). It appeared 
that increasing the concentration of CS increased the thermal stability of loaded 
nanoparticle formulations likely due to increased ionic interactions (i.e. AG:CS mass 
ratio approaches stoichiometric proportion). Sarmento and others (2006) determined that 
increasing CS concentration had a direct relationship with increasing the value of 
exothermic peaks. This was not observed in this study as there is no clear indication of 
this relationship. However, it can be concluded that changing the mass ratio of AG:CS 
resulted in different interaction between polymers with more stable complexes forming 
at higher CS concentrations.  Optimizing process parameters also played a role in the 
thermal characterization. AG:CS 1.5:1 was the only mass ratio with optimized 
processing parameters and was the only ratio to display thermal stability (i.e. broad 
exothermic and endothermic peaks). Thus, this could suggest thermal stability where a 
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high number of polymeric complexes and ionic bonds create small compact particles 
increasing the stability of the formulation.  It is also a possibility that more energy was 
required to remove higher concentrations of residual water absorbed to nanoparticles in 
high AG:CS mass ratios while less energy was released during breaking of ionic 
interactions from low AG:CS mass ratios (Ruo 2012; Zhang and others 2008). Moving 
forward, DSC will be useful for determining impacts of heating properties of 
nanostructure, tolerances of processing, temperature abuse, and temperature triggered 
controlled release system importance. 
 
 
 
Figure 4.7. Effects of different mass ratios of at alginate to chitosan on thermal stability 
of trans-cinnamaldehyde loaded particles (LCA-NP) 
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4.3.3 Transmission Electron Microscopy (TEM)  
Transmission electron microscopy analysis confirmed the presence and size as 
well as morphological information regarding shape and surface characteristics of 
nanoparticles. Morphology showed that LCA-NP most resembled a spherical shell and 
core type arrangement (i.e. spherical, distinct, and regular) (Figures 4.8 (a) - (e)).  LCA-
NP appeared to be smooth and surrounded by a 10-50 nm thick wall while ULCA-NP 
(control) were not of distinct spherical shape. Rather, they seemed to have less physical 
integrity and appear almost hollow. The change in morphology from UCA-NP to LCA-
NP suggests the existence of amorphous products with the presence of a single 
compound in the complex (TC entrapment) (Hill and others 2013a; Teixeira and others 
2013; Kamimura and others 2014; Zhang and others 2008). Thwala (2012) found the 
opposite to occur where inclusion complexes with tagete oil showed rough appearances 
while control particles showed a smooth appearance. Similar morphological 
characteristics and particle size were obtained in studies by Silva and others (2011) and 
Li and others (2008) where paraquat and nifedipine were successfully loaded into CS-
AG NP (20-50 nm).  
TEM images confirmed the size of LCA-NP. In fact, sizes of nanoparticles 
measured by TEM were smaller than the sizes attained from particle size analysis. Sizes 
seemed to be in two general regions; 10-50 nm and 100 nm. This occurrence was 
observed in particle size analysis as a bimodal size distribution for several sample 
formulation (Appendix 2). Silva and others (2011) explains this phenomena as a result of 
the dehydration of nanoparticles during TEM sample preparation. Additionally, dynamic 
 148 
 
light scattering measures the hydrodynamic radius of the NP which includes the layers 
that form around hydrophilic particles which often leads to overestimation of particle 
size.  
Similarly to beta-cyclodextrins complexes studied by Hill and others (2013a), 
there is evidence of agglomeration where large particles are attracting smaller particles. 
This could explain the difficulty in obtaining monodisperity during particle size analysis. 
There is a strong tendency to from clusters. However, this could be due to TEM‘s 
sample preparation method of charging particles on the grid in order to set and adhere 
the sample to ultimately separate into smaller particles on TEM images (Hill and others 
2013a). This could explain the difficulty in obtaining monodisperity during particle size 
analysis. There also appears to be slight amounts of free polymer in the medium which 
could potentially coagulate CS and AG (Zohri and others 2011). 
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Figure 4.8 (a). Control: chitosan-alginate nanoparticles with no incorporated trans-
cinnamaldehyde (71,000 Magnification). 
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Figure 4.8 (b). Control: chitosan-alginate nanoparticles with no incorporated trans-
cinnamaldehyde (71,000 Magnification). 
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Figure 4.8 (c). Inclusion Complex: chitosan-alginate nanoparticles with incorporated 
trans-cinnamaldehyde (71,000 Magnification). 
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Figure 4.8 (d). Inclusion Complex: chitosan-alginate nanoparticles with incorporated 
trans-cinnamaldehyde (140,000 Magnification). 
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Figure 4.8 (e). Inclusion Complex: chitosan-alginate nanoparticles with incorporated  
trans-cinnamaldehyde (11,000 Magnification). 
 
 
4.3.4 Antioxidant Capacity in Apple Juice 
The method used to survey antioxidant capacity of LCA-NP was the 2,2-
diphenyl-1-picrylhydrazyl radical scavenging test (i.e. DPPH test). The principle of this 
method was based on the reduction of DPPH in the presence of a hydrogen donating TC 
due to the formation of diphenylpicryl-hydrozine. LCA-NP reduced the color of DPPH 
due to its proton radical scavenging ability. Discoloration of violet DPPH to a yellow 
coloration clearly demonstrated the effect of nanoparticles as antioxidants. The 
scavenging effect (SE) applies to the antioxidant capacity of the sample.  
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DPPH scavenging potential of LCA-NP in apple juice is depicted in Figure 4.9. It 
can be concluded that: (1) scavenging ability was LCA-NP concentration dependent; (2) 
ULCA-NP (control) showed marginal SE; (3) inclusion complex maintained TC 
antioxidant activity. The final SE in apple juice was 62%. The EC50 value (i.e. the 
concentration of antioxidant required to reduce DPPH to 50% of its original 
concentration) was used to compare scavenging potential of LC-NP in this study to 
antioxidants in other studies. The EC50 value of LCA-NP in this study was 1 mg/ml. The 
following studies obtained comparable results: (1) Woranuch and Yoksan (2013) found 
54% SE of eugenol loaded CS NP; (2) Teixeira and others (2013) found the SE of black 
pepper oleoresin loaded beta-cyclodextrins to be 68%; (3) Nallamuthu and others (2013) 
determined SE of thymoquinone loaded PLGA NP to be 71% at 1 mg/ml (EC50 = .4 
mg/ml); (4) Zhang and others (2008) found SE of quercetin loaded CS NP to be 80% at 
2 mg/ml (EC50 = 1.5 mg/ml). 
LCA-NP had a higher scavenging activity in apple juice (EC50 = 1 mg/ml) in 
comparison to LCA-NP resuspended in 0.2 μm filtered water (control; EC50 = 1.75 
mg/ml) at all polymer concentrations tested (data not shown). However, some of this 
effect may be attributed to the initial 9.4% increase of DPPH scavenging in apple juice 
compared to the control. Chien and others (2007) also observed this result as chitosan 
solubilized in apple juice (EC50 = 0.18 mg/ml) had a higher DPPH radical activity than 
in aqueous solution (EC50 = 1 mg/ml) due to apple juice‘s strong hydrogen donating 
capacity (Figure 4.9). 
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Figure 4.9. Scavenging effect of trans-cinnamaldehyde loaded nanoparticles and 
unloaded nanoparticles (control) at different concentrations in apple juice at 25°C. 
 
 
ULCA-NP (control) showed limited scavenging capacities resuspended in both 
aqueous solution and apple juice. Scavenging effect of LCA-NP and ULCA-NP were 
statistically significant (p < 0.05). Similar results were obtained in a study by Zhang and 
others (2008) where quercetin was entrapped with CS; control particles showed limited 
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scavenging capacities while quercetin loaded nanoparticles showed increasing 
scavenging effects as concentration increased (EC50 = 1.5 mg/ml) (Figure 4.9).  
   The nanoparticle inclusion complex helped maintain TC antioxidant 
activity. As the concentration of LCA-NP increased so did the amount of TC, thus 
increasing concentration of antioxidant. Free TC did not show a significantly higher 
EC50 (7.7 μg/ml; Appendix 3) value in comparison to loaded TC (p < 0.05) based on 
entrapment efficiency tests (EC50 = 10.38 μg/ml) indicating TC was just as available to 
react in free form as it was in inclusion complexes. This is likely due to a large fraction 
of TC escaping LCA-NP in the 30 min DPPH scavenging window at the acidic pH range 
of apple juice. Additionally, other studies have found essential oils to release faster at pH 
1.5 in comparison to pH 7.4 meaning that LCA-NP are pH sensitive and these particles 
could have rapid release in acidic environments such as apple juice (Li and others 2008; 
and Thwala 2012). Xu and others (2014) and Teixeira and others (2013) observed the 
same effect with curcumin loaded carrageenan nanoparticles and black pepper oleoresin 
loaded beta-cyclodextrins, respectively. Results confirm that TC encapsulated in LCA-
NP is available for complexing DPPH and could be beneficial antioxidant delivery 
systems by increasing shelf life and quality of aqueous food systems such as acidic 
beverages. 
4.3.5 Minimum Inhibitory and Bactericidal Concentration 
Minimum inhibitory and bactericidal concentrations (MIC, MBC) of TC, LCA-
NP, and ULCA-NP against Escherichia coli O157:H7 and Listeria monocytogenes are 
shown in Table 4.12 and Table 4.13, respectively. MIC values for free TC were 500 
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μg/ml for both E. coli O157:H7 and L. monocytogenes. MIC values for LCA-NP were 
7,031.25 μg/ml for E. coli O157:H7 and 14,062.5 μg/ml for L. monocytogenes. 
Bactericidal effects were not observed for the majority of concentrations tested and 
MBCs (>3.0 log10 CFU/ml reduction of the pathogen) were not consistent across plate 
replicates (high variability). All antimicrobial compounds tested are believed to have 
bactericidal abilities, but at higher concentrations than those used in this study (> 28,125 
μg/ml) (Hill and others 2013a). Results of the positive controls indicated complete 
absence of inhibition by both bacteria species (data not shown). 
 
 
Table 4.12 Minimum inhibitory and bactericidal concentration against Escherichia coli 
O157:H7 for selected antimicrobial compounds. 
 
Antimicrobial Compound MICa [μg/ml] MBCa [μg/ml] 
Trans-Cinnamaldehyde 500 1000 
ULCA-NP >14062.5  >28125 
LCA-NP 7031.25 (730)c >28125 (2920)c 
a Values are the lowest concentration of unencapsulated or chitosan-alginate encapsulated essential oil 
for which a ≤0.05 OD630 change was observed after 24 h incubation at 35°C in tryptic soy broth.  
b Values preceded by a higher than sign (>) means that tested concentrations were not sufficient to 
determine the MIC or MBC values. 
c Values are the representative concentrations of free trans-cinnamaldehyde at the respective LCA-NP 
concentration. 
1LCA-NP represents chitosan alginate nanoparticles loaded with trans-cinnamaldehyde while ULCA-
NP represents nanoparticles with no incorporated trans-cinnamaldehyde (control). 
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Table 4.13. Minimum inhibitory and bactericidal concentration against Listeria 
monocytogenes for selected antimicrobial compounds. 
 
Antimicrobial Compound MICa [μg/ml] MBCa [μg/ml] 
Trans-Cinnamaldehyde 500 2000 
ULCA-NP1 >14062.5 >28125 
LCA-NP1 14062.5 (1460)c >28125 (2920)c 
a Values are the lowest concentration of unencapsulated or chitosan-alginate encapsulated essential oil 
for which a ≤0.05 OD630 change was observed after 24 h incubation at 35°C in tryptic soy broth.  
b Values preceded by a higher than sign (>) means that tested concentrations were not sufficient to 
determine the MIC or MBC values. 
c Values are the representative concentrations of free trans-cinnamaldehyde at the respective LCA-NP 
concentration. 
1LCA-NP represents chitosan alginate nanoparticles loaded with trans-cinnamaldehyde while ULCA-
NP represents nanoparticles with no incorporated trans-cinnamaldehyde (control). 
 
 
All antimicrobial compounds showed different degrees of inhibition against E. 
coli O157:H7 and L. monocytogenes.  The growth of both microorganisms was inhibited 
by TC as well as LCA-NP; being this concentration the minimum inhibitory 
concentration in the broth resulting in lack of visible microorganism growth changes. At 
the MIC, a delay in the lag phase, a slower growth rate, and thus a lower final cell 
concentration of microorganism were observed (Burt 2004; Kalemba and Kunicka 
2003). The concentration of TC in LCA-NP would correspond to a MIC of 
approximately 730 and 1,460 μg/ml of antimicrobial compound (TC) for inhibition of E. 
coli O157:H7 and L. monocytogenes, respectively considering loading and maximum 
entrapment efficiency (73.24%). This value suggests if all theoretically entrapped oil 
was removed, both microorganisms would be inhibited (TC concentration > 500 μg/ml). 
However, it is likely that not all entrapped TC escapes nanoparticles in the 24 h 
incubation period.  The broth used for particle dissolution in this study had a pH of 
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approximately 7.4. Other studies have found essential oils to release from hydrophilic 
systems slower at pH 7.4 in comparison to acidic pH ranges meaning that LCA-NP  may 
not have released sufficient trans-cinnamaldehyde for antimicrobial effects to be 
observed (Li and others 2008; and Thwala 2012).  
Similar results to this study were obtained by Gomes and others (2011) with a 
combination of TC and eugenol loaded in PLGA with MIC at 10,000 and 20,000 μg/ml 
(corresponds to 800 and 1,600 μg/ml entrapped essential oil) for Salmonella spp. and 
Listeria spp., respectively. Additional studies that support this study include: (1) Hill and 
others (2013a) observed lower TC MIC (400 and 500 μg/ml) and MBC (1,000 and 2,000 
μg/ml) for representative Gram-negative and Gram-positive microorganisms; (2) Pozzo 
and others (2012) found MIC of free TC against Staphylococcus spp. to be 800-1600 
μg/ml and MBC to range from 800-6,400 μg/ml; (3) Huaiqiong and others (2013) found 
free TC MIC of 200 μg/ml and MBC of 900-1,400 μg/ml for L. monocytogenes. 
MIC/MBC results indicate that L. monocytogenes was more tolerant to the 
inhibition by TC inclusion complex in comparison to E. coli O157:H7. It is generally 
accepted that Gram-positive microorganisms are more predisposed to inhibition of 
essential oils versus Gram-negative microorganisms due to the absence of a 
lipopolysaccharide outer membrane that screens entry of hydrophobic compounds into 
microbial cells (Kim and others 1995; Kalemba and Kunicka 2003; Hill and others 
2013b; Burt 2004). L. monocytogenes, however, is a common exception to the statement 
that Gram-positive organisms are generally susceptible to inhibition by essential oils. In 
fact, L. monocytogenes has shown high tolerances to inhibition by essential oils as 
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confirmed by previous studies (Gomes and others 2011; Kalemba and Kunicka 2003; 
Kim and others 1995).   
LCA-NP did not seem to enhance the antibacterial effect of TC (p > 0.05). In 
fact, results suggest that nanoparticles marginally decreased the inhibitory effect of TC 
because more respective TC was needed for inhibition of both microorganisms tested 
(Table 4.12 and Table 4.13). This is likely attributed to preparation methods and trans-
cinnamaldehyde release mechanisms. Lyophilized nanoparticles had to be resuspended 
and added into test wells rapidly as not to cause burst release before addition of 
inoculum. This may have affected the TC release in the 24 h incubation period in broth 
(i.e. only adsorbed TC released corresponding to maximum release of 876 μg/ml [30%]). 
Again, essential oil release from hydrophilic systems has been shown to be slower at pH 
7.4 in comparison to acidic values where rapid breakdown of particles and release of 
active drug takes place (Li and others 2008; and Thwala 2012). Increasing the initial 
incubation period to 48 or 72 h could help clarify results by allowing particles to break 
down further (i.e. sustained release function) and release additional internalized TC from 
loaded NP (Hill and others 2013b). Factors affecting release rate are solubilization and 
dissolution rate in broth medium because the release medium penetrates into particles 
and dissolves entrapped active molecules. This affects both the controlled release study 
and antimicrobial assays. Comparable results were obtained in the following studies: 
Hill and others (2013b) obtained a MIC value of 549.23 μg/ml for cinnamon bark loaded 
PLGA NP where PLGA loaded particles showed a lower MIC; Zohri and others (2010) 
found MIC of Nisin loaded CS-AG NP was 500 μg/ml after 72 h for Staphylococcus 
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aureus and was much lower than free Nisin (2000 μg/ml); (3) Sadeghi and others (2008) 
found MIC and MBC of CS NP was 2000 μg/ml against Staphylococcus aureus with 
entrapped insulin. Differences between results in this study and others reported by 
authors could be due to the composition of essential oils or MIC/MBC techniques 
employed. Also, cinnamon essential oil composition can be varied depending on where 
it was extracted (Pozzo and others 2012).  
Different oils have different inhibition/bactericidal mechanisms (Kalemba and 
Kunicka 2003). In terms of essential oils, thymol and carvacrol have higher anti-listerial 
activity compared to eugenol and TC which was observed in this study (Huaiqiong and 
others 2013). TC is more polar than eugenol, thymol, and carvacrol (highest water 
solubility at 1.76 g/L at 20°C) and thus may be less effective in disrupting cytoplasmic 
membrane.  
The lipophilic character of the hydrocarbon skeleton has been reported as a main 
reason for essential oil antimicrobial action (Kong and others 2010). Results suggest that 
TC and LCA-NP inhibition mechanisms (MIC) against E. coli O157:H7 and L. 
monocytogenes are comparable.  The antimicrobial mechanisms responsible for 
inhibition by free TC were less available to interact with microorganisms due to its 
inclusion in CS-AG inclusion complex.  
 Shan and others (2007) described the antimicrobial mechanism of TC as follows: 
(1) binding to cell surface to penetrate target sites (e.g. phospholipid bilayer of 
cytoplasmic membrane, membrane bound enzymes); (2) inhibition of proton motive 
force, respiratory chain, electron flow, active transfer, and substrate oxidation; (3) 
 162 
 
coagulation of cell contents. Additionally, uncoupling of phosphorylation, loss of 
metabolites, and disruption of DNA, RNA, lipid, protein, and polysaccharide synthesis 
take place. The hydrophilic components of TC (e.g. aldehyde group) interact with polar 
parts (e.g. outer membrane proteins) of the bacterial cell membrane while hydrophobic 
components react with lipids on the membrane and result in increased membrane 
permeability, disturbing enzyme systems and genetic material (Kong and others 2010; 
Ruengvisesh and others 2014). Subsequent damage to cell wall and cytoplasmic 
membrane disrupt the permeability barrier causing expansion and destabilization of the 
membrane thus increasing membrane fluidity, increasing ability of TC to pass through 
and manifest itself as leakage of various vital intracellular constituents such as ions, 
ATP, nucleic acid and amino acids. Finally, cell death results when there is extensive 
loss of cell contents, the exit of critical molecules and ions, or the initiation of the 
autolytic process (Kong and others 2010; Kalemba and Kunicka 2003). In addition, 
modes of antibacterial action are dependent on the type of microorganism and its 
respective cell wall structure and outer membrane arrangement.  
The hydrophobic nature of TC creates challenges to deliver oil for microbial 
inhibition. However, encapsulation of TC could effectively distribute oil throughout 
media and to microbial cells while also protecting it from adverse interactions to 
maintain the potential for antimicrobial influence (Hill and others 2013a; Ruengvisesh 
and others 2014). If TC is indeed delivered to microbial cells, the hydrophobic nature of 
TC allows high affinity to cell membrane allowing for easy partition into cell membrane. 
Without this encapsulation, Hill and others (2013a) explain that TC may never come into 
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contact with microorganisms and may instead coalesce to limit hydrophilic and 
hydrophobic interactions or lose potency over time in solution (Burt 2004; Kong and 
others 2010). Overall, these results indicated that LCA-NP could be useful antimicrobial 
delivery systems with the ability to inhibit a broad spectrum of microorganisms. Further 
improved methodology and synthesis techniques could elucidate that these nanosystems 
are stable and effective preservatives for increasing shelf life of fresh or ready to eat 
foods. Additional testing should be carried out at increased incubation times (e.g. 48 and 
72 h) and with a combination of loaded essential oils (e.g. cinnamaldehyde and thymol) 
(Pei and others 2009; Gomes and others 2011). 
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5. CONCLUSION 
5.1 Conclusions 
This study explored combinations of alginate (AG) and chitosan (CS) for use as 
entrapment matrices for the essential oil trans-cinnamaldehyde (TC) which is poorly 
soluble in aqueous media. The following conclusions were drawn based on the specific 
objectives of the study:  
Preliminary Nanoparticles Synthesis and Formulation Study: 
i. The ionotropic gelation polyelectrolyte complexation method (IG-PEC) 
successfully prepared nanoparticles (NP) with entrapped hydrophobic active 
compound at the highest payload potential at the smallest size.  
ii. The best working AG to CS mass ratio was determined to be 1.5:1 at a pH 
dispersion of 4.7.  Particle size and entrapment efficiency were further optimized 
at this mass ratio using an AG:CaCl2 mass ratio of 4.8:1, AG:TC mass ratio 
37.5:1, 18 gauge syringe needle, stirring times of 90 minutes, 15 minutes of 
homogenization, and equilibration time of 24 hours. Both particles size and EE 
of optimized LCA-NP was 166.26 nm and 73.24%, respectively. 
iii.  Results confirmed that AG:CS mass ratio, pH, and syringe size had the largest 
effect on particle size and EE.  
iv. The final nanoparticle system with modified and optimized processing reduced 
size by 43.6% and increased entrapment efficiency by 17.2%. Optimized 
nanoparticles showed increased shelf life (6 weeks) and translucency in solution.   
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v. These results may ultimately prove that smaller particles are a result of functional 
groups being available in stoichiometric proportion. 
Nanoparticle Characterization Study: 
vi. Release tests showed TC release from LCA-NP best followed the bioexponential 
model.  
vii. The total amount of TC released decreased after 10 h (32.5%). Following initial 
burst release, another stage of controlled release was observed from 10 to 72 h 
with final release of 62.31%.  
viii. DSC confirmed TC inclusion into LCA-NP by indirectly comparing thermal 
stability of free TC with the encapsulated TC in LCA-NP. TC‘s sharp 
endothermic peak at 247°C corresponding to its boiling point disappeared in 
LCA-NP thermograms indicating molecular encapsulation of TC in inclusion 
complex. AG:CS 1.5:1 was the only mass ratio with optimized processing 
parameters and it was the only ratio to display thermal stability (i.e. broad heat 
flow stress response). Thus, this could suggest thermal stability where a high 
number of polymeric complexes and ionic bonds create small compact particles 
increasing the stability of the formulation. 
ix. TEM confirmed presence and size of nanoparticles.  
x. Nanoparticles most resembled a spherical shell and core type arrangement (i.e. 
spherical, distinct, and regular) and were in the size region of 10-100 nm. LCA-
NP appeared to be smooth and surrounded by a 10-50 nm thick wall while 
control NP were not of distinct spherical shape. The change in morphology from 
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UCA-NP to LCA-NP suggests the existence of amorphous products with the 
presence of a single compound in the complex.  
Antioxidant and Antimicrobial Nanoparticle Study: 
x. DPPH scavenging ability was LCA-NP concentration dependent and inclusion 
complex maintained TC antioxidant activity while control NP showed only a 
marginal DPPH scavenging effect.  
xi. The final scavenging effect of LCA-NP in apple juice was 62% (EC50 = 1 mg/ml) 
of DPPH radicals.  
xii. LCA-NP had a higher scavenging activity in apple juice in comparison to LCA-
NP resuspended in 0.2 μm filtered water (EC50 = 1.75 mg/ml) at all polymer 
concentrations tested.  
xiii. Free TC did not show a significantly different EC50 (7.7 μg/ml) value in 
comparison to loaded TC based on entrapment efficiency tests (EC50 = 10.3 
μg/ml) indicating TC was just as available to react in free form as it was in 
inclusion complexes.  
xiv. Results confirm that TC encapsulated in LCA-NP is available for complexing 
DPPH and could be beneficial antioxidant delivery systems by increasing shelf 
life and quality of aqueous food systems such as acidic beverages. 
xv. MIC values for free TC were 500 μg/ml for both E. coli O157:H7 and L. 
monocytogenes. MIC values for LCA-NP as a function of free TC were 730 
μg/ml for E. coli O157:H7 and 1,460 μg/ml for L. monocytogenes considering 
loading and maximum entrapment efficiency (73.24%).   
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xvi. Bactericidal effects were not observed for the majority of concentrations tested 
and MBCs (> 2,920 μg/ml).  
xvii. Results indicate that L. monocytogenes was more tolerant to the inhibition by TC 
inclusion complex in comparison to E. coli O157:H7. LCA-NP did not seem to 
enhance the antibacterial effect of TC.  
xviii. Overall, these results suggest that LCA-NP could be useful antimicrobial 
delivery systems with the ability to inhibit a broad spectrum of microorganisms. 
General Conclusions 
xix. Optimizing processing parameters of the IG-PEC method will continue to 
increase the significance of characterizing polymeric nanoparticles with 
entrapped oil 
xx. Optimized particle preparation and formulation will assist in future utility of 
post-processing and food applications such as the stabilization of lipophilic 
flavoring agents, shelf life stability, antioxidant and antibacterial potential, and 
the reduction of unpleasant odors and flavors.  
xxi. Small size of LCA-NP are desirable because they are not visible to the human 
eye and cannot be detected in the mouth so they will not adversely affect texture 
or appearance of food products where antimicrobials are applied.  
xxii. The use of CS-AG NP as carriers for essential oils and other antimicrobial 
compounds shows potential and could improve efficacy of drug loading and 
delivery due to the ability to entrap hydrophobic compounds, controlled and 
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sustained release, and small size (easy diffusion and movement into cytoplasm of 
microorganisms) 
xxiii. Encapsulation of lipophilic compounds such as trans-cinnamaldehyde into 
aqueous-soluble nanoparticle systems will provide further solutions to several 
problems in the food industry by both improving solubility and providing a 
controlled way to deliver and release drug payload with full potential. 
xxiv. The analysis of LCA-NP allowed proper characterization of these systems as 
nanoscale, bioactive, or stable and helped clarify structural and functional 
relationships between carrier molecule and active entrapped compound. 
xxv. Antioxidant and antimicrobial testing yielded substantial data for further research 
and design applications into food products (e.g. acidic beverages). LCA-NP 
holds forth tremendous promise to provide benefits not just within food products 
but also surface contact materials (i.e. packaging). 
xxvi. Recent technological advances in nanomaterials in parallel with the food 
industries ambition to discover new and alternative solutions has created a new 
sector in the food industry where nanotechnology has emerged as a new solution 
for improving quality and safety in foods. This research only attempts to 
substantiate these efforts to control and structure foods with greater functionality 
and value. 
5.2 Future Considerations  
Moving forward, trans-cinnamaldehyde loaded chitosan-alginate nanoparticle 
synthesis and characterization could be further improved by:  
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Methodology: 
i. Testing different types of CS and AG (e.g. molecular weight, polymer 
concentration, deacetylation of chitosan, lower guluronic acid content of 
alginate) in initial formulation.  
ii. Filtering using simple techniques such as ultracentrifugation as an alternative to 
tangential flow filtration. Tangential flow filtration is an expensive process and 
large polymers can congest filtration membranes slowing down filtration and 
increasing equilibration time. Ultracentrifugation could speed up nanoparticles 
preparation process and reduce cost.  
iii. Using smaller syringe size, reduced droplet rate, and increased temperature of 
solution (>25°C) during calcium chloride, trans-cinnamaldehyde, and chitosan 
addition to attempt to increase pre-gel viscosity, increase ionic interactions, and 
speed up solubilization of polymers and oil. 
iv. Changing stage of TC incorporation (e.g. add TC to CaCl2 solution) to determine 
effects on size and entrapment.  
v. Layering fully developed nanoparticles with an additional layer of trans-
cinnamaldehyde and chitosan to alter burst release mechanics.  
Thermal and Physical Characterization:  
vi. Completing controlled release and antioxidant testing at a range of  temperatures 
and pH values to determine TC release characteristics and better model release 
behavior. 
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vii. Utilizing the Ritger and Peppas (1987) or Gomes and others (2011) equations for 
modeling release of TC from LCA-NP. 
viii. TEM and particle size analysis being performed with non-lyophilized samples. 
Antioxidant and Antimicrobial Assays:  
ix. Addition of LCA-NP directly to food commodity (e.g. fresh produce). 
x. Testing range of temperatures in the DPPH antioxidant study to help determine if 
release behavior has a larger effect than observed in this study.  
xi. Using a combination of loaded essential oils (e.g. cinnamaldehyde and thymol) 
(Pei and others 2009; Gomes and others 2011).  
xii. MIC/MBC testing carried out at increased incubation times (e.g. 48 and 72 h). 
xiii. Acidifying the broths used for incubation of microorganisms in order to change 
the release behavior of TC from NP.  
xiv. Completing a controlled release test in parallel with MIC/MBC assay to 
determine if release behavior in antimicrobial test is similar to the PBS buffer for 
the NP batch tested (i.e. same amount of trans-cinnamaldehyde release).  
xv. Testing controlled release tests in TSB to confirm TC release is similar to PBS. 
xvi. Clarifying the mechanisms of antimicrobial activity of LCA-NP (e.g. confocal 
microscopy). 
xvii. Determining L. monocytogenes stress tolerance and why tolerance increased in 
the presence of TC.  
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xviii. Further improved methodology and synthesis techniques could elucidate that 
these nanosystems are stable and effective preservatives and antioxidants for 
increasing shelf life of fresh or ready to eat foods.  
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Figure 1-A. Standard calibration curve of trans-cinnamaldehyde for determination of 
encapsulation efficiency in acetonitrile. TC (0.93-4.65 μg/ml) was dissolved in 
acetonitrile and measured spectrophotometrically at 280 nm in triplicate to obtain 
absorbance (Genesys 10S UV-Vis, Thermo Scientific, Madison, WI). Regression 
followed equation y = 4.294x (R2 = .975). Samples were further diluted with acetonitrile 
for proper spectrophotometric readings when necessary. 
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APPENDIX 2 
 
 
 
Figure 2-A. Size distribution curve for solubilized chitosan (.05% w/v). Measurements 
were obtained for chitosan by dynamic light scattering (DLS) in a Malvern Nanoseries 
ZetaSizer (Nano–ZS90, 633 nm He-Ne 200; scattering angle of 90°; refractive index of 
1.590; 25 °C; 100 iterations was performed in triplicate). 2 ml of .05% (w/v) solubilized 
chitosan was transferred to cuvette (1 cm path length; disposable polystyrene cuvette) 
for analysis. 
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Figure 2-B. Size distribution curve for alginate (.06% w/v). Measurements were 
obtained for chitosan by dynamic light scattering (DLS) in a Malvern Nanoseries 
ZetaSizer (Nano–ZS90, 633 nm He-Ne 200; scattering angle of 90°; refractive index of 
1.590; 25 °C; 100 iterations was performed in triplicate). 2 ml of .06% (w/v) solubilized 
alginate was transferred to cuvette (1 cm path length; disposable polystyrene cuvette) for 
analysis. 
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Figure 2-C. Example of bimodal size distribution curve for optimized control 
nanoparticles. Measurements were obtained for unloaded (control) chitosan-alginate 
nanoparticles (ULCA-NP) by dynamic light scattering (DLS) in a Malvern Nanoseries 
ZetaSizer (Nano–ZS90, 633 nm He-Ne 200; scattering angle of 90°; refractive index of 
1.590; 25 °C; 100 iterations was performed in triplicate). 200 μg of resuspended 
lyophilized ULCA-NP in 2 ml of 0.2 µm transferred to cuvette (1 cm path length; 
disposable polystyrene cuvette) for analysis. 
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Figure 2-D. Size distribution curve for optimized control nanoparticles. Measurements 
were obtained for unloaded (control) chitosan-alginate nanoparticles (ULCA-NP) by 
dynamic light scattering (DLS) in a Malvern Nanoseries ZetaSizer (Nano–ZS90, 633 nm 
He-Ne 200; scattering angle of 90°; refractive index of 1.590; 25 °C; 100 iterations was 
performed in triplicate). 200 μg of resuspended lyophilized ULCA-NP in 2 ml of 0.2 µm 
transferred to cuvette (1 cm path length; disposable polystyrene cuvette) for analysis. 
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Figure 2-E. Size distribution curve for optimized trans-cinnamaldehyde loaded 
nanoparticles. Measurements were obtained for loaded chitosan-alginate nanoparticles 
(LCA-NP) by dynamic light scattering (DLS) in a Malvern Nanoseries ZetaSizer (Nano–
ZS90, 633 nm He-Ne 200; scattering angle of 90°; refractive index of 1.590; 25 °C; 100 
iterations was performed in triplicate). 200 μg of resuspended lyophilized LCA-NP in 2 
ml of 0.2 µm transferred to cuvette (1 cm path length; disposable polystyrene cuvette) 
for analysis. 
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Figure 2-F. Size distribution curve for trans-cinnamaldehyde loaded nanoparticles 
showing bimodal distribution. Measurements were obtained for loaded chitosan-alginate 
nanoparticles (LCA-NP) by dynamic light scattering (DLS) in a Malvern Nanoseries 
ZetaSizer (Nano–ZS90, 633 nm He-Ne 200; scattering angle of 90°; refractive index of 
1.590; 25 °C; 100 iterations was performed in triplicate). 200 μg of resuspended 
lyophilized LCA-NP in 2 ml of 0.2 µm transferred to cuvette (1 cm path length; 
disposable polystyrene cuvette) for analysis. 
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Figure 3-A. Scavenging effect of free trans-cinnamaldehyde versus entrapped trans-
cinnamaldehyde (theoretical values based on maximum encapsulation efficiency). 1 ml 
of 100 μM DPPH solution in methanol was added to working concentrations of free TC 
(0-20 μg/ml). Samples were agitated and incubated (35°C) for 30 minutes and resulting 
absorbance was read at 517 nm against a blank (Genesys 10S UV-Vis, Thermo 
Scientific, Madison, WI). 
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APPENDIX 4 
 
 
Figure 4-A: TEM images of control nanoparticles at 71,000 magnification. Surface 
morphology of particles was visualized using a FEI Morgagni Transmission Electron 
Microscope (FEI Company, Hillsboro, OR) at the School of Veterinary Medicine and 
Biomedical Sciences at Texas A&M University (College Station, TX) using a negative 
staining technique (300 mesh Cu/Ni grid filmed with carbon; 0.2% uranyl acetate). 
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Figure 4-B: TEM images of control nanoparticles at 11,000 (left) and 71,000 (right) 
times magnification. Surface morphology of particles was visualized using a FEI 
Morgagni Transmission Electron Microscope (FEI Company, Hillsboro, OR) at the 
School of Veterinary Medicine and Biomedical Sciences at Texas A&M University 
(College Station, TX) using a negative staining technique (300 mesh Cu/Ni grid filmed 
with carbon; 0.2% uranyl acetate). 
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Figure 4-C: TEM images of loaded nanoparticles at 140,000 (left) and 71,000 (right) 
times magnification. Surface morphology of particles was visualized using a FEI 
Morgagni Transmission Electron Microscope (FEI Company, Hillsboro, OR) at the 
School of Veterinary Medicine and Biomedical Sciences at Texas A&M University 
(College Station, TX) using a negative staining technique (300 mesh Cu/Ni grid filmed 
with carbon; 0.2% uranyl acetate). 
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Figure 4-C: TEM images of loaded nanoparticles at 36,000 times magnification. 
Surface morphology of particles was visualized using a FEI Morgagni Transmission 
Electron Microscope (FEI Company, Hillsboro, OR) at the School of Veterinary 
Medicine and Biomedical Sciences at Texas A&M University (College Station, TX) 
using a negative staining technique (300 mesh Cu/Ni grid filmed with carbon; 0.2% 
uranyl acetate). 
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APPENDIX 5 
 
 
 
Figure 5-A: Picture of lyophilized chitosan alginate nanoparticles. Frozen retentate was 
placed into a freeze dryer (Labconco Freeze Dry-5, Kansas City, MO) at -50°C under 5-
7 mtorr (9.67 x 10-5 psi) for 48 -72 h to sublimate all moisture from nanoparticles. 
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Figure 5-B: Picture of lyophilized chitosan alginate nanoparticles. Lyophilized samples 
were stored in an air tight container in a freezer (-20°C) (Frigidaire FRT21) until further 
use. 
 
